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INTRODUCTORY.
1.
The c l i n i c a l  i n v e s t i g a t i o n s  which form th e  b a s i s  o f  
t h i s  t h e s i s  were c a r r ie d  out i n  th e  C ity  o f  Glasgow 
C orporation  Fever H o sp ita l  a t  R u c h i l l ,  between May 1926 
and March 13$Q* A study was made f i r s t  o f  S c a r le t  Fever  
and secon d ly  o f  E r y s ip e la s  w ith  s p e o ia l  r e fe r e n c e  to  th e  
th e r a p e u t ic  v a lu e  o f  s p e o i f i o  serum.
P r e v io u s ly  i n  t h i s  h o s p i t a l ,  serum treatm en t has 
been co n fin ed  t o  c a s e s  o f  s e p t i c  S c a r le t  Fever which have 
been t r e a t e d  w ith  r e p e a te d  doses  o f  P o ly v a le n t  a n t i -  
s t r e p t o c o c c a l  serum. T h is  r o u t in e  measure has been  
found, however, t o  g iv e  very v a r y in g  r e s u l t s .  The method 
o f  a d m in is tr a t io n  c o n s i s t s  i n  th r ee  i n j e c t i o n s  g iv e n  per  
rectum, each  c o n ta in in g  30o c s .  o f  the  serum, th e  i n j e c t i o n s  
being  g iv e n  every  e ig h t  hours u n t i l  9O0 0 8 . has been 
a d m in is ter ed , t h i s  amount being  rep eated  on a l t e r n a t e  days.
The use o f  c o n v a le s c e n t  serum in tram u scu lar ly  has 
a ls o  been t r i e d  w ith  a degree o f  s u c c e s s ,  but i s  ra th er  
im p o ss ib le  on account o f  th e  la rg e  amount o f  serum which 
i s  n ecessa ry  fo r  a s u c c e s s f u l  dose .
In  connexion  w ith  E r y s ip e la s  th e  treatm ent w ith  
serum has been c o n f in e d  to  th e  use o f  P o ly v a le n t  A n t i-  
s t r e p t o c o c c a l  serum in  a d d it io n  to  th e  many v a r ie d  but 
w e l l  r e c o g n ise d  l i n e s  o f  t o p i c a l  th era p y .
SCARLET FEVER.
The serum therapy of S c a r le t  Fever d a te s  back at  
l e a s t  a quarter  o f  a cen tu ry  when Moser (1) w ith  
ap p arently  c o n s id e r a b le  su c c e s s  t r e a t e d  c a s e s  o f  S c a r le t  
Fever w ith  serum which was prepared by immunising h o rses  
w ith  s t r e p t o c o c c i ;  th e s e  organisms were d er iv ed  from th e  
t h r o a t s  o f  acute c a se s  o f  the d i s e a s e .  Other workers, 
however, f a i l e d  t o  observe  b e n e f i c i a l  r e s u l t s  w ith  serum 
ob ta in ed  in  t h i s  manner and t h i s  th e r a p e u t ic  method f e l l  
in to  d is r e p u te  and d i s u s e .  During th e  l a s t  decennium, 
however, a g rea t  d e a l  o f  i n v e s t i g a t i o n  has been c a r r ie d  
out on th e  s t r e p t o c o c c a l  group o f  organisms and i n t e r e s t  
has been r ev iv ed  in  c e r t a i n  d i s e a s e s  p a r t i c u la r ly  w ith  
regard t o  e t i o l o g y  and tr e a tm e n t .  t o  th e
work o f  T u n n i c l i f f  (2 ) and Zingher (3 ) and t h e  D icks (4)* 
th e  haem olytic  s t r e p t o c o c c i  appear to  be w e l l  d e f in e d  and 
t h i s  work has ten ded  to  change th e  s c i e n t i f i c  and 
m edica l v iew s on th e  c o n tr o l  and trea tm en t o f  S c a r le t  
F ever.
Dochez ( 5 ) ,  in  h is  r e c e n t  paper on t  :ie e t i o l o g y  o f
ft
S c a r le t  Fever makes out a very s tr o n g  case  fo r  th e  haemo- 
l y t i o  s t r e p to c o c c u s  as th e  c a u sa l  organism, a d m itt in g  
n e v e r t h e le s s  th a t  th e r e  are  s t i l l  many s c i e n t i s t s  who 
hold th e  o p in io n  th a t  t h i s  organism a lth ou g h  g e n e r a l ly  
p resen t in  t h i s  d i s e a s e  i s  not the main fa c to r  and i s  
probably /
3*
probably secondary to  a f i l t e r  p a ss in g  m icro-organism .
I t  i s  known th a t  c e r t a in  s p e c i f i c  s t r a in s  o f  
haem olytic  s t r e p t o c o c c i  and t h e i r  to x in s  produoe when 
in j e c t e d  in to  h o r se s  an a n t i t o x i c  serum which d i f f e r e n t
i n v e s t i g a t o r s  have used w ith  v a ry in g  r e s u l t s .
The most recen t advance i s  th e  p rod u ctio n  o f  serum
prepared from h o r se s  which have been su b je c te d  to
rep ea ted  in traven ou s  i n j e c t i o n s  o f  s t r e p t o c o c c i  and 
t h e i r  to jc in s , and in  a d d it io n ,  nave had the  mouth and 
fa u c es  swabbed w ith  v i r u le n t  c u l t u r e s  o f  th e  organism  
u n t i l  a very  h igh  s ta g e  o f  immunity has been reached.
T h is  serum i s  th u s  a S c a r le t  f e v e r  s tr e p to c o c c u s  a n t i ­
t o x in  and i s  c la im ed  to  be a n t i b a c t e r i a l .
C o n f l i c t in g  r e p o r ts  have s in c e  then  been p u b lish ed  
as t o  th e  b e n e f i c i a l  r e s u l t s  ob ta in ed  from th e  use o f  
t h i s  serum in  th e  treatm en t o f  S c a r le t  f e v e r .
The i n v e s t i g a t i o n s  o f  Blake ( 6 ) ,  Park C7)» Hobb ( 8 ) ,  
Gushing (9) and H arr ies  (10) are more or l e s s  in  agreement 
th a t  serum therap y  i s  j u s t i f i a b l e  and o f  b e n e f i t  when th e  
serum i s  ad m in istered  e a r ly .
Toomey (1 1 ) on th e  o ther  hand, a f t e r  an e x te n s iv e  
survey o f  th e  l i t e r a t u r e  o f  th e s e  i n v e s t i g a t o r s  and many 
o th e r s ,  does not th in k  th a t  th e  a n t i t o x in  treatm ent  
j u s t i f i e s  th e  expense  and r i s k  to  th e  p a t i e n t ,  and 
s u g g e s t s  th a t  im m unisation i s  p r e fe r a b le .
CLINICAL WORK DURING EPIDEMIC.
I t  i s  now th e  general o p in io n  in  th e  s o l e n t i f i o  
world t h a t  th e  ty p e  o f  S o a r le t  f e v e r  now p r e v a le n t  i s  
l e s s  se v er e  th a n  form erly ; n e v e r th e le s s ^ in  ep idem ios  
th e r e  are s t i l l  found many se v e r e  o a s e s ,  and a c a se  o f  
S o a r la t in a  Sim plex i s  s t i l l  l i a b l e  t o  d eve lop  com pli­
c a t io n s*
I t  was thought th a t  i f  th e  most r e o e n t ly  produoed 
s o a r l e t  fe v e r  a n t i t o x i n  was a c tu a l ly  a s p e c i f  io  serum i t  
would show t o  advantage in  th e  trea tm en t o f  th e  most 
se v er e  c a s e s  o f  S c a r la t in a *
An i n v e s t i g a t io n  a s  to  the va lu e  o f  t h i s  S o a r le t  
f e v e r  a n t i t o x in  was undertaken a t  the beg in n in g  o f  th e  
epidem ic  o f  S o a r le t  f e v e r  in  May 1926, and co n tin u ed
*
u n t i l  January 1927 .
During t h i s  ep id em ic , th e  g e n e r a l  run o f  c a s e s  were 
o f  th e  m ild  ty p e ,  but during th e  l a t t e r  h a l f  o f  th e  yeafc 
th e  standard o f  s e v e r i t y  r o s e ,  and many se v er e  o a se s  
were adm itted  t o  th e  wards. In  order t o  t e s t  thorou gh ly  
th e  e f f i o a c y  o f  th e  serum, on ly  s e l e c t e d  c a s e s  were 
t r e a t e d .  There were c a s e s  whioh shewed some or o ther  
m a n ife s ta t io n s  o f  c o n s id e r a b le  toxaem ia  and amounted t o  
110 o a s e s ;  e ig h t  o a s e s  o f  th e  s e p t i c  typ e  were t r e a t e d ,  
while- t h e r e  were two o a s e s  o f  m align ant S o a r le t  fever*  
T h u s /
Thus, in  an epidem io in  which th e  standard o f  type  
s e v e r i t y  rose  above the u s u a l ,  120 o a s e s  in  a l l  r e p re sen t­
ing th e  most a c u te ly  i l l  s o a r l e t  f e v e r  p a t i e n t s  adm itted  
t o  h o s p i t a l  during th e  epidemio were d e a l t  w ith  by serum 
th erap y .
h .
TYPE OF SERUM.
The serum  u se d  In  t h i s  i n v e s t i g a t i o n  was e o n o e n tr a te d  
S o a r l e t  F ev er S tre p to c o c c u s  a n t i t o x i n  s u p p l ie d  by
(1 ) M essrs  B u rro u g h s , W ellcome & Co*(B.W.& Co*)*** 10 o a s e s
(2)  M essrs P a rk e , D av is  & Co* (P.D.& C o . ) ...................... 110 o a se s
The p o tenoy  o f  b o th  ty p e s  o f  serum  i s  t e s t e d  a f t e r  p re p a r ­
a t i o n  and th e  serum  i s  p u t  up in  am poules c o n ta in in g  lO o o s. 
w hich  r e p r e s e n t s  one th e r a p e u t i c  d o se . T h is  dose  o f  
a n t i t o x i n  i s  c la im e d  t o  be a b le  t o  n e u t r a l i s e  500 ,000  s k in -  
t e s t  d o se s  o f  S c a r l e t  F e v e r  t o x i n .
The recommended d o se s  o f  b o th  ty p e s  o f  serum  i s  lO oos. 
f o r  m ild  o a se s  o f  S o a r le t  F e v e r and 20 t o  40qos. f o r  
s e v e re  o a s e s .
m m -
The m ethod o f  a d m in i s t r a t io n  o f  th e  serum  a d o p te d  a s  
a r o u t in e  was t h a t  o f  in tr a m u s o u la r  i n j e c t i o n  in to  th e  
l a t e r a l  a s p e c t  o f  t h e  t h i g h  and t h i s  was found  in  a l l  
o a se s  t o  be s a t i s f a c t o r y  i n  e v e ry  r e s p e c t .
The u s u a l  a s e p t i c  p r e c a u t io n s  were s t r i c t l y  a d h ered  
t o ,  and t h e r e  w ere no i l l  e f f e c t s  o b se rv e d  fo l lo w in g  
a d m in i s t r a t io n  o f  t h e  serum  o th e r  th a n  s l i g h t  s t i f f n e s s  
o f  th e  m u so les  ro u n d  th e  s i t e  o f  t h e  i n j e c t i o n .
I n  t h r e e  s e r io u s  c a s e s  w here im m ediate  r e a c t i o n  was 
r e q u i r e d ,  a t te m p ts  a t  in tr a v e n o u s  i n j e c t i o n s  were made, 
b u t /
7*
b u t had t o  be abandoned on acco u n t o f  th e  e x i s t i n g  low 
b lo o d -p re s s u re s *  As a  r u l e  one dose  o f  lO oos. o f
serum  p roved  e f f e c t i v e ,  b u t some o a s e s  r e q u i r e d  a  second
s i m i l a r  d o se ; th e  l a t t e r  c a se s  w ere p a r t i c u l a r l y  s e v e re  
in  ty p e .  The tim e  o f  a d m in i s t r a t io n  o f  t h e  serum  
v a r i e d  c o n s id e r a b ly .  Some p a t i e n t s  w ere g iv e n  serum  
on a d m iss io n  t o  h o s p i t a l  w h ile  some were k e p t u n d e r 
o b s e r v a t io n  f o r  24 h o u rs .  The m a jo r i ty  o f c a s e s  r e c e iv e d  
th e  serum on th e  second o r  t h i r d  day o f  i l l n e s s  b u t some
had been  i l l  f o r  a s  lo n g  a s  s i x  days*
CLINICAL MATERIAL.
An e x a m in a tio n  o f  th e  C l i n i c a l  B eoords o f  th e  c a s e s  
o f  S o a r l e t  f e v e r  a d m itte d  t o  B u o h i l l  f e v e r  H o s p i ta l  
d u r in g  th e  1926 ep id em ic  r e v e a le d  th e  f a c t  t h a t  th e  
d is e a s e  was p r e s e n t  in  d i f f e r e n t  forms*
The fo l lo w in g  ty p e s  o f  S c a r l a t i n a  w ere o b se rv ed  -
(1 ) S c a r l a t i n a  M a lig n a .
(2) S c a r l a t i n a  A ng inosa .
(3 ) S c a r l a t i n a  S im p lex .
The m a jo r i ty  o f  t h e  c a s e s  w ere S c a r l a t i n a  S im plex  
b u t o f  t h i s  g ro u p  many were o f  a  s e v e re  form , w h ile  a  
few c a s e s  o f  th e  Adynamic ty p e  w ere o b se rv e d .
The o a s e s  s e l e c te d  fo r  serum  th e r a p y  num bered 120 i n  
a l l  and w ere c l a s s i f i e d  a s  fo l lo w s  -
( i ) /
(1^ S c a r l a t i n a  M a lig n a , 2 o a s e s .
(2 ) S c a r l a t i n a  A ng inosa , 3 o a s e s .
(3 ) S c a r l a t i n a  S im p lex , ( s e v e r e )  103 o a s e s .
(4 )  S c a r l a t i n a  S im p lex , (adynam ic) 5 o ases*
The e a s e s  o f  S c a r l a t i n a  S im plex  ( s e v e r e )  a l l  shewed 
t o  a  g r e a t e r  o r  l e s s  d eg ree  some o r  o th e r  o f  th e  m ani­
f e s t a t i o n s  o f  an  a c u te  a t t a c k  o f  S o a r l e t  f e v e r  accom panied  
by toxaem ia*
T a b le s  I  t o  Y II have  been p re p a re d  shew ing th e  sex  
in c id e n c e ,  t h e  age in c id e n c e  and th e  t im e  in c id e n c e *
T hese  t a b l e s  i n d ic a t e  t h a t  th e  g roup  o f  120 o a s e s  o f  
S c a r l e t  f e v e r  in c lu d e d  b o th  s e x e s  and a l l  a g e s  be tw een  1 
and 63 y e a r s  o f  a g e , t h e  y o u n g e s t c h i l d  b e in g  14 m onths 
and th e  o ld e s t  p a t i e n t  64  y e a r s  o f  a g e .
T a b le s  I I I  t o  Y II i n d i c a t e  t h e  v a r i a t i o n  in  t h e  tim e
o f th e  a d m in i s t r a t io n  o f  th e  serum . The "Day o f  A dm ission” 
colum n i n d i c a t e s  t h e  l e n g th  o f  t im e ,  in  d a y s , t h a t  th e
in d iv id u a l  p a t i e n t  h a s  been  i l l  on th e  day o f  a d m iss io n  t o
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I s  t . [2n d .
 i_____
0 - 5 5 11 5 2 2
5 - 1 0 5 27 14 4 -
10 -  15 - 10 3 3 -
15 -  20 - 1 2 5 -
o v e r  20 1 8 7 4 1
11 57 31 18 3
3 r d . 4 t h .
o v e r 








TABLE I I I .
TIME INCIDENCE.
(Age P e r io d  0 - 5  y e a r s )
DAY OF DAY OF ADMINISTRATION
ADMISSION OF SERUM.
1 
mm ~ — -
2 3 4 4+
- 4 - 1 - 5
mm 5 6 - - 11
- - - 5 - 5
- - - - 2 2
mm a . 2 2
L „ . » J L - - - J ____ ______
9 6 6 4 25
NUMBER 
OF CASES.
1 s t  Day 
2nd Day
3 r d  Day 
4 th  Day 




(Age p e r io d  5 - 1 0  y e a r s )
DAY OF 
ADMISSION. ___________________
DAY OF ADMINISTRATION 
OF SERUM.
NUMBER
OF CASES L_________ __. . .---------- r r —-----------------
1 2 3 4 4+
h— - h - J
1 s t  Day 3 2 «*■ - 5
2nd Day - 12 13 - 2 27
3 rd  Day - - 10 3 1 . 14
4 th  Day - - - 3 1 4
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TABLE V.
TIME INCIDENCE.
(Age p e r io d  10 -  15 y e a r s )
» DAY OF 
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________________________________ _t ----------------------- —  -| 1 1
1 2 3 4 4+J h— H --------- -J
! 1 s t  Day -
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! 4 th  Day - - - 3 - 3
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i r ---- -i




(Age p e r io d  15 -  20 y e a r s )
DAY OF 
ADMISSION
DAY OF ADMINISTRATION 
OF SERUM.
NUMBER 1
OF c a s e s ;
1 2 3 4 4+
1 s t  Day |
2nd  Day - 1 - - - 1 ;
3 r d  Day - - 2 - - 2 !
4 th  Day - - - 3 - 3 |
Over 4 t h  Day • - - 2 - 2 ;
1 2 5 8 !
TABLE V II .
TIME INCIDENCE.
(Age p e r io d  o v e r  21 y e a r s )
DAY OF 
ADMISSION.
























































! l 5 ! 6 7 ! 2 ii 2 11 i
1 s t  Day 
2nd Day 
3 r d  Day 
4 th  Day 
o v er 4 th  Day
RESULTS.
The im m edia te  e f f e c t s  o f  t h e  serum  were f a i r l y  
c o n s ta n t ,  a s  o b se rv e d  in  t h e  o a s e s  u n d e r re v ie w . D e f in i t e  
e f f e c t s  w ere n o te d  in  c o n n ex io n  w ith  t h e  fo l lo w in g  p o in t s ,
(1 ) The c o u rs e  o f  th e  te m p e r a tu re .
(2 ) The c i r c u l a t o r y  sy s tem .
( 3) The T oxaem ia.
( 4 ) The S k in .
(5 ) The Mouth and T ongue.
O b s e rv a tio n s  w ere made on t h e  rem o te  e f f e c t s  w ith  
r e f e r e n c e  t o
(1 ) C o m p lic a tio n s .
(2 ) Serum R e a c t io n s .
(3 ) D u ra tio n  o f  d e te n t io n  in  h o s p i t a l .
( 4 ) R e la p s e s .
(5 ) Case M o r t a l i t y .
17-
IMMEDIATE EffffEQTS.
( I )  The C ourse o f  th e  T e m p e ra tu re *
The most c o n s ta n t  e f f e c t  o f  serum  when g iv e n  e a r ly  
i n  th e  c o u rs e  o f  th e  d is e a s e  was t o  p ro d u ce  a  c r i t i c a l  
f a l l  o f  te m p e ra tu re .  In  $Of<> o f  t h e  e a s e s  an  i n i t i a l  
r i s e  o f  te m p e ra tu re  was o b se rv e d  w i th in  8 h o u rs  o f  th e  
a d m in i s t r a t io n  o f  th e  serum , a f t e r  w hioh  th e  te m p e ra tu re  
d ropped  s t e a d i ly  d u r in g  th e  n e x t 24 o r  36 h o u r s .  T h is  
i n i t i a l  r i s e  o f  te m p e ra tu re  re s e m b le s  t h a t  w hich  may 
fo llo w  th e  i n j e c t i o n  o f  d i p h t h e r i a  a n t i t o x i n .  I n  v e ry  
s e v e re  o a se s  and in  o a s e s  w here t h e  serum  was n o t a d m in is­
t e r e d  u n t i l  a f t e r  th e  f o u r th  day o f  i l l n e s s ,  th e  te m p e ra ­
t u r e  te n d e d  t o  f a l l  more by l y s i s  th a n  by o r i s i s ,  and 
t h i s  f a l l  to o k  p la c e  o v e r 48 h o u r s .
( I I )  The C i r c u la to r y  S y stem .
The e f f e c t  o f  th e  a d m i n i s t r a t io n  o f  t h e  serum  on th e  
c i r c u l a t o r y  sy s tem  was o b se rv e d  t o  be a lm o s t a s  c o n s ta n t  
a s  on th e  te m p e ra tu re .  A m arked b e n e f i c i a l  e f f e c t  was 
p ro d u ced  on th e  c o n d i t io n  o f  th e  h e a r t ,  th e  p u ls e  r a t e  b e in g  
d im in ish e d  and th e  q u a l i t y  o f  t h e  p u ls e  g r e a t l y  im proved 
w ith  a  d e f i n i t e  r i s e  o f  b lo o d - p r e a s u r e .
( I I I )  The T oxaem ia.
One o f  t h e  m ost s t r i k i n g  e f f e c t s  o b se rv e d  was th e  
e x t r a o r d in a r y  change in  th e  to x aem lo  c o n d i t io n  o f  S o a r l e t  
T e v e r /
F e v e r p a t i e n t s  w i th in  12 t o  24 h o u rs  o f  a d m in i s t r a t io n  
o f  t h e  serum* The d is a p p e a ra n c e  o f  m a la is e ,  h e ad a ch e , 
d e l i r iu m , p a in s  in  m u sc le s  and j o i n t s ,  e t c . ,  c a u se d  an 
in te n s e  f e e l i n g  o f  r e l i e f  and w e l l - b e in g ;  m ost o f  th e  
p a t i e n t s ,  how ever i l l  th e y  had  b e en  to  b e g in  w i th ,  w ere 
w i th in  36 h o u r8 w a n tin g  t o  s i t  up and w ere dem anding a  
more l i b e r a l  d i e t .
(IY) The S k in .
The e f f e c t  o f  th e  serum  on th e  r a s h  was t o  l e s s e n  
i t s  i n t e n s i t y  and d u r a t io n  and su b se q u e n t d e sq u am a tio n  
was re n d e re d  l e s s  p r o f u s e .  The o a s e s  o f  S o a r l e t  F e v e r  
e x h ib i t in g  r a s h e s  o f  u n d e r 48 h o u rs  d u r a t io n  and w hich  
w ere t r e a t e d  w i th  serum  on a d m iss io n  were o b se rv ed  t o  
have a  v e ry  q u ic k  f a d in g  o f  t h e  e r u p t io n ;  th e  r a s h  in  
75^ o f  th e s e  c a s e s  d is a p p e a r in g  w i th in  12 h o u r s .  I t  was 
n o te d  p a r t i c u l a r l y  in  s i x  o a s e s  t h a t  t h e r e  was a  
minimum o f  d esq u am a tio n . In  th e  case  o f  o h i ld r e n  u n d e r 
t h i s  c a te g o r y ,  th e  su b se q u e n t d esq u am a tio n  was a lm o st 
Im peroep t i b l e .
\V )  The Tongue and T h r o a t .
The e f f e c t  on th e  f a u c i a l  a n g in a , th e  o e r v i c a l  
a d e n i t i s  and d is c h a rg e s  from  t h e  nose  and t h r o a t  was 
q u i te  a s  s t r i k i n g  in  p a t i e n t s  who were t r e a t e d  e a r ly  in  
th e  o o u rse  o f  th e  i l l n e s s .  Soon a f t e r  serum  t r e a tm e n t ,  
m arked /
19*
marked changes in  th e  mouth and th r o a t  to o k  p la c e .  The 
disappearance o f  dry l i p s ,  sord es  and dry to n gu e , was 
observed . The p a in fu l  th r o a t  d isappeared  rap id ly  and 
c a s e s  where th e r e  was marked f a u c ia l  c o n g e s t io n ,  p a la t a l  
angina, and oedema o f  th e  uvu la , showed a marked su b s i ­
dence w ith in  24 hours. An a t y p ic a l  p e e l in g  o f  t h e  
tongue was observed in  most o a se s  which were t r e a t e d  
e a r ly  by serum.
He mote h f f e c t  o f  Serum Therapy.
(1 ) The In c id en ce  o f  C o m p lic a t io n s .
The q u e s t io n  o f  th e  e f f e c t  o f  t h i s  serum on t h e
c o m p lic a t io n s  o f  S o a r le t  Fever was con sid ered  t o  be o f
prime im portance. I t  was noted  in  s e v e r a l  c a s e s  which
were com p lica ted  by rh in orrh oea , o torrh o ea , and c e r v ic a l
a d e n i t i s  on ad m iss ion  t o  h o s p i t a l  th a t  th e se  c o m p lic a t io n s
su b sid ed  in  a few days a f t e r  th e  a d m in is tr a t io n  o f  the
serum. C om p lica tion s  arose  a f t e r  serum trea tm en t but 
were e i t h e r  t r a n s i e n t  or o f  a m ild  form. Late
a d e n i t i s  was observed in  a few o a se s  but was always
t r a n s i e n t ;  th e r e  were no c a s e s  o f  su p p u rative  a d e n i t i s ;
o t i t i s  media com p lica ted  very few serum c a se s  and on ly
one c a se  which showed hypertrophy o f  t o n s i l s  and adenoids
t o  a marked d e g r ee ,  was d e ta in e d  in  h o s p i t a l  beyond s i x
weeks. There were no c a s e s  com p lica ted  by acute
m a s t o i d i t i s /
20.
m a s t o i d i t i s ;  r h in o r rh o e a  o c c u rre d  m ain ly  in  c h i l d r e n  h u t 
was found  more am enable  t o  t r e a tm e n t  t h a n  in  p a t i e n t s  
who had  n o t  r e c e iv e d  a n t i t o x i n ;  a r t h r i t i s  was o b se rv e d  
in  one case  b u t i t  was t r a n s i e n t  and p o s s ib ly  in  th e  
n a tu r e  o f  a  serum  a r t h r i t i s ;  and  n e p h r i t i s  o c c u rre d  o n ly  
in  one serum  c a s e ,  th e  p a t i e n t  g e t t i n g  out o f  bed on 
h i s  f o u r t h  day a g a in s t  r e g u l a t i o n s .  A lb u m in u ria  
im m ed ia te ly  fo l lo w in g  t h e  i n j e c t i o n  o f  th e  serum  was 
o b se rv ed  in  s e v e r a l  c a s e s  b u t  r a r e l y  l a s t e d  more th a n  
one o r two d ay s. E n d o c a r d i t i s  o c c u r re d  i n  tw o  c a se s ;  
one c a se  o f  s e p t i c  S c a r l e t  E ever t e r m in a t in g  f a t a l l y  b u t 
t h e  o th e r  p a t i e n t  made an  e x c e l l e n t  r e c o v e ry .
( I I )  Serum R e a c t io n s .
E v id en ce  o f  serum  d i s e a s e  was c o n f in e d  t o  th e  
a p p ea ra n c e  o f  a  se ru m  r a s h  w hich  o c c u r re d  in  s e v e r a l  o a s e s  
b u t was u r t i c a r i a l  and o f  a  t r a n s i e n t  n a tu r e ,  c a u s in g  no 
in c o n v e n ie n c e  and r e q u i r in g  no t r e a tm e n t .  The in c id e n c e  
in  th e  c a se s  t r e a t e d  was 14$
( I I I )  D u ra tio n  o f  D e te n t io n  in  H o s p i t a l .
D e te n t io n  i n  h o s p i t a l  beyond th e  u s u a l  q u a ra n t in e  
p e r io d  o f  s i x  weeks was c o n f in e d  on ly  t o  two c a s e s ,  and 
was on a c c o u n t o f s o r e s  on th e  u p p e r l i p  and in  th e  
n o s t r i l s  a lth o u g h  th e  n a s a l  d i s c h a rg e  had  ofeased.
The r o u t in e  p ro c e d u re  w ith  re g a rd  t o  t h e  d e te n t io n
o f /
o f  p a t i e n t s  in  bed (4  weeks) and in  h o s p i t a l  as co n v a l­
e s c e n t s  (2 weeks) was s t r i c t l y  adhered t o ,  a lthou gh  i t  
was found th a t  60% o f  th e  p a t i e n t s  t r e a t e d  w ith  a n t i t o x i n  
appeared s u f f i c i e n t l y  w e l l  in  a l l  r e s p e c t s  at the end 
o f  th ree  weeks t o  warrant d is m is sa l  from h o s p i t a l .
(IV ) R e la p s e s .
One serum t r e a t e d  c a s e  e x h ib i t e d  a  t r u e  r e l a p s e  
d u r in g  th e  f o u r th  week o f  t h e  d i s e a s e .  No second  
a t t a c k s  o c c u rre d  w i th in  two y e a r s  so f a r  a s  i t  was 
p o s s ib le  t o  a s c e r t a i n .
(V) Case M o r t a l i t y .
The im p o r ta n t  q u e s t io n  o f  th e  e f f e c t  on th e  m o r t a l i t y  
r a t e  i s  v e ry  d i f f i c u l t  t o  c o n s id e r  s t a t i s t i c a l l y  a s  i t  
i s  a  re c o g n is e d  f a c t  t h a t  th e  m o r ta l i t y  r a t e  h a s  b een  
d e c re a s in g  a lo n g  w ith  t h e  d e c r e a s e  in  th e  s e v e r i t y  o f  t h e  
ty p e  o f  S c a r l e t  F e v e r now p r e v a l e n t .  In  t h i s  s e r i e s  
o f  c a se s  two d e a th s  o c c u r re d , one a  s e p t i c  c a se  c o m p lic a te d  
by e n d o c a r d i t i s  and th e  o th e r  a  case  s u f f e r i n g  from  g a s t r o ­
e n t e r i t i s  and b roncho -pneum on ia  in  a d d i t i o n  t o  S o a r le t  
F e v e r .
When i t  i s  t a k e n  i n to  oons i d e r a t i o n  t h a t  t h e  o a s e s  
d e a l t  w i th  i n  t h i s  s e r i e s  w ere a l l  o f  a  p a r t i c u l a r l y  
s e v e re  n a tu r e  and w hioh m oreover in o lu d e d  two p a t i e n t s  who 
w ere m oribund  on a d m is s io n  and who re c o v e re d , i t  i s  
r e a s o n a b le /
r e a s o n a b le  t o  c o n c lu d e  t h a t  w ith o u t serum th e  number o f  
d e a th s  w ould have been  g r e a t e r .
EXAMPLES Off GASES.
The fo l lo w in g  b r i e f  r e c o r d s  a re  g iv e n  t o  i l l u s t r a t e  
ty p e s  o f  S c a r l a t i n a  and th e  e f f e c t s  o f  Serum T h erap y .
( I )  S c a r l a t i n a  M a lig n a .
L u r in g  th e  c o u rs e  o f  th e  ep id em ic  two o a se s  o f  
S c a r l a t i n a  M a lig n a  were a d m itte d  t o  h o s p i t a l ,  and a l th o u g h  
b o th  w ere m oribund on a d m iss io n  t o  th e  w ards th e s e  two 
c a s e s  r e a c te d  in  r a t h e r  d ra m a tic  m anner and b o th  made 
e x c e l l e n t  r e c o v e r i e s .
Case 1 5 .
S h i s  boy o f  10 y e a r s  was a d m it te d  on th e  f o u r th  day 
o f  i l l n e s s ;  t h e  r a s h  had a p p ea re d  a f t e r  t h r e e  days o f  
h ead ach e , v o m itin g  and so re  t h r o a t ;  p e r s i s t e n t  d i a r r h o e a  
had been  p r e s e n t  a n d  th e  boy was in  a  low ty p h o id  s t a t e  
when f i r s t  se e n  in  h o s p i t a l .  The W idal R e a c tio n  was 
p e r s i s t e n t l y  n e g a t iv e .
The c l i n i c a l  s ig n s  o f  S c a r l a t i n a  M a lig n a  were p r e s e n t  
and 2 0 co s. o f  serum  a d m in is te r e d .  Im provem ent was n o te d  
in  24 h o u rs  and an u n in te r r u p te d  re o o v e ry  to o k  p la c e s  
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DAY OP ILLNESS 
ON ADMISSION 4t h  day .
DAY OP SERUM THE ATM EM!. 4t h  day
45.
W.M. (M a le ).
10 y e a r s .






M oribund on a d m is s io n .
P e r s i s t e n t  v o m itin g ;  d ia r r h o e a .
W idal R e a c tio n  n e g a t iv e .
T .1 0 2 . P . 144- R*44*
2 4 h rs  a f t e r  T . 98* P . 1 0 0 . R*3o.
M arked im provem ent a f t e r  serum  th e r a p y .
G e n e ra l is e d  dusky  e ry th e m a ; p u n c ta te  
r a s h  i n  a x i l l a e ;  fa d e d  36 h o u rs  l a t e r .  
D esquam ation  16t h  day .
M oderate  f a u c i a l  c o n g e s t io n .
P e e le d .
Y ery m arked ; c y a n o s is  m arked ; p u ls e  
im p e r c e p t ib le  a t  t im e s ;  s e m i-c o n s c io u s .
COMPLICATIONS. E n t e r i t i s  ( p r e s e n t  on a d m iss io n  t o  





E x c e l le n t  r e c o v e ry .
A n t i to x in  2 0 co s. (P.D .&  C o . ) .
Im m ediate r e a c t i o n  t o  serum  in t r a m u s c u la r ly  
D ism issed  w e ll  i n  41 d a y s .
R ecovery  o f  a  case  o f  S c a r l a t i n a  M a lig n a .
24*
Case 8 1 *
T h is  boy o f  7 y e a r s  was in  e x tr e m is  on a d m iss io n  
t o  h o s p i t a l  on th e  f o u r th  day o f  i l l n e s s ;  t h e r e  was a  
g e n e r a l i s e d  dusky  e ry th em a  w hich fa d e d  48 h o u rs  a f t e r  
serum  th e r a p y ;  d e sq u am a tio n  was o b se rv e d  on th e  1 0 th  
day o f  i l l n e s s .  T h ere  was m arked a n g in a  o f  fa u c e s  
and p a l a t e .  D e lir iu m  was v e ry  m arked; B lood P r e s s u r e  
40mm. HGr• In t r a v e n o u s  serum  th e r a p y  was a tte m p te d  
b u t f a i l e d  owing t o  low b lo o d  p r e s s u r e .  lO oos. o f
serum  was g iv e n  in t r a m u s c u la r ly ,  fo llo w e d  by s l i g h t  
im provem ent. 2 0 c c s . o f  serum  w ere g iv e n  12 h o u rs  l a t e r ,  
fo llo w e d  by m arked im provem ent. H ecovery to o k  p la c e  
w i th in  4 d a y s .
x> 10
m


















S S I *
DAY OS ILLNESS ON ADMISSION 
DAY OP SERUM TREATMENT.
81.
W .l. (M a le ).
7 y e a r s .
S c a r l a t i n a  M a lig n a .
4t h  day 
4t h  day.
CLINICAL NOTES. C ase o f  t r u e  t o x i c  S o a r l e t  S e v e r in  e x tre m is
on a d m is s io n . G re y ish  and cy an o se d ; p u ls e  
im p e r c e p t ib le .  lO c c s . S o a r l e t  f e v e r  A n ti­
t o x i n ,  fo llo w e d  by s l i g h t  im provem ent. 20OCS,
a d d i t i o n a l  serum  fo llo w e d  by m arked im prove­
m ent. G rad u a l r e c o v e ry  in s id e  a  week.
B e fo re  serum  3*104  f * l8 0 ( ? )  R .3 2 .
(1 ) 12 h r s .  a f t e r  serum  T .lO O  P .1 7 0  R .36 .
( 2) 24 " " " 3 . 98 P .156 a . 3 2 .
RASH. G e n e ra l is e d  r a s h  -  dusky  p u n c ta te  e ry th e m a .
fa d e d  48 h o u rs  a f t e r  serum . D esquam ation  
10t h  d a y . .
THROAT* M arked a n g in a  o f  p a l a t e  and oedema o f  t h e
u v u la  w ith  u l c e r a t i o n  o f  mucous m em branes.
TOXAEMIA* D e lir iu m ; p u ls e  a lm o s t im p e r c e p t ib le .
Tongue dry  and  p e e l in g .  B lood p r e s s u r e  
40mm» Hg.
COMPLICATIONS* (1) C e rv ic a l  A d e n i t i s .
(2 ) O to r rh o e a .
T o n s i l s  and A denoids rem oved, 





3 0 c c s . A n t i to x in  (P.D .&  C o .) .
R eoovery o f  a  o ase  o f  S c a r l a t i n a  M a lig n a  
w hich  was a d m it te d  on 4t h  day o f  i l l n e s s  
i n  e x tre m is*
( I I )  SCARLATINA ANGINOSA.
The r e s u l t s  o f  serum  i n  co m b a tin g  th e  s e p t i c  
c o m p l ic a t io n s  o f  S c a r l a t i n a  A ng inosa  a re  r a t h e r  u n s a t i s ­
f a c t o r y ;  o f  th e  e ig h t  o a se s  t r e a t e d  by serum  th e r a p y ,  
one c a s e  d ie d  o f  e n d o c a r d i t i s ,  t h r e e  c a s e s  w ere d e f i n i t e l y  
n o t a f f e c t e d  by th e  serum , and , w h ile  th e  r e s u l t s  in  tw o 
o th e r  c a s e s  were e n c o u ra g in g  o n ly  two o u t o f  t h e  e ig h t  
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BAY OF ILLNESS OK ADMISSION. 
BAY OF SEBUM TREATMENT.
41.
T .K . (M ale).
4i  y e a r s .
S c a r l a t i n a  A nginoea.









M o d era te ly  i l l  on a d m iss io n : v e ry  i l l  
on 2nd d ay . lO c c e . serum  g iv e n  w ith o u t 
b e n e f i t •
F e b r i l e  c o u rs e  o f  23 d ays c o m p lic a te d  
by u l c e r a t i o n  o f  t h r o a t :  a d e n i t i s :  
a r t h r i t i s  and e n d o c a r d i t i s .
M o d e ra te ly  b r i g h t .
I n te n s e  f a u c i a l  c o n g e s t io n  p ro c e e d in g  
a f t e r  serum  th e ra p y  t o  oedema o f  u v u la  
and p a la t e  and th e n  t o  e x te n s iv e  u l c e r -  
a t  io n  o f  f a u c e s .
C o n s id e ra b le  r e s t l e s s n e s s  and I r r i t a b i l i t y .
» (1) U lc e r a t io n  o f  f a u c e s .
(2 ) C e rv ic a l  a d e n i t i s .
(3 ) A r t h r i t i s .
( 4 ) E n d o o a rd i t i s .
D ied.
lO c o s . (P.D.& C o .) S o a r le t  F e v e r A n ti­
t o x in .
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2 y e a r s .
S o a r l a t i n a  A ng inosa .
DAY OF ILLNESS OH ADMISSION. 7t h  day








T y p ic a l  e a se  o f  S e p t ic  S o a r le t  F e v e r ;  
p ro fu s e  d i s c h a r g e s ,  o e r v io a l  a d e n i t i s :  
I r r e g u l a r  f e v e r :  t r e a t e d  by th r e e  s u c c e s s ­
iv e  d o se s  o f  P o ly v a le n t  A n ti s t r e p to c o c c ic  
serum  (£•%.& C o*), w ith o u t a p p a re n t e f f e c t .  
lO c c s . A n t i to x in  (P.D .&  C o .) g iv e n  i n t r a ­
m u sc u la r ly  on 13t h  day . T .P .R . norm al 
w i th in  36 h o u rs ,  m arked im provem ent.
Faded on a d m iss io n  t o  h o s p i t a l .
I n te n s e  c o n g e s t io n  o f  f a u c e s :  u l c e r a t i o n  
o f  t o n s i l s .  P o s t  n a s a l  d is c h a rg e  p ro f u s e .
Rot m arked.
(1 ) R h in o rrh o e a . ( p re s e n t  on a d m is s io n ) .
(2 ) C e rv ic a l  a d e n i t i s  ( p re s e n t  on a d m is s io n ) .
(3 ) D ouble o to r r h o e a .  ( a f t e r  serum  th e r a p y ) .
I n t e r e s t i n g  r e s u l t .
S .F .A n t i to x in  lO co s. (R.D.& C o .) .
REMARKS. T h is  c a se  was t r e a t e d  w ith o u t  b e n e f i t  by 
P o ly v a le n t  A n t i s t r e p t io o o c ic  serum  p r i o r  
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a a p e .
DAY OF ILLNESS ON ADMISSION. 
DAY OF SERUM TREATMENT .
35-
E.H .
3i  y e a r s .
S c a r l a t i n a  A ng inosa .
4t h  day . 







T y p ic a l  s e p t i c  S o a r le t  F ev er c a s e .
B lo tc h y  r a s h ;  p ro fu s e  rh in o r rh o e a  
and c e r v i c a l  a d e n i t i s *
T *P.R . n o t a f f e c t e d  by a d m in i s t r a t io n  
o f  se ru m  b u t r h in o r rh o e a  and a d e n i t i s  
su b s id e d  i n  7 d a y s .
M o d era te ly  b r ig h t  r a s h :  b lo tc h y  on 
e x t r e m i t i e s .
I n te n s e  c o n g e s t io n  o f  f a u c e s  and  p h a ry n x : 
p ro fu s e  p u ru le n t  n a s a l  and p o s t  n a s a l  
d isc h a rg e *  U lc e r a t io n  o f t o n s i l s *
Not m arked; t y p i c a l  s e p t ic  c a se .
(1) R h inorrhoea*  ( p r e s e n t  on a d m is s io n ) .
(2 ) C e rv ic a l  a d e n i t i s ,  ( p re s e n t  on ad m iss io n )*  
(3J E n d o c a r d i t i s .
(4 ) A lb u m in u ria .
(5) Serum o r  s e p t ic  rash*
S a t i s f a c to r y  in  a s  much as co m p le te  
re c o v e ry  was o b ta in ed *
SERUM. lO c c s . S .F .A n t i to x in  (P.D.& C o .) .
REMARKS * P ro b a b ly  q u i te  in a d e q u a te  i n i t i a l  d o se . 
No p o ly v a le n t  a n t i s t r e p to o o c o a l  serum 
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3 0 .
CASE Ho. 4 4 .
NAME. M.D. (F em ale ).
AGE. 18 y e a r s .
TYPE. S c a r l a t i n a  A ng inosa .
DAY OP ILLNESS ON ADMISSION. 4 th  d ay .
DAY OP SERUM TREATMENT. 4t h  day . ( 1 s t  d o s e ) .
8t h  d ay . ( 2nd d o s e ) .
CLINICAL NOTES. t y p i c a l  o a se  o f  S e p tio  S o a r le t  P e v e r  w i th
p ro fu s e  n a s a l  and p o s t  n a s a l  d is c h a r g e s :  
d o u b le  0to r r h o e a :  u l o e r a t i o n  o f  f a u o e s :  
o e r v io a l  a d e n i t i s .  C e s s a t io n  o f  a l l  
d i s c h a rg e s  by 18t h  d ay . F e b r i l e  c o u rs e  
ended by lo n g  l y s i s  on 18t h  day .
RASH. B r ig h t  g e n e r a l i s e d  r a s h .
THROAT. E xtrem e d eg ree  o f  c o n g e s t io n  and oedema o f
f a u o e s .
U lc e r a t io n  o f  t o n s i l s  and p i l l a r s  o f  f a u o e s .  
N a sa l and p o s t  n a s a l  d i s c h a rg e s  v e ry  p r o fu s e .
TOXAEMIA. Hot m arked .
COMPLICATIONS On a d m iss io n  (1 ) C e rv ic a l  a d e n i t i s  ( b i l a t e r a l )
(2 ) O to r rh o e a . ( b i l a t e r a l ) .
( 3 ) N asa l and p o s t  n a s a l  
d is o  h a rg e s .
RESULT. E x c e l le n t  r e s u l t  t o  v e ry  s e v e re  c a s e  o f  th e
" s e p t i c  ty p e .  A ll  d is o h a rg e  c e a s e d  by 1 8 th
d ay : a llo w ed  up 22nd d ay ; d is m is s e d  35t h  
day o f  i l l n e s s .
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CASE No. 9 0 .
NAME. W.B.
AGE* 7 y e a rs*
TYPE. S c a r l a t i n a  A ng inosa . (” S u rg io a l  S c a r l e t ” )•
BAY OP ILLNESS ON AM ISSIOH* 4t h  day .
BAY Off SERUM TBEASMEIg ♦ 5 th  .d ay .
CLINICAL NCTES. W hitlow  o f  f i n g e r :  c e l l u l i t i s  o f  h an d .
Very i l l  on 5 tb  d ay . T .104* P .1 6 0 . B.28*
P a l l  o f  te m p e ra tu re  by l y s i s  t o  1 1 th  d ay . 
P u ls e  r a t e  120 p e r  m in . 12 h o u rs  a f t e r  serum . 
M arked im provem ent in  g e n e ra l  c o n d i t io n .
BASH* B r ig h t  g e n e r a l i s e d  p u n c ta te  e ry th e m a .
THROAT» C o n g e s tio n  o f  f a u c e s :  t o n s i l s  sw o lle n .
Much im proved a f t e r  serum  th e r a p y .
TO Y aw tA . M arked d e l i r iu m :  ab sen ce  o f  d e l i r iu m  
12 h o u rs  a f t e r  serum .
SEPTICAEMIA* I r r e g u l a r  p y re x ia  (11 d a y s ) :  p o s t  n a s a l
d is c h a rg e :  p u ru le n t  d is o h a rg e  from  w h itlo w .
COMPLICATIONS Bone.
RESULT * Good.
SEBUM. lO c c s . (P.B.& C o .) S o a r le t  F e v e r A n ti­
t o x in .
REMARKS. M arked b e n e f i c i a l  e f f e c t  in  s h o r te n in g
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CASE No. 57 -
SAME. T.W. (M ale).
AGE. 5 y e a r s .
TYPE. S c a r l a t i n a  A ng inosa .
DAY OP ILLNESS OH ADMISSION. 2nd day .
DAY Off SEBUM TREATMENT. 3rd  day .
CLINICAL NOTES. A cute S o a r l e t  F ever d e v e lo p in g  s e p t i c  ty p e .
A f te r  24 h o u rs  o b s e r v a t io n  T .102  P .1 4 8 . R .36
36 h o u rs  a f t e r  s e r u m -  T . 99 P .1 0 8  R. 26
A f e b r i le  on 3t h  day o f  i l l n e s s  a f t e r  l y s i s *  
Marked im provem ent in  g e n e r a l  c o n d i t io n  




B rig h t  g e n e r a l i s e d  e ry th em a .
Marked f a u c i a l  u l c e r a t i o n  and oedema 
o f  u v u la .
A ngina o f  s o f t  p a l a t e :  c e r v i c a l  a d e n i t i s .  
P u ru le n t  n a s a l  and p o s t  n a s a l  d i s c h a r g e s .
Rot m arked.
COMPLICATIONS* A d e n i t i s .
P u ru le n t  R h i n i t i s .
RESULT. Good.
SERUM. lO co s. (P.D.& C o .) .  S o a r le t  F e v e r  A n t i -
to x in .
REMARKS. R e su lt  e n c o u ra g in g  f o r  S e p t ic  T ype.
' D e te n t io n  8 w eeks. R h i n i t i s  due t o
H y p ertro p h y  o f  T o n s i ls  and A deno ids. 
Removal s a t i s f a c t o r y .
I I I .  SCARLATINA STMPLTQE (S e v e re d
The l a r g e s t  g roup  o f  o a se s  t r e a t e d  by serum  was 
t h a t  o f  t h e  ty p e  S o a r l a t in a  Sim plex* A ll th e s e  o a s e s  
w ere a c u te ly  i l l ,  and some, i t  m ust be n o te d , w ere u n d e r  
o b s e r v a t io n  fo r  v a ry in g  p e r io d s ,  in  v iew  o f  t h e  p o s s ib ­
i l i t y  o f  a  sp o n ta n eo u s  c r i s i s  and im provem ent e a r ly  i n  
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CASE No. 10 .
NAME. J.M cK. (M ale).
AGE. 9 y e a r s .
TYPE. S c a r l a t i n a  S im plex  (S e v e re ) .
DAY Off ILLNESS OK AIM I  SSI OH. 3 rd  day .
DAY Off SEBUM TREATMENT. 4t h  day .
CLINICAL NOTES. A cute a t t a c k  o f  S o a r l e t  E e v e r.
B e fo re  serum  5 .1 0 2  P .1 2 0  R.2 6
24 h o u rs  a f t e r  serum  5 . 98 P . 100 . B .2 4 .
R h in o rrh o e a  p r e s e n t  on a d m iss io n  -  c e a s e d  
48 h o u rs  l a t e r .
RASH. I n te n s e  r a s h .  P e te o h ia e  m arked on c h e s t
and f l e x u r e s .
THROAT. M arked f a u c i a l  c o n g e s t io n :  oedema o f
u v u la .
JOMBMUk' M arked to x a e m ia . S e v e re  h e a d a c h e :
in so m n ia : r e s t l e s s n e s s :  s o f t  r a p id  p u l s e .
COMPLICATIONS Hone.
RESUIT. Good.
lO c o s . S o a r le t  E ever A n t i to x in  (P.D.& C o .) .
REMARKS. Im m ediate  r e a c t io n  t o  serum .
U n in te r ru p te d  c o n v a le s c e n c e .
H o te : C e s s a t io n  o f  n a s a l  d is c h a rg e  48 h o u rs
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CASE No- 32•
HAKE. H .G .(F e m a le ) .
AGE. 14  y e a r s .
TYPE * S c a r l a t i n a  S im plex  ( S e v e r e ) .
BAY OP ILLNESS 0N ADMISSION. 2nd day .
DAY OP SEBUM ^ heatmeipp . 2nd day .
CLINICAL NOTES. A c u te ly  i l l ;
B e fo re  serum  T .1 0 2  P .1 4 4 . R .3 2 .
24 h o u rs  a f t e r  serum  T*98 P . 100 . B .2 4 . 
Marked b e n e f i c i a l  e f f e o t  n o te d  24 h o u rs  
a f t e r  serum .
U n in te r ru p te d  c o n v a le sc e n c e *
RASH. Very b r i g h t  g e n e r a l i s e d  ra sh *
THROAT. Very p a i n f u l .  C o n g e s tio n  o f  f a u c e s .
Oedema o f  u v u la ;  e x u d a te  on t o n s i l s  (swab 
n e g a t iv e .)  Im provem ent n o te d  24 h o u rs  
a f t e r  serum .
TOXAEMIA. W ell m arked to x a e m ia ;  d ry  tongue*
low t e n s i o n  p u ls e s  s e v e re  h e a d a c h e .
COMPLICATIONS None.
RESULT. Very good .
SERUM. lO c o s . (P.B.&  Co*) S o a r l e t  f e v e r  A n t i to x in .
R g cy & g . Im m ediate r e a c t i o n  and b e n e f i c i a l  re s p o n s e
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CASE Ho, 40.
A*D. (F e m a le ) .
12 y e a r s .
S o a r l a t i n a  S im plex  (S e v e re ) .
BAY OF ILLNESS OH AUTISSION. 2nd day .
BAY OF SERUM TKEAEMENT. 2nd d a y .
CLINICAL NOTES. A c u te ly  i l l  and to x io  on a d m is s io n .
B e fo re  serum  T .1 0 5 . P * l6 o . B*36 
48 h o u rs  a f t e r  serum  T* 9 8 . P*88 . R*2o.
M arked im provem ent in  g e n e r a l  c o n d i t io n .
Hash fa d e d : t h r o a t  im proved .
M o d e ra te ly  B rig h t g e n e r a l i s e d  r a s h .
In te n s e  o o n g e s t io n  o f  f a u c e s :  oedema o f  
u v u la  and s o f t  p a l a t e :  u l c e r a t i o n  o f  
t o n s i l s .  Im provem ent v e ry  m arked 36 h o u rs  
a f t e r  serum .
M arked by d e l i r iu m :  d ry  u l c e r a t e d  to n g u e  
and s o r d e s .  Low t e n s io n  r a p id  p u lse *
COMPLICATIONS Serum a r t h r i t i s  {12 h o u rs*  d u r a t i o n ) .
L a te  c e r v i c a l  a d e n i t i s  (24  hou rs*  d u r a t i o n ) .
RESULT. Very d ra m a tic  r e s u l t .
SEBUM. lO co s. (P.B.&  C o .) S c a r l e t  F e v e r  A n t i ­







REMARKS. Im m ediate  c r i s i s  in  36 h o u rs  a f t e r  serum  
w ith  m arked im provem ent o f  t h r o a t  c o n d i t i o n ,  
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CASE Ho. 4 7 .
NAME♦ H.McD. (M ale).
AGE. 11 y e a r s .
TYPE. S c a r l a t i n a  S im plex  (S e v e re ) .
DAY OP ILLNESS ON ADMISSION. 2nd d ay .
DAY OP SEBUM TREATMENT. 2nd day .
CLINICAL NOTES. A cute c a s e :  v e ry  to x io  on a d m iss io n .
B e fo re  serum  T .100. P .1 4 0 . R .2 8 . 
24 h o u rs  a f t e r  serum  T . 93* P . 124 . B .24 . 
Marked im provem ent in  g e n e ra l  o o n d i t io n  
24 h o u rs  l a t e r .
U nin t e r  ru p t  e d 0 o n v a le  soeno e .
BASH. In te n s e  r a s h ;  p e t e c h i a l  r a s h  on c h e s t
and f l e x u r e s .
THROAT. C o n g e s tio n  o f  f a u c e s :  oedema o f  u v u la .
U lc e r a t io n  o f  t o n s i l s .
M arked im provem ent 24 h o u rs  a f t e r  serum .
TOXAEMIA. Marked by h ead ach e : d ry  f u r r e d  to n g u e :
s o rd e s :  low t e n s io n  p u ls e .
COMPLICATIONS None.
RESULT. Very good.
SERUM. 1 0 co s . (P.D.& C o .) S o a r l e t  E ev e r A n ti­
to x in .
REMARKS. Im m ediate re sp o n se  t o  serum  th e r a p y .
om
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t y p e .
MY OF ILLNESS OH ABMISSION. 
BAY OF SERUM TREATMENT .
6 0 .
W.J.
28 y e a r s .
S c a r l a t i n a  S im plex  (S e v e re ) .
3 rd  day .









A oute S c a r l e t  F e v e r .
B e fo re  serum  T*A03 P»130 R .24  
24 h o u rs  a f t e r  serum  T . 99 £• §2 R .22 
Marked im provem ent a f t e r  c r i s i s .
Very b r i g h t .  Faded r a p i d l y  (12 h o u r s ) .
I n te n s e  e o n g e s t io n  o f  f a u o e s t  v e ry  p a i n f u l :  
Oedema o f  u v u la  and s o f t  p a l a t e :  some 
u l c e r a t i o n  o f  t o n s i l s .  C o n d itio n  
im proved soon  a f t e r  serum  th e r a p y .
Very m arked . Bry to n g u e  and l i p s .  S o rd e s . 
Low t e n s io n  r a p id  p u ls e .  R e s t l e s s n e s s .
T r a n s ie n t  A r t h r i t i s  (se ru m ? ).
Very good.
lO o o s. (P.B .&  C o .) S c a r l e t  F ev e r A n ti­
t o x in .
(Case N o.66 W .J. a  so n  o f  t h i s  p a t i e n t  N o.60) 
Serum a d m in is te re d  t o  son  on 5t h  d ay , 
r e s u l t  n o t so good .
Serum a d m in is te re d  t o  f a t h e r  on 3rd  d ay , 
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CASEJSo. 6 6 .
NAME. W .J. (M ale ).
AGE. 9 y e a r s .
TYPE. S o a r l a t in a  S im plex  (S e v e re ) .
DAY OF ILLNESS OH ADMISSION. 2nd d ay .
DAY OF SERUM TREATMENT * 5 th  d ay .
CLINICAL NOTES. Case o f  S o a r le t  F ev er u n d er o b s e r v a t io n :
m o d e ra te ly  i l l :  p a t i e n t  on 5 t h  day s t i l l  
i l l :  r a s h  s t i l l  b r i g h t :  t h r o a t  s t i l l  
p a i n f u l .
B efo re  serum  1 .1 0 0  P .1 3 0  R.2 4  
24 h o u rs  a f t e r  serum  1# §9 P .1 2 0  R .22 








B r ig h t  u n t i l  6t h  d ay .
C o n g e s tio n  o f  f a u c e s :  sw o lle n  t o n s i l s .
No im provem ent u n t i l  a f t e r  serum  on 5t h  
day .
Marked by low t e n s io n  p u l s e :  v a ry in g  
h e ad a ch e . Tongue dry and f u r r e d :  d ry  
and p e e le d  on 4t h  day .
> A d e n i t i s  3 th  day .
H y p e r tro p h ie d  t o h s i l s .  T o n s i l l i t i s  
4t h  week.
T o n s i l s  and a d e n o id s  removed.
I n t e r e s t i n g  com pared t o  Case N o.6 0 .
lO c o s . (P.D.& C o .) S o a r l e t  F ev e r A n ti­
t o x i n  on 5i k  day .
T h is  c a se  i n d i c a t e s  th e  n e c e s s i t y  f o r  
e a r ly  a d m in i s t r a t io n  o f  serum .
40 .
IV . S GAEL AT ENA SIMPLEX (ADYNAMIC) .
The c a s e s  o f  t h e  Adynamio t y p e  a l l  re sp o n d e d  
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CASE No. 11 .
NAME. T .H . (M ale ) .
AGE. 6 y e a r s .
TYPE. S c a r l a t i n a  S im plex  (Adynamic Form ).
BAY OF ILLNESS ON ADMISSION. 2nd day .
BAY OF SEBUM TREATMENT. 2nd day .
CLINICAL NOTES. Acute a t t a o k  marked by w eakn ess :  a p a th y :
c y a n o s i s :  s h a l lo w  r e s p i r a t i o n s :  v e ry  
low t e n s i o n  p u l s e ,  c a r d i a c  sounds 
m u f f le d .
B e fo re  serum  T . I 03 £*138 R*32
24 h o u rs  a f t e r  serum T . 95 P . 120 B .22
Busky p u n c ta t e  e ry th e m a  w i t h  p e t e c h i a e  
marked i n  t h e  a re a s  a ro u n d  t h e  j o i n t s  
(k n e e s ,  e lbow s and a n k l e s ) .
THROAT. M oderate  f a u o i a l  c o n g e s t i o n .
TOXAEMIA. Marked by w eakness, s o r d e s ,  c i r c u l a t o r y
d i s t u r b a n c e .
COMPLICATIONS. O to r rh o e a  l a s t i n g  14 d a y s .
BESULT. Good.
SERUM. lO c o s .  S c a r l e t  F ev e r  A n t i t o x i n  (P.B.& Co)
REMARES. Im m ediate  r e a c t i o n  12 h o u r s  a f t e r  admin­
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CASE No. 14 .
NAME * R.C* (Male)
AGE. 4 y e a rs*
TYPE. S o a r l a t i n a  S im plex  (Adynamic Form ).
BAY OF ILLNESS ON ADMISSION. 2nd day .
DAY OF SERUM TREATMENT . J r d  day .
CLINICAL NOTES. Acute a t t a c k  m arked by w eak n ess :  c y a n o s i s :
f a l l o w  r e s p i r a t i o n s :  v e ry  s o f t  p u l s e .
Dry o o a te d  to n g u e :  s o r d e s .  C a rd ia c  
sounds s o f t*
B efo re  serum  5*101 P*132 R. 26
24 h o u rs  a f t e r  serum  5* 98 P*120 R.2 4
RASH. I n t e n s e  dusky ery them a* ( g e n e r a l i s e d ) .
THROAT. F a u o ia l  c o n g e s t i o n :  p a i n f u l .
TOXAEMIA* Marked by c i r c u l a t o r y  d i s t u r b a n c e  o h i e f l y .
COMPLICATIONS, None.
RESULT. Good.
SERUM. lOcos* S o a r l e t  F e v e r  A n t i t o x i n .  (P.D*& C o ).
REMARKS. C l i n i c a l l y  a  c a s e  o f  Adynamic S o a r l e t
F e v e r  w hich  re sp o n d ed  im m e d ia te ly  t o  
serum . Marked Improvement w i t h i n  12 
h o u r s •
COm os
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7 y e a r s .
S o a r l a t i n a  S im plex  (Adynamic)*
DAY OF ILLNESS ON ADMISSION. 3 rd  day .
DAY OP SERUM TREATMENT. 3 rd  day .
CLINICAL NOTES. A c u te ly  i l l :  w eakness  and a p a th y  marked*
P u ls e  v e ry  s o f t  and r a p i d .  H e a r t  sounds 
s o f t - g a l l o p  ry thm . C y a n o tic  t i n g e  % 
p r e s e n t  on e a r s  and l i p s .  Dry to n g u e :  
s o r d e s .
B e fo re  serum  T.lOO P . 124 R.2 4








I n t e n s e  dusky r a s h ;  p e tech i& e  m arked i n  
f l e x u r e s  and a x i l l a e .
Pauoes c o n g e s te d :  u l c e r a t i o n  o f  t o n s i l s .
W ell marked by l i s t l e s s n e s s :  d ry  to n g u e ,  
so rd e s  and s o f t  r a p i d  p u l s e .
None .U n i n t e r r u p t e d  c o n v a le s c e  n e e .
Very good ; marked im provement i n  c a r d i o ­
v a s c u l a r  sy s te m  w i t h i n  24 h o u rs  o f  serum.
lO o cs . (P.D.& Co*) S o a r l e t  P e v e r  A n t i ­
t o x i n .
E x c e l l e n t  r e s u l t  i n  a  c a s e  o f  Adynamic 
S o a r l e t  P e v e r .
Summary o f  R e s u l t s .
The f o l lo w in g  t a b l e s  V I I I  -  X I I  have been  p r e p a r e d  
t o  i l l u s t r a t e  t h e  number o f  c a se s  o f  S c a r l a t i n a  t r e a t e d  
b e fo r e  and a f t e r  t h e  f o u r t h  day o f  i l l n e s s ,  t o g e t h e r  
w i th  t h e  p e r c e n t a g e s  o f  o a s e s  e x h i b i t i n g  e x c e l l e n t  
r e c o v e ry  and c o m p l i c a t io n s  in  e a c h  g ro u p .
Out o f  a  t o t a l  o f  120 c a s e s  o f  S c a r l a t i n a  w hich  
were t r e a t e d  by serum  t h e r a p y ,  T0% r e c e iv e d  t r e a tm e n t  
p r i o r  t o  th e  f o u r t h  day o f  i l l n e s s .  I n  t h i s  e a r l y  
g roup  66% made an  e x c e l l e n t  r e c o v e ry ,  w h i le  34# e x h i b i t e d  
some o r  o t h e r  w e l l  r e c o g n i s e d  c o m p l i c a t io n  o f  S c a r l a t i n a .
The number o f  c a s e s  t r e a t e d  by serum  a f t e r  t h e  
f o u r t h  day o f  i l l n e s s  was 3 7 » end i n  t h i s  g ro u p  on ly  
48#  made an  e x c e l l e n t  r e c o v e r y  w i th o u t  c o m p l i c a t i o n s ,  
t h u s  i n d i c a t i n g  t h e  a d v i s a b i l i t y  o f  e a r l y  a d m i n i s t r a t i o n  
o f  serum .
4>
TABLE V I I I .
CASES TREATED BY SERUM THERAPY.
Cases t r e a t e d  b e f o r e  4 t h  day o f  i l l n e s s  85
Cases t r e a t e d  a f t e r  4 th  day o f  i l l n e s s  37
Cases t r e a t e d .  TOTAL 120
TABLE IX.
« RESULTS OF SERUM THERAPY BEFORE 4 t h  DAY o f  ILLNESS, i 
 ---------------------------------------------------  n
i C ases t r e a t e d  (70# o f  whole) • 83 !
J Cases w i th  e x c e l l e n t  r e c o v e r y  (66#) 55 J
i Cases w i th  c o m p l ic a t io n s  (34#) 28 |
TABLE X.
CASES TREATED BEFORE 4 t h Day.
; COMPLICATIONS. NUMBER OF CASES.
{ A d e m t  i s  . 9
! A d e n i t i s  + Serum Rash* 4
i A d e n i t i s  + Serum R ash + R h i n i t i s + O t i t i s *  1
j A d e n i t i s  + A r t h r i t i s . 1
! A d e n i t i s  + R h i n i t i s * 1
J A d e n i t i s  + O t i t i s  Media* 1
J A r t h r i t i s  (Serum?) 2
! R h i n i t i s  ( T r a n s ie n t ) 5
p e p h r i t i s . 1
J o t i t i s  Media* 4
! E n d o c a r d i t i s . 1
i f o t a l  dumber $£^£$$33-_____ ___ ™ ________2£L
j (Serum R ash  11*7# 14) •
TABLE X I.
RESULTS OF SERUM THERAPY AFTER 4 t h  DAY OF ILLNESS.
C ases t r e a t e d . 37
Cases w i t h  e x c e l l e n t  r e c o v e r y .  
Cases w i t h  c o m p l i c a t i o n s .
( 4 8 $ 18
19
TABLE X I I .
Cases t r e a t e d  a f t e r  4 t h  Day.
COMFLI CAT IONS. Number o f  Cases
A d e n i t i s .
A d e n i t i s  + o t i t i s .
A d e n i t i s  + A r t h r i t i s .
A r t h r i t i s  •
A lb u m in u r ia .
E n t e r i t i s  + Broncho Pneum onia. + E n d o c a r d i t i s  
O t i t i s  M ed ia .
O t i t i s  Media + R h i n i t i s .
O t i t i s  ♦ R h i n i t i s  + C o n j u n c t i v i t i s . .
R h i n i t i s .
E n d o c a r d i t i s  + Serum R a sh .
S u b - C o n ju n c t iv a l  Haemorrhage •
T o n s i l l i t i s •
19* ~___
3) .
1 Jfttttbec ~ o f  -  Css es * -  „ -  ~ -  - 







CgHER FEATURES Qg THE IHVESTIGATIOH.
(1) E f f e o t  on Ward R o u t in e .
The e x t r a o r d i n a r y  abatem ent o f  t h e  a o u te  mani­
f e s t a t i o n s  o f  S o a r l e t  F e v e r  w hich  fo l lo w e d  t h e  c r i s i s  
p r e c i p i t a t e d  by t h e  a n t i t o x i n  n a t u r a l l y  red u o ed  t h e  
a c t u a l  n u r s in g  o f  t h e  c a s e s  o f  S c a r l a t i n a  c o n s i d e r a b ly .
I n  f a c t ,  t h e  a p p e a ra n c e  o f  a  s c a r l e t  f e v e r  ward h a s  
c o m p le te ly  c h a rg e d  s in c e  t h e  r o u t i n e  a d o p t io n  o f  serum  
t h e r a p y ,  a s  t h e  m a j o r i t y  o f  p a t i e n t s  a r e  c o m fo r ta b le  
c o n v a le s c e n t s  w i t h i n  a  day o r  two o f  a d m is s io n ,  e x c e p t i o n s  
o f  c o u rs e  b e in g  c a s e s  o f  S c a r l a t i n a  A ng in osa . Even 
t h e s e  c a s e s ,  how ever, r e s p o n d  i n  v a r y i n g  d e g re e s  t o  
serum t h e r a p y .
(2) Cost o f  T r e a tm e n t . ^
The e s t i m a t i o n  o f  t h e  c o s t  o f  any new l i n e  o f  
t r e a tm e n t  sh o u ld  a lw ays be b o rn e  i n  m ind, t o g e t h e r  w i th  
t h e  v a lu e  o f  t h e  e f f e c t s  o b t a in e d .
Serum th e r a p y  i s  u n d o u b ted ly  c o s t l y ,  b u t  a p a r t  
a l t o g e t h e r  from  repaym ent i n  t h e  s a v in g  o f  human l i f e ,  
p a r t i c u l a r l y  i n  o a s e s  o f  S c a r l a t i n a  M a lig n a ,  t h e  a c t u a l  
o o s t  o f  serum  th e r a p y  p e r  p a t i e n t  so t r e a t e d  i s  amply 
r e p a i d  by th e  s a v in g  w hich  i s  p ro d u ced  by t h e  b e n e f i o i a l  
e f f e c t s  o f  t h e  serum  t r e a t m e n t .
T h e /
The c u t t i n g  s h o r t  o f  t h e  a o u te  i l l n e s s  and th e  
l e s s e n i n g  o f  t h e  d e t e n t i o n  p e r io d  h a s  d e f i n i t e l y  
e f f e c t e d  an economy o f  t h e  t im e  o f  t h e  n u r s i n g  s t a f f  
and o f  t h e  c o s t  o f  h o s p i t a l i s a t i o n  o f  t h e  p a t i e n t s .
(3) D ia g n o s t ic  Value o f  S o a r l e t  F ev e r  A n t i t o x i n .
D u rin g  t h e  ep idem io  o f  1926 t h e  u se  o f  t h e  S c h u l t s  
C h a r l to n  o r  b la n c h in g  t e s t  on t h e  s o a r l e t  f e v e r  r a s h  
was made i n  many o a s e s .  (1 2 ) .
A s e r i e s  o f  50 c a s e s  w i th  b r i g h t  r a s h e s  a l l  u n d e r  
48 h o u rs  d u r a t i o n  were s u b j e c t e d  t o  i n t r a d e r m a l  i n j e c t i o n s  
o f  s c a r l e t  f e v e r  a n t i t o x i n  i n t o  t h e  abdom inal w a l l .  The 
i n j e c t i o n s  were made i n  4 p l a c e s  and w ere o f  4 s t r e n g t h s  
o f  se rum , v i s :
1 * 1
(1) u n d i l u t e d ,  (2) l15. (3 ) l6 o .  ( 4) IbOO.
B oth  t y p e s  o f  Commercial Serum, i . e .  P a r k e ,  D av is  & C o . ,
and B u rro u g h s ,  Wellcome & Co. were u se d ,  and e a c h
i n j e c t i o n  c o n s i s t e d  o f  0 . 2oc o f  t h e  serum  d i l u t e d  o r
o th e r w is e .
The r e s u l t s  were u n ifo rm ly  im p re s s iv e #
W ith in  from  4 h o u r s  t o  38 h o u rs  t h e r e  a p p e a re d  t h e  
b la n c h e d  a r e a  o f  abou t 2 c e n t im e te r s  i n  d i a m e te r  a roun d  
t h e  s i t e  o f  t h e  i n j e c t i o n .
The u n d i l u t e d  serum  r e s u l t e d  i n  t h e  m ost d e f i n i t e  
e x t i n c t i o n  phenomenon, w h i l e  t h e  r e s u l t s  o f  t h e  f i r s t
two d i l u t i o n s  were d i f f i c u l t  t o  d i f f e r e n t i a t e .
T h e /
50.
l
The b la n c h in g  r e a c t i o n s  o f  1000 d i l u t i o n s  o f  serum
were q u i t e  d e f i n i t e l y  l e s s  d i s t i n o t  t h a n  t h e  f i r s t  two 
d i l u t i o n s .
5!he S c h u l tz  C h a r l to n  r e a c t i o n  watt t r i e d  a l s o  i n  
se v e n  p a t i e n t s  e x h i b i t i n g  enema r a s h e s .  In  a l l  c a s e s  
th e  r e a c t i o n  was n e g a t iv e .
In  two o a s e s  o f  c h ic k e n p o x ,  p ro d ro m al s o a r l a t i n f o r m  
e r u p t i o n s  were t e s t e d  and p ro v ed  n e g a t i v e .
E le v en  o a s e s  o f  m e a s le s  were a l s o  t e s t e d  by t h e  
S c h u l t z  C h a r l to n  method and th e  b la n o h in g  r e a c t i o n  f a i l e d  
in  a l l  o a s e s .
(4) P r o p h y l a o t i c  V alue o f  S o a r l e t  g e v e r  A n t i t o x i n .
D u rin g  t h e  y e a r s  1926-1930 t h e  v a lu e  o f  t h e  D ick  (13) 
t e s t  and t h e  p r o p h y la o t io  u se  o f  s o a r l e t  f e v e r  a n t i t o x i n  
h a s  been p rov ed  on 6 d i f f e r e n t  o c c a s io n s  when s o a r l e t  
f e v e r  h a s  a p p ea re d  i n  a  w ard  o f  d i p h t h e r i a  p a t i e n t s .
The r o u t i n e  p ro c e d u re  c o n s i s t e d  i n  p e r fo rm in g  th e  
D ick  t e s t  on a l l  c o n t a c t s  and in  a d m i n i s t e r i n g  an i n t r a ­
m u sc u la r  i n j e c t i o n  o f  2*5°° o f  S o a r l e t  P e v e r  A n t i t o x i n  
t o  a l l  D ick  p o s i t i v e  c o n t a c t s .
T h is  p ro c e d u re  h a s  p ro v ed  e f f e c t i v e  on t h e s e  6 
o c c a s io n s  b u t  i t  must be remembered t h a t  th e  s o a r l e t  
f e v e r  p a t i e n t  was on eac h  o c o a s io n  im m e d ia te ly  i s o l a t e d  
so  t h a t  to o  much r e l i a n c e  may n o t  be p l a c e d  on t h e  e f f i o a c y  
o f /
51-
o f  t h e  serum# N e v e r t h e l e s s  t h e r e  axe many i n s t a n c e s  on 
re o o rd  o f  ward e p id e m ic s  o f  s o a f l e t  f e v e r  on o t h e r  
o c c a s io n s  when t h e  serum  was w i th h e ld .
The v a lu e  o f  t h i s  serum u se d  by t h e  m ethod o f  
S o h u l t i  and C h a r l to n  a p p e a rs  o f  g r e a t  v a lu e  from  a 
d i a g n o s t i c  p o in t  o f  v iew , and p a r t i c u l a r l y  so in  c o n ju n ­
c t i o n  w i th  t h e  Diefc t e s t  w hich  i n d i c a t e s  t h e  i n d i v i d u a l  
s u s c e p t i b i l i t y  t o  the  t o x i n  o f  s o a r l e t  f e v e r  by a  s l d n  
r e a c t i o n  s i m i l a r  t o  t h e  SohioJc t e s t .
52.
CONCLUSIONS.
A c a r e f u l  s tu d y  from th e  c l i n i c a l  p o i n t  o f  view  
o f  S o a r l a t i n a  i n  ep idem ic  form  in  1926 was made. D uring  
th e  p e r io d  t h e  use  o f  s p e c i f i c  serum was i n t r o d u c e d  f o r  
t h e  f i r s t  t im e  i n  R u c h i l l  F e v e r  H o s p i t a l .
The r e s u l t s  a p p e a r  t o  J u s t i f y  t h e  f o l lo w in g  o p in io n :
(1) Marked ’b e n e f i c i a l  e f f e c t s  f o l lo w  t h e  u se  of S o a r l e t  
F e v e r  S t r e p to o o o c u s  A n t i t o x i n  when u se d  as a  t h e r a ­
p e u t i c  m ea su re ,  i n  S c a r l a t i n a .
I n  t h i s  c o n n e x io n  i t  i s  im p o r ta n t  t o  n o te  t h a t  t h e s e  
o b s e r v a t io n s  show ( s e e  T a b le s  8 -1 2 )  t h a t  t h e  e a r l i e r  
t h e  serum was a d m i n i s t e r e d  i n  t h e  c o u r s e  o f  t h e  
d i s e a s e  th e  more marked were t h e  b e n e f i c i a l  r e s u l t s .
(2 ) S p e o i f i c  serum i n  S o a r l a t i n a  w h ile  n o t  p r e v e n t in g  
c o m p l ic a t io n s  t e n d s  t o  make th e m  more am enable  t o  
t r e a tm e n t  when a l r e a d y  p r e s e n t  and t o  make them  
t r a n s i e n t  i n  n a tu r e  and o f  d im in is h e d  s e v e r i t y ,  sh o u ld  
th e y  a r i s e ,  t h u s  l e s s e n i n g  t h e  p e r i o d  o f  d e t e n t i o n  in  
h o s p i t a l .
( 3 ) S p e c i f i c  serum i s  a v a lu a b le  a d d i t i o n  t o  t h e  arm a­
m en tarium  o f  m e d ic a l  s c i e n c e  no t only  from t h e  p o i n t  
o f  v iew  o f  t h e r a p y  b u t  a l s o  o f  h o s p i t a l  a d m i n i s t r a t i o n .
(4) The maximum b e n e f i t  i s  o b ta in e d  i n  t h e  t r e a t m e n t  by 
s p e o i f i c  serum  o f  c a s e s  o f  S o a r l a t i n a  M a lig n a  where 
b e n e f i t  c an n o t  be o v e r e s t im a te d .
(5 ) /
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( 5 ) The serum  sh o u ld  he u se d  a s  a  r o u t i n e  t h e r a p e u t i o  
m easure  in  a l l  o a s e s  o f  S o a r l a t i n a  S im plex  o t h e r  
t h a n  v e ry  m ild  o a s e s .
(6 ) The v a lu e  o f  serum  i s  d o u b t f u l  in  S o a r l a t i n a  A nginosa  
e x cep t  combined w i th  t r e a tm e n t  by P o l y v a le n t  A n ti­
s t r e p t o c o c c i c  Serum.
(7)  S o a r l e t  P e v e r  A n t i t o x i n  h a s  a  c o n s i d e r a b le  d i a g n o s t i o  




I n  conseq uence  o f  th e  work o f  t h e  D icks  on S c a r l e t  
F ev e r  and o f  th e  p r o d u c t io n  of an a n t i t o x i n  w hich  h a s ,  i n  
t h e  hands o f  c l i n i o a l  i n v e s t i g a t o r s ,  p ro ved  o f  marked 
b e n e f i t  a s  a  t h e r a p e u t i c  m easu re , i t  only a p p e a r s  r e a s o n ­
a b le  f o r  i n v e s t i g a t o r s  to  ren ew  t h e i r  i n t e r e s t  and e f f o r t s  
i n  c o n n e c t io n  w i t h  o t h e r  s t r e p t o c o c c a l  d i s e a s e s .
A s tu d y  o f  th e  l i t e r a t u r e  r e v e a l s  tine name o f  
F e h l e i s e n  ( 1 ) as  p ro b a b ly  one o f  th e  e a r l i e s t  w o rk e rs  i n  
t h e  e t i o l o g i c a l  i n v e s t i g a t i o n  o f  e r y s i p e l a s :  t h i s  was in  
1883.
More r e c e n t l y  R u e d ig e r  ( 2 ) ,  S c h o re r  ( 3 ) ,  T u n n i o l i f f  ( 4 ) ,  
and  Boughton  (3 )  Lave c o n t r i b u t e d  t o  t h i s  same work and 
t h e i r  r e s u l t s  seem to  j u s t i f y  th e  o p in io n  t h a t  c u l t u r e s  
i s o l a t e d  from C e l l u l i t i s ,  E r y s i p e l a s ,  S e p t ic a e m ia  and
S c a r l a t i n a  d i f f e r  a n t i g e n i o a l l y  an d  t h a t  by means o f  
a g g l u t i n a t i o n  and a b s o r p t io n  t e s t s  91% o f  h a e m o ly t ic  s t r e p t o ­
c o c c i  from e r y s i p e l a s  c a s e s  c o u ld  be d i f f e r e n t i a t e d  i n t o  
one t y p i c a l  g ro u p .
I n  1895 C h a r r i n  & R ogers  (6 ) p rod uced  an a n t i s t r e p t o ­
c o c c ic  serum  f o r  t r e a tm e n t  i n  e r y s i p e l a s  and  Marms'rek (7) 
Arons An ( 8 ) and  M oser (9 ) a l s o  r e p o r t e d  f a v o u r a b ly .  The 
r e s u l t s  o f  t r e a t m e n t  have however been  v e ry  v a r i a b l e .
I n  F e b ru a ry  1924 R i v e r s  (10) p rodu ced  w i th  a  haemo-
l y t i o /
l y t i c  s t r e p t o c o c c u s  i s o l a t e d  from  a c a s e  o f  e r y s i p e l a s  a 
s k in  i n f e c t i o n  i n  r a b b i t s  and  d e s c r ib e d  a l s o  a  method f o r  
d e m o n s t r a t in g  t h e  p r o t e c t i v e  p r o p e r t i e s  o f  immune s e r a  
a g a i n s t  t h i s  s t r e p t o c o c c u s .
I n  August 1924 B irk h a u g  (11) was a b l e  t o  d e m o n s tra te  
by in t r a d e r m a l  p r o t e c t i o n  t e s t s  i n  t h e  r a b b i t  t h e  a n t i g e n i c  
r e l a t i o n s h i p  o f  s t r a i n s  o f  s t r e p to c o o c u s  E r y s i p e l a t i s .
B irk h au g  i n  F e b ru a ry  o f  1926, a s  a  r e s u l t  o f  f u r t h e r  
e x p e r im e n ta l  work was a b le  t o  p roduce  a  s o l u b l e  t o x i n  from  
t h e  s t r e p t o c o c c u s  e r y s i p e l a t i s  and e s t a b l i s h e d  t h e  f a c t  
t h a t  w i t h  t h i s  t o x i n  a  s k i n  t e s t  may be o f  u se  t o  i n d i c a t e  
s u s c e p t i b l e  i n d i v i d u a l s .
T h i s  B irk h a u g  t e s t  i s  t h u s  s i m i l a r  t o  t h e  S c h ic k  
and  D ick  r e a c t i o n s *
F i n a l l y  he d e m o n s t r a te d  t h a t  t h i s  s o l u b l e  t o x i n  
s t i m u l a t e d  t h e  p r o d u c t i o n  i n  a n im a ls  o f  an a n t i t o x i n  
which* n e u t r a l i s e d  t h e  to x in *
T h is  a n t i t o x i n  ( s t r e p t o c o o c u s  e r y s i p e l a t i s )  i s  
c la im e d  t  0 be a s  s p e c i f i c  in  e r y s i p e l a s  a s  t h e  S t r e p t o ­
c o c c u s  S o a r l a t i n h  A n t i t o x i n  i s  i n  S c a r l e t  F e v e r .
5 6 .
THB CLIHICAL DfVgSE IQAXIOHS.
The o l i n i o a l  stu dy  was c a r r ie d  out in  R u o h ill f e v e r  
H o sp ita l betw een March 1926 and llaroh 1930* d u rin g  whioh  
tim e an attem pt was made t o  a s o e r ta in  th e  v a lu e  o f  serum  
th era p y . A few  o a s e s  whioh e x h ib ite d  m ild  l e s io n s  
w ith ou t toxaem ia  were n oted  during th e  in v e s t ig a t io n s  but 
a l l  o a s e s  d e a lt  w ith  by serum th erap y  were a c u te ly  i l l  
w ith  p y r e x ia  ranging from 1 0 0 ° f .  t o  106^ f: th e  l e s io n s  
were a l l  w e ll  marked and th e  toxaem ia  was m a n ife s te d  by 
headache, o f t e n  by d e lir iu m , fu r re d  tongue and so r d e s  
and a p u lse  o f  v a r ia b le  q u a l i t y  but seldom  in c r e a se d  in  
r a te  in  p r o p o r tio n  to  th e  e le v a t io n  o f  tem p eratu re .
Yhe p a t ie n t s  were o f  b o th  sexes and o f  a l l  a g e s  but 
young o h lld r e n  were n o t in c lu d e d  in  th e  grou p s d e a lt  w ith  
by serum th era p y .
T hese o a se s  were e s s e n t i a l l y  o f  th e  lo w e s t  grade o f  
h o s p i t a l  p a t ie n t  and many were unemployed and i l l  n o u r ish ed . 
I t  i s  I n t e r e s t in g  to  n o te  th a t  th r e e  p a t ie n t s  o f  th e  m iddle  
o la s s  o f  s o o ie t y  a l l  responded in  qu iok  and r a th e r  dram atic  
fa sh io n  t o  serum th era p y . These th r e e  p a t ie n t s  were
(1 ) a n u rse , (2 )  a  m ed ica l s tu d e n t , (3 )  a oom m eroial 
t r a v e l l e r .
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CLASSIFICATION OF CASES.
The c a s e s  r e s o l v e d  th e m s e lv e s  i n t o  t h e  f o l lo w in g  
g ro u p s  -
(1) I d i o p a t h i o  E r y s i p e l a s  (P r im ary )  •
(2) I d i o p a t h i c  E r y s i p e l a s  (R e c u r re n t )  .
(3) T ra u m a tic  E r y s i p e l a s .
(4) P o s t  O p e ra t iv e  E r y s i p e l a s .
(5) C o m p lic a ted  E r y s i p e l a s .
i . e .  c a s e s  i n  w h ich  e r y s i p e l a s  was e s s e n t i a l y  
an  i n t e r c u r r e n t  i n f e c t i o n  i n  a p a t i e n t  a l r e a d y  
s u f f e r i n g  from  some d i s e a s e .
TOPICAL THERAPY.
A p r e l i m i n a r y  s tu d y  o f  t o p i c a l  th e r a p y  in c l u d i n g  
many o f  th e  w e l l  known and  w e l l  recommended l o t i o n s  and  
o in tm en ts w as made but i t  was v ery  soon  e v id e n t  th a t  
th e s e  v a r ia t io n s  o f  l o c a l  trea tm en t were o f  no th e r a ­
p e u t ic  v a lu e  in  a d is e a s e  w hich was a s s o c ia t e d  w ith  some 
o r  o t h e r  ddgree o f  to x a em ia .
I t  was th e n  d e c id e d  to  assume t h a t  i f  t h e  d i s e a s e  
waft- a s s o c i a t e d  w i th  a s t r e p t o c o c c a l  to x ae m ia  some 
b e n e f i t  m ig h t  be o b ta in e d  by serum t h e r a p y .
SERUM.
D uring  th e  i n v e s t i g a t i o n s  f i v e  ty p e s  o f  serum w ere
u s e d .
(1) P o ly v a le n t  A n t i s t r e p t o c o c c i c  Serum.
(2) S c a r l e t  F e v e r  S t r e p to c o c c u s  A n t i t o x i n  (P .D . & Co.)
( 5 ) /
(3)  S o a r l e t  F e v e r  S t r e p to c o c c u s  A n t i t o x i n  (B.W. & C o .)
(4) E r y s i p e l a s  S t r e p to o o o c u s  A n t i t o x i n .  (p .D .  & Co.)
(5)  A n t i - d i p h t h e r i t i c  Serum. (B.W.& Co.)
N.B. (1) T hese  s e r a  a re  a l l  c o n c e n t r a t e d  and  r e f i n e d .
(2) As th e  day o f  i l l n e s s  a p p ea re d  d o u b t f u l  
a c c o rd in g  t o  t h e  h i s t o r y  (many p a t i e n t s  
b e in g  d e l i r i o u s  on a d m is s io n  t o  h o s p i t a l )  
serum  th e r a p y  was c a r r i e d  out as e a r l y  as  
p o s s i b l e .
DOSAGE.
V a r i a t i o n  i n  dosage  was t r i e d  w i th  a view t o  f i n d i n g  
an a d e q u a te  d o se .
METHODS.
The a d m i n i s t r a t i o n  o f  t h e  serum  was
(1 )  I n t r a d e r m a l  a lo n g  t h e  s p r e a d in g  m a rg in  o f  t h e  
l e s i o n .
(2 )  I n t r a m u s c u l a r ,  i n t o  t h e  l a t e r a l  a s p e c t  o f  t h e  
t h i g h .
(3)  I n t r a v e n o u s ,  i n t o  t h e  m edian  b a s i l i c  v e i n .
GENERAL TREATMENT.
I n  a d d i t i o n  t o  any serum  th e r a p y  a l l  p a t i e n t s  were 
t r e a t e d  on t h e  g e n e r a l  l i n e s  o f  an i n f e c t i o u s  f e v e r .  
T o p ic a l  t h e r a p y  was. c o n f in e d  t o  th e  a p p l i c a t i o n  t o  t h e  
l e s i o n  o f  one o f  t h e  f o l lo w in g  s e d a t i v e  o in tm e n ts  b o th  o f  
which were found  o f  e q u a l  v a lu e .
(1) O i l  o f  C lo v es  -  1 p a r t .  (2 )  C a r b o l ic  A cid  -  2 p a r t s .
O i l  o f  E u c a ly p tu s  — 5 p a r t s .  M enthol — 3 p a r t s .
V a s e l in e  t o  ±00 p a r t s .  Camphor -  3 p a r t s .
L a n o l in  ) e q u a l  p a r t s




RESULTS OF CLINICAL INVESTIGATIONS.
(1) INTRADERMAL METHOD.
A ttem p ts  to  p r e v e n t  th e  s p r e a d  o f  th e  l e s i o n  o f  
e r y s i p e l a s  w ere  made i n  s e v e r a l  c a s e s  w here  a s u i t a b l e  
a c t i v e l y  s p r e a d in g  l e s i o n  was p r e s e n t .
The m ethod  a d o p te d  was t h a t  o f  i n t r a d e r m a l  
i n j e c t i o n  o f  d i f f e r e n t  ty p e s  o f  s e r a  (a) i n  d i f f e r e n t  
p a t i e n t s ,  (b) i n  th e  same p a t i e n t .  I n  a l l  c a s e s  p a r t  
o f  t h e  s p r e a d in g  m a rg in  was l e f t  u n t r e a t e d  a s  c o n t r o l .
The r e s u l t s  i n  10 c a s e s  w ere  a l l  th e  same -  u n s a t i s ­
f a c t o r y .  The s p r e a d in g  l e s i o n s  c o n t in u e d  t o  w ander 
I g n o r in g  a l l  b a r r i c a d e s  o f  d e f e n c e .
A lthough  th e  number o f  c a s e s  i s  r e l a t i v e l y  s m a l l ,  
th e  t r e a tm e n t  a p p e a re d  to o  p a i n f u l  to  w a r r a n t  any f u r t h e r  
number o f  p a t i e n t s  b e in g  s u b j e c t e d  t o  t h i s  l i n e  o f  
i n v e s t i g a t i o n .
(2) INTRAMUSCULAR SERUM THERAPY.
A number o f  c a se s  w ere  t r e a t e d  by i n t r a m u s c u l a r  
i n j e c t i o n  o f  serum  i n t o  th e  l a t e r a l  a s p e c t  o f  th e  t h i g h  
w i t h  v a r i a t i o n  o f  -
(1) Type o f  Serum.
(2) Dosage o f  Serum .
T h e /
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The S e ra  u s e d  w ere  -  
*
(1) P o ly v a le n t  A n t i s t r e p t o c o c c i c .
(2) A n t i - d i p h t h e r i t i c  Serum.
(3) E r y s i p e l a s  A n t i t o x i n .
(4) S c a r l e t  F ev e r  A n t i t o x i n .  (P .D . & Co.)
(5) " " " (B.W. & Co.)
( 1) The u s e  o f  p o ly v a l e n t  a n t i s t r e p t o c o c c i c  serum was 
em ployed i n  tw e lv e  c a s e s  o f  e r y s i p e l a s  -  7 f a c i a l ,  5 
i c o r p o r a l .
I n  o n ly  one case  was any a p p a r e n t  b e n e f i t  d e r iv e d  
from  th e  t r e a t m e n t .
(2) Three c a s e s  o f  f a c i a l  e r y s i p e l a s  w i th  s e v e r e  f a a c ia l  
c o n g e s t io n  w ere  t r e a t e d  by A n t i - d i p h t h e r i t i c  Serum .
No b e n e f i t  e x c e p t  i n  t h e  t h r o a t  was o b s e r v e d :  th e
e r y s ip e la s  runn ing  c o u r ses  v a r ie d  from 10 -  15 days 
b&tor* sp ontan eou s cure#
(3) F iv e  c a se s  o f  E r y s ip e la s  o f  t h e  fa c e  w ere  t r e a t e d  by 
E r y s i p e l a s  A n t i t o x i n ,  th e  dose  in  eac h  i n s t a n c e  b e in g  
20 c c s .  o f  serum .
The r e s u l t s  were m ost d i s a p p o i n t i n g .  The f e v e r  was 
m a in t a in e d  from  9 to  22 days and th e  serum d i d  n o t  
s h o r t e n  th e  tim e o f  to x aem ia  o r  have  any a p p a r e n t  e f f e c t  
on  th e  l e s i o n .
(4) The t r e a t m e n t  o f  e r y s i p e l a s  by i n t r a m u s c u la r  i n j e c t i o n  
o f  S c a r l e t  F e v e r  A n t i t o x i n  (P .D . & Co.) was s t u d i e d  i n  
t e n  c a s e s .  The d o se s  o f  serum w ere  10 c . c  (one c a se )  : 
15 c . c /
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15 c . c  (one c a s e ) : 20 c . c .  (two c a se s )  and  30 c . c .
( s i x  c a se s )  •
.T hree  p a t i e n t s  d i e d ,w h i l e  o n ly  one c a s e  a p p e a re d  to  
d e r i v e  im m edia te  b e n e f i t .
(5) A more e x t e n s i v e  s tu d y  was made o f  th e  u s e  o f  t h e  
o t h e r  ty p e  o f  S c a r l e t  F e v e r  A n t i t o x i n ,  t h a t  o f  (B.W.& 
Co.) a s  th e  r e s u l t s  w ere  d i s t i n c t l y  p ro m is in g  from th e  
o u t s e t .
In  a l l  41 p a t i e n t s  w ere t r e a t e d  by i n t r a m u s c u l a r  
i n j e c t i o n  o f  S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.)
T here  w ere  8 p a t i e n t s  who r e c e i v e d  20 c . c .  o f  serum 
w h i le  33 p a t i e n t s  r e c e i v e d  30 c . c .  o f  se ru m .
A l l  c a se s  responded by a c r i t i c a l  f a l l  o f  tem perature  
w ith  sd b s id en ee  o f  toxaem ia w i t h in  36 h o u rs and a lth o u g h  
i n  30# o f  c a s e s  th e  l e s i o n  was fo u n d  to  sp read  a f t e r  th e  
t r e a tm e n t  i t s  i n t e n s i t y  was v e ry  d e f i n i t e l y  l e s s e n e d .
The l e s s e n i n g  o f  th e  to x aem ia  was n o t  m arked  q u i t e  so 
soon  i n  th o s e  p a t i e n t s  r e c e i v i n g  th e  s m a l l e r  dose o f  
se ru m .
INTRAVENOUS SERUM THERAPY.
An e x te n s i v e  s tu d y  was made o f  th e  u s e  and  v a lu e  
o f  serum g iv e n  by th e  in t r a v e n o u s  r o u t e  i n  c a s e s  o f  
s e v e r e  e r y s i p e l a s  o f  t h e  f a c e  (90 c a se s )  and  body (7 
c a se s )  •
The f o l l o w in g  v a r i e t i e s  o f  serum  w ere u s e d  -
(1) P o ly v a le n t  A n t i s t r e p t o c o c c i c  Serum .
(2) E r y s i p e l a s  A n t i t o x i n .
(3) S c a r l e t  F e v e r  A n t i t o x i n  (P .  D. & Co.)
(4) " w ” (B. W. & Co.)
(1) In  t h r e e  c a s e s  o f  e r y s i p e l a s  and  c e l l u t i t i s  
o c c u r r i n g  t o g e t h e r  t h e  v a lu e  o f  P o ly v a le n t  A n t i s t r e p ­
t o c o c c i c  Serum was t r i e d .  The i n j e c t i o n s  w ere  
fo l lo w e d  by no r i g o r s  and  by no c r i s i s  and  t h e r e  was 
l i t t l e  e v id e n c e  o f  any  t h e r a p e u t i c  v a l u e ,  th e  l e s i o n  
s p r e a d in g  f o r  s e v e r a l  d ays  a f t e r  t r e a tm e n t  w i th  
c o n t i n u a t i o n  o f  to x a e m ia .
(2) F i f t e e n  c a s e s  o f  s e v e re  f a c i a l  e r y s i p e l a s  w ere  
t r e a t e d  by th e  in t r a v e n o u s  i n j e c t i o n  o f  20 c . c .  o f  
E r y s i p e l a s  A n t i t o x i n .
T h i r t e e n  p a t i e n t s  h a d  a r i g o r  w i t h i n  one h o u r  o f  
t h e  i n j e c t i o n  b u t  t h i s  was f o l lo w e d  by im provem ent i n  
o n ly  two c a s e s s  F o u r  o th e r  p a t i e n t s  a p p e a re d  to  
r e s p o n d  d u r in g  th e  n e x t  few d a y s ,  w h i le  s e v e n  c a s e s  
showed no b e n e f i t  a t  a l l .  f e n  p a t i e n t s  o f  t h i s  g ro u p  
d i e d /
6 3 ,
d ie d  a f t e r  3 - 7  days  to x aem ia  from
(a) B ronchopneum onia .
(b) C a rd ia c  f a i l u r e .
R e c u r re n c e  o f  th e  e r y s i p e l a s  o c c u r r e d  i n  t h r e e  o f  
t h e s e  c a s e s  w h i le  7 p a t i e n t s  d e v e lo p e d  c o m p l i c a t i o n s ,  
su c h  a s  S c a lp  A b s c e s s ,  S u p p u ra t iv e  A d e n i t i s ,  T o n s i l l ­
i t i s ,  Bronchopneum onia and O to r r h o e a .
(3) S ix  c a s e s  o f  v e ry  s e v e re  f a c i a l  e r y s i p e l a s  w ere  
t r e a t e d  by in t r a v e n o u s  i n j e c t i o n s  o f  30 c . c .  (P .D . & Co.) 
S c a r l e t  F e v e r  A n t i t o x i n .  Only one p a t i e n t  a p p e a re d  t o  
have  a  c r i s i s  w i th  d e c id e d  b e n e f i c i a l  r e s u l t s ;  w h i l e
0
a n o th e r  p a t i e n t  d ie d  from  ( 1) s e n i l i t y ,  (2) m y o c a r d i t i s ,
(3) to x ae m ia  o n  5 th  d a y .  The o t h e r  f o u r  c a s e s  d i d  n o t  
show any s i g n  o f  r e s p o n s e  to  t r e a t m e n t  u n t i l  a f t e r  th e  
10t h  day i n  e a c h  c a s e ,  w h i le  t h r e e  o f  t h e s e  c a s e s  
d e v e lo p e d  c o m p l i c a t io n s  ( r e s i d u a l  a b s c e s s e s )  •
(4) 73 c a s e s  o f  e r y s i p e l a s  (69 f a c i a l  and  4 c o r p o r a l )  
w ere  t r e a t e d  by in t r a v e n o u s  i n j e c t i o n  o f  S c a r l e t  F e v e r  
A n t i t o x i n  (B.W. & Co.)
A l l  t h e s e  c a se s  w ere  a c u t e l y  i l l  and  m a n i f e s t e d  
s i g n s  o f  e x trem e  to x a e m ia :  a l l  e x h i b i t e d  w e l l  m arked
e r y s i p e l a s •
Ten p a t i e n t s  d ie d  o f  whom s e v e n  s u f f e r e d  from 
c h ro n ic  a lc o h o l i s m  and  s e n i l i t y :  f i v e  p a t i e n t s  d y in g
from  t e r m i n a l  pneumonia and tij:*ee from  to x a e m ia  and  
c a r d i a  c /
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c a r d i a c  f a i l u r e :  one p a t i e n t  d e v e lo p ed  pneumonia d u r in g
c o n v a le s c e n c e  w hich  p ro v ed  f a t a l ,  w h i le  a n o th e r  d i e d  
from  s p e c i f i c  m e s a o r t i t i s .
Three o f  th e  c a s e s  w hich  en ded  f a t a l l y  w ere  i n  
e x t r e m is  o n  a d m is s io n  to  h o s p i t a l *
The r e s u l t s  o f  t h e  t r e a tm e n t  e x c e p t  i n  two i n s t a n c e s  
w ere  u n i f o r m ly  i m p r e s s iv e .  G e n e ra l ly  a r i g o r  f o l lo w e d  
w i t h i n  one h o u r  accom panied  by s l i g h t  r e s p i r a t o r y  
d i s t r e s s  and  o f t e n  a s l i g h t  c y a n o s i s .  I n  a sm a l l  
number o f  c a s e s  th e  d e l i r i u m  when p r e s e n t  became more 
m ark ed . T h is  r i g o r  a p p e a re d  t o  be c o n t r o l l e d  i n  some 
i n s t a n c e s  by th e  u s e  o f  a d re n a l in  m.X by h ypoderm ic  
i n j e c t i o n  b u t  t h i s  r e s u l t  was n o t  c o n s t a n t#
The p a t i e n t s  w e r e ,  h o w ev er ,  g e n e r a l l y  q u i t e  c o m fo r ta b le  
two h o u r s  a f t e r  th e  serum i n j e c t i o n :  from  12 h o u r s  to
48 h o u rs  t h e r e a f t e r  a  c r i s i s  to o k  p la c e  i n  a l l  c a s e s  
accom panied  by a f a l l  i n  th e  p u l s e  and r e s p i r a t i o n  r a ' t e s .  
W i th in  24 h o u r s  th e  s ig n s  o f  to x aem ia  s u b s id e d .
In  40 $  o f  c a s e s  th e  l e s i o n  c o n t in u e d  to  s p r e a d  
a f t e r  th e  c r i s i s  b u t  a lw ays a p p e a re d  to  be l e s s  i n t e n s e  
and  l e s s  a c t i v e .
In  60$ o f  c a s e s  th e  l e s i o n  commenced to  s u b s id e  
soon  a f t e r  th e  c r i s i s  and heavy  d e sq u a m a tio n  commenced 
w i t h i n  48 h o u r s  o f  th e  c r i s i s .  Many p a t i e n t s  e x p r e s s e d  
t h e /
t h e  d e s i r e  t o  be a l lo w e d  u p  w i t h i n  two days  o f  th e  
t r e a tm e n t  b u t  th e  r o u t i n e  p ro c e d u re  was c o n f in e m e n t  to  
bed  f o r  7 days f o l lo w e d  by 4 days  c o n v a le s c e n c e  b e f o r e  
d i s m i s s a l  from  h o s p i t a l .
R e c u r re n c e  o f  th e  e r y s i p e l a s  w i t h o u t  to x ae m ia  
d e v e lo p e d  i n  e i g h t  p a t i e n t s  who h a d  r e c e i v e d  i n t r a v e n o u s  
serum t h e r a p y  o f  S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.) 
f i v e  o f  whom h ad  a lo n g  h i s t o r y  o f  r e c u r r e n t  a t t a c k s .
In  t h i s  g roup  c o m p l ic a t io n s  d e v e lo p e d  i n  o n ly  f i v e  
c a s e s :  a d e n i t i s  (one case)  , t o n s i l l i t i s  (one case )  , 
r e s i d u a l  a b s c e s s  o f  e y e l i d  (2 c a se s )  ,  o f  s c a l p  (one case)
THE RESULTS OF SERUM THERAPY 
IN ERYSIPELAS.
In  th e  e s t i m a t i o n  o f  th e  r e s u l t s  o f  serum t h e r a p y  
i n  E r y s i p e l a s ,  i r r e s p e c t i v e  o f  th e  ty p e  o f  c a s e ,  o f  th e  
ty p e  o f  serum o r  o f  th e  m ethod o f  a d m i n i s t r a t i o n ,  th e  
o b s e r v a t i o n s  were p a r t i c u l a r l y  n o te d  f i r s t  i n  c o n n e c t io n  
w i t h  im m edia te  e f f e c t s  and s e c o n d ly  i n  t h e  rem o te  e f f e c t s .
The im m edia te  e f f e c t s  o f  serum th e r a p y  w ere n o te d  i n  
c o n n e c t io n  w i t h  th e  f o l lo w in g  p o i n t s : -
(1) The C ourse  o f  t h e  T e m p e ra tu re .
(2) The C i r c u l a t o r y  System .
(3) The Toxaem ia .
(4) The E r y s i p e l a s  L e s io n .
(5) Serum R e a c t i o n s .
O b s e r v a t io n s  w ere  made o n  th e  rem o te  e f f e c t s  o f  
serum th e r a p y  w i t h  r e f e r e n c e  to  -
(1) C o m p l ic a t io n s .
(2) Serum R e a c t i o n s .
(3) D e te n t io n  i n  H o s p i t a l .
(4) R e l a p s e s .
(5) Case M o r t a l i t y .
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IMMEDIATE EFFECTS.
(1) The C ourse  o f  th e  T e m p e ra tu re *
I n  e r y s i p e l a s  th e  te m p e r a tu re  i s  g e n e r a l l y  h e l d  to  
he h ig h  and  to  r u n  a v a r i a b l e  c o u rse  from  f i v e  t o  f i f t ­
e e n  days o r  l o n g e r .  I n  a  s m a l l  s e r i e s  o f  c o n t r o l  
c a s e s  o b s e rv e d  i n  th e  p r e l im in a r y  i n v e s t i g a t i o n  on  
t o p i c a l  th e r a p y  i n  E r y s i p e l a s  t h i s  was fo u n d  to  be s o ,  
th e  lo w e s t  t e m p e r a tu re  r e c o r d e d  b e in g  100 ° F .  and  th e  
h i g h e s t  te m p e r a tu re  1 0 5 ° F . ,  w h i l e  th e  a v e ra g e  d u r a t i o n  
o f  th e  p y r e x i a  was 10 d a y s .
The r e s u l t s  o f  serum th e r a p y  i n  t h e  o a s e s  u n d e r  
r e v ie w  show t h a t  o n ly  one ty p e  o f  serum h a s  any sem blance  
to  a  c o n s t a n t  e f f e c t  on  th e  c o u r s e  o f  th e  t e m p e r a t u r e .
The group o f  c a s e s  o f  e r y s i p e l a s  t r e a t e d  by S c a r l e t  
F e v e r  A n t i t o x i n  (B.W. & Co.) a l l  showed w i t h i n  from  
tw e lv e  h o u r s  to  f o r t y - e i g h t  h o u r s  a  c r i t i c a l  f a l l  i n  th e  
t e m p e r a t u r e .  In  a sm a l l  p e rc e n ta g e  o f  c a s e s  a p o s t  
c r i t i c a l  e l e v a t i o n  o f  te m p e ra tu re  was o b s e rv e d  and  m igh t 
be due to  r e c r u d e s c e n c e  o f  to x ae m ia  a s  no o th e r  c a u s e s  
c o u ld  be f o u n d .
T h is  p o s t  c r i t i c a l  e l e v a t i o n  o f  t e m p e r a tu re  r a r e l y  l a s t e d  
lo n g e r  t h a n  12 -  24 h o u r s .
I n  th e  c a s e s  t r e a t e d  by th e  in t r a v e n o u s  m ethod many 
c a s e s /
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o a s e s  e x h i b i t e d  a  r i g o r  a s s o c i a t e d  w i th  h y p e rp y r e x ia  
and a  d ra m a tic  c r i s i s .
I t  i s  i n t e r e s t i n g  t o  n o te  t h a t  r e l a p s e s  were a s s o c i a t e d  
w i th  l i t t l e  f e b r i l e  d i s tu r b a n c e *
(2) The C i r c u l a t o r y  S.vstem.
I t  was n o te d  i n  a l l  c a s e s  t h a t  th e  c o n d i t i o n  o f  
t h i s  sy s tem  was d i r e c t l y  d e p en d e n t  on th e  i n t e n s i t y  o f  
th e  i n t o x i c a t i o n .
The g rou p  o f  c a s e s  t r e a t e d  by B c a r l e t  -c'ever A n t i t o x i n  
(B.Y*. & C o .)  a l l  m a n i f e s te d  an im m edia te  im provement i n  
th e  c i r c u l a t o r y  sy s tem  a f t e r  serum  t h e r a p y .
A l l  o a s e s  t r e a t e d  by serum  i n t r a v e n o u s l y  who e x h i b i t e d  
a  r i g o r  m a n i f e s te d  a l s o  s i g n s  o f  a d e f i n i t e  i n c r e a s e  i n  
t h e  r a t e  and t h e  f o r c e  o f  th e  a c t i o n  o f  th e  h e a r t ,  b a t  
w i t h i n  a  few h o u r s  t h e r e  was n o te d  a  v e ry  d e f i n i t e  im prove­
ment i n  th e  r a t e  and q u a l i t y  o f  th e  p u l s e .
(3 )  THE TOXAEMIA.
I n  a l l  t h e  c a s e s  t r e a t e d  by serum  t h e r a p y  t h e  to x a e m ia  
was d e f i n i t e l y  and m arked ly  e s t a b l i s h e d  b e in g  f r e q u e n t l y  
m a n i f e s te d  by a  low t e n s i o n  p u l s e ,  a  d ry  f u r r e d  to n g u e  and 
s o r d e s ,  r e s t l e s s n e s s ,  i r r i t a b i l i t y ,  m arked in so m n ia  and 
f r e q u e n t ly  by d e l i r i u m .
I t  was found d i f f i c u l t  t o  d i f f e r e n t i a t e ,  i n  some c a s e s ,  
t o x i c  d e l i r i u m  and a l c o h o l i c  d e l i r i u m  a s  many o f  t h e  male 
c a s e s /
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c a s e s  and  a s m a l le r  p e rc e n ta g e  o f  th e  fem a le  c a s e s  were 
found  $o have  a d e f i n i t e  h i s t o r y  o f  a lc o h o l ism *
The e l i m i n a t i o n  o f  the  to x aem ia  was fo u n d  t o  be 
e a r l y  and  c o n s t a n t  o n ly  i n  c a s e s  o f  e r y s i p e l a s  t r e a t e d  by 
S c a r l e t  F e v e r  A n t i t o x i n  (B*W* & Co.) and  th e  maximum e f f e c t s  
w ere o b t a i n e d  by l a r g e  d o se s  o f  serum g i v e n  by i n t r a m u s c u l a r  
i n j e c t i o n  o r  i n  th e  more a c u t e l y  i l l  c a s e s  by th e  i n t r a v e n ­
ous r o u te *
(4) The E r y s i p e l a s  L e s io n *
A l l  th e  c a se s  o f  e r y s i p e l a s  u n d e r  r e v ie w ,  w h e th e r  
c o r p o r a l  o r  f a c i a l ,  e x h i b i t e d  w e l l  m arked l e s i o n s  
f r e q u e n t l y  w i th  v e s i c u l a t i o n .
No serum th e r a p y  was fo u n d  to  have  a  c o n s t a n t  e f f e c t  on  t h e  
l e s i o n  b u t  S c a r l e t  F e v e r  A n t i t o x i n  (5*W* & Co*) h a d
a p p a r e n t l y  some e f f e c t  i n  many o f  th e  c a s e s .
In  th e  g ro u p  t r e a t e d  by t h i s  ty p e  o f  serum th e  l e s i o n  
c o n t in u e d  to  s p r e a d  i n  40$ o f  c a s e s  b u t  a p p e a re d  on  
c r i t i c a l  and  c a r e f u l  o b s e r v a t i o n  and e x a m in a t io n  t o  be l e s s  
i n t e n s e  and  l e s s  a c t i v e .
In  60$ o f  c a s e s ,  h o w e v er ,  th e  e r y s i p e l a s  l e s i o n  commenced 
to  s u b s id e  w i t h i n  24 h o u rs  o f  th e  c r i s i s ,  a p p a r e h t l y  b ro u g h t  
ab o u t  by serum t h e r a p y ,  and th e  t y p i c a l  h eavy  d e sq u a m a tio n  
begaA to  m a n i f e s t  i t s e l f  w i t h i n  43 h o u r s  o f  th e  c r i s i s .
( 5 ) /
7 0 .
(5) Serum R e a c t i o n s .
No u n to w a rd  e f f e c t s  i n  serum r e a c t i o n s  w ere  
o b se rv e d  a f t e r  i n t r a d e r m a l  serum th e r a p y  o r  a f t e r  
i n t r a m u s c u la r  serum th e ra p y *
The in t r a v e n o u s  r o u t e ,  h o w ev er ,  when a d o p te d ,  
p roduced  f r e q u e n t l y  a r i g o r  w i t h i n  one h o u r ;  t h i s  
was accom panied  by i n c r e a s e  i n  p u ls e  r a t e  and r e s p i r a ­
t i o n  r a t e  and  som etim es by s l i g h t  c y a n o s i s :  o c c a s i o n a l l y
th e  d e l i r i u m  a p p e a re d  to  be more m arked : p r o fu s e
sw ea tin g  fo l lo w e d  a r i s e  i n  te m p e r a tu re  (so m etim es 107°F .)  
b u t  w i t h i n  from  f i v e  m in u te s  to  20 m in u te s  t h e  p a t i e n t  
r e t u r n e d  to  a norm al s t a t e  o f  t h in g s *  T h is  r e a c t i o n  was 
n o t  c o n s t a n t l y  b u t  o f t e n  c o n t r o l l e d  by a d r e n a l i n  i n j e c t i o n  
and  was lo o k e d  on  a s  p o s s ib l y  i n  th e  n a t u r e  o f  a  b r o n c h i a l  
spasm o r  h y p e r  s e n s i t i v e  n e ss  t o  some f o r e i g n  p r o t e i n  i n  th e  
serum .
The serum r e a c t i o n s  w ere  l a t t e r l y  e l i m i n a t e d  a lm o s t  
e n t i r e l y  by th e  p e r f e c t i o n  th ro u g h  p r a c t i c e  o f  th e  
t e c h n iq u e  o f  serum th e r a p y  by th e  in t r a v e n o u s  r o u t e ,  th e  
f e a t u r e s  w h ich  w ere  l a t t e r l y  s t r e s s e d  b e in g  -
( 1) th e  p re v io u s  s k i n  t e s t i n g  f o r  su p e r  s e n s i t i v e n e s s  o f  
p a t i e n t s  p r i o r  t o  in t r a v e n o u s  serum t h e r a p y .
(2) The h e a t  o f  th e  serum was a p p ro x im a te d  to  b lo o d  h e a t*
(3) The r a t e  o f  a d m i n i s t r a t i o n .
No u n to w a rd  r e s u l t s  w ere o b se rv e d  i n  th e  c a s e s  u n d e r
rev ie w  •
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REMOTE EFFECTS.
(1) C o m p lic a t io n s .
The c o m p l ic a t io n s  o f  e r y s i p e l a s  may be e i t h e r  
o f  a s e r i o u s  n a t u r e ,  e . g .  n e p h r i t i s ,  pneumonia and 
e n d o c a r d i t i s  o r  w ha t i s  more co m m o n ,res id u a l  a b s c e s s  
f o r m a t io n .
In  a  s e r i e s  o f  50 c a s e s  o b s e rv e d  as  c o n t r o l  
c a s e s  w i th o u t  serum th e r a p y ,  c o m p l ic a t io n s  d e v e lo p e d  as  
f o l l o w s : -
N e p h r i t i s  2 $
Pneumonia 4$
E n d o c a r d i t i s  2 $
A bscess  30$
These c o m p l ic a t io n s  w ere  fo u n d  to  be p r e s e n t  in  
a lm o s t  th e  same p e r c e n ta g e s  o f  a l l  th e  c a s e s  o f  
e r y s i p e l a s  u n d e r  r e v ie w ,  e x c e p t  i n  th o s e  c a s e s  t r e a t e d  
by S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.) , w h ich  g ro ups  
e x h i b i t e d  c o m p l ic a t io n s  o n ly  i n  f i v e  o u t  o f  a t o t a l  o f  
73 c a s e s  t r e a t e d  by th e  i n t r a v e n o u s  m ethod , and  no 
c o m p l ic a t io n s  i n  41 c a s e s  t r e a t e d  by in t r a m u s c u la r  se rum .
These c o m p l ic a t io n s  w ere  (1) T o n s i l l i t i s  (one c a se )  ,
(2) A d e n i t i s  (one c a s e ) ,  and (3) A bscess  f o r m a t io n  ( 4 . 1 $ ) .
T h is  f i g u r e  4 .1 $  f o r  a b s c e s s  f o r m a t io n  i s  v e ry  
s t r i k i n g /
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s t r i k i n g  compared to  30$  -  th e  f i g u r e  o f  a b s c e s s  
f o r m a t io n  fo u n d  in  a  s e r i e s  o f  50 c o n t r o l  c a se s*
The a b sen c e  o f  c o m p l ic a t io n s  i n  th e  g ro u p  t r e a t e d  
by th e  in t r a m u s c u la r  r o u t e  i s  d i f f i c u l t  t o  i n t e r p r e t  
e x c e p t  t h a t  a l l  th e  m ost s e v e re  c a s e s  w t r e a t e d  by 
i n t r a v e n o u s  serum  th e r a p y  i n  th e  hope o f  a more 
im m ediate  b e n e f i c i a l  r e a c t i o n .
(2) Serum R e a c t i o n s .
There  w ere  no c a s e s  o f  d e la y e d  serum s i c k n e s s  
b u t  2 c a se s  e x h i b i t e d  on  th e  1 1 th  and  1 4 th  day o f  th e  
serum th e r a p y  by th e  in t r a v e n o u s  r o u t e  w e l l  m arked 
serum r a s h e s .
These r a s h e s  w ere  b o th  u r t i c a r i a l  and  q u i t e  t r a n s ­
i e n t  i n  n a t u r e .
(3) D e te n t io n  i n  H o s p i t a l .
D e te n t io n  in  h o s p i t a l  was d e f i n i t e l y  l e s s e n e d  in  
th e  g ro u p  t r e a t e d  by S c a r l e t  F ev e r  A n t i t o x i n  (B.W. & Co.) 
Average d u r a t i o n s  i n  h o s p i t a l
(1) C ases t r e a t e d  by S c a r l e t  F e v e r  A n t i t o x i n  (B. W. & Co.)
15 d a y s •
(2) Cases n o t  t r e a t e d  by serum (50 C o n t r o l  Cases) . . . 2 8  d a y s .
(3) Cases t r e a t e d  by o t h e r  v a r i e t i e s  o f  se ru m ............... 26 d a y s .
(4) R e l a p s e s .
I f  a r e l a p s e  i s  ta k e n  to  mean a r e c r u d e s c e n c e  o f  
e r y s i p e l a s  w i t h i n  a few days t h e n  a l l  g ro u p s  o f  c a s e s  
w i t h  v a r i o u s  s e r a  e x h i b i t e d  r e l a p s e s  w i t h  th e  e x c e p t i o n  
o f /
73-
0f  S c a r l e t  F ev e r  A n t i t o x i n  (B. W. & Co*)
In  th e  l a t t e r  g ro u p ,  h o w e v er ,  a r e c u r r e n c e  o f  th e  
d i s e a s e  was o b se rv e d  in  e i g h t  c a s e s  o c c u r r i n g  from  
th r e e  days to  s i x  months a f t e r  d i s m i s s a l  from  h o s p i t a l .  
A l l  t h e s e  r e c u r r e n c e s  w ere  re m a rk a b le  f o r  th e  ab sen ce  
o f  to x ae m ia  and th e  p re s e n c e  o f  th e  l e s i o n  i n  th e  same 
s i t e  a s  t h a t  o f  th e  p re v io u s  a t t a c k .
(5) Case M o r t a l i t y .
In  t h i s  s e r i e s  o f  178 c a s e s  t r e a t e d  by serum 
th e ra p y  18 d e a th s  o c c u r r e d  g iv in g  a f i g u r e  o f  a f r a c t i o n  
o ve r  10$ f o r  th e  m o r t a l i t y  r a t e .
I t  i s  w o r th y  o f  n o t e ,  h o w ev er ,  t h a t  t h i s  f i g u r e  i s  
i n c l u s i v e  o f  a l l  p a t i e n t s  r e c e i v i n g  serum th e r a p y  and 
t h a t  among th e s e  c a s e s  o f  t h i s  s e r i e s  u n d e r  r e v ie w  w ere 
5 p a t i e n t s  m oribu nd  Gfcsadmission to  h o s p i t a l  and  12 
p a t i e n t s  s u f f e r i n g  from  some a d d i t i o n a l  d i s e a s e  o f  a 
s e r i o u s  n a tu r e  w hich  m ig h t  w e l l  be e s t i m a t e d  a s  th e  
cause  o f  d e a th  r a t h e r  th a n  th e  e r y s i p e l a s  to x a e m ia .
EXAMPLES OF CASES.
The f o l lo w in g  b r i e f  r e c o r d s  o f  c a s e s  a r e  g iv e n  
to  i l l u s t r a t e  th e  c l i n i c a l  co u rse  o f  e r y s i p e l a s  
t r e a t e d  w i th o u t  serum and w i t h  th e  d i f f e r e n t  ty p e s  o f  
serum .
C ases  No. 2 ,  4 and 6 r e p r e s e n t  c o n t r o l  c a s e s  
u n t r e a t e d  by serum and i l l u s t r a t i n g  th e  p o s s i b i l i t y  
o f  any e r y s i p e l a s  l e s i o n  assum ing  th e  w a n d e r in g  ty p e  
w i th  a p ro lo n g e d  p y re x ia  and  to x aem ia  and  th e  p o s s i b i l ­
i t y  a l s o  o f  r e s i d u a l  a b s c e s s  f o r m a t io n ,  th u s  c a u s in g  a 
long  i l l n e s s  and  h eavy  c o s t  o f  h o s p i t a l i s a t i o n  o f  th e  
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CASE NO. 2 .  ( C o n t r o l  Case) .
NAME • J  .E •
AGE. 38 y e a r s .
TYPE. I d i o p a t h i c  (P rim ary )
CLINICAL NOTES. A c u te ly  i l l :  a p p a r e n t l y  o r d i n a r y  ty p e
o f  f a c i a l  e r y s i p e l a s  w hich  p r o g r e s s e d  
i n to  th e  w a n d e r in g  ty p e  w i t h  20 days 
p y r e x i a ,  10 days to x a e m ia :  l e s i o n
s u b s id e d  a f t e r  24 d a y s .
LESION. B i l a t e r a l  f a c i a l  s p r e a d in g  o v e r  s c a l p ,
n e c k ,  s h o u l d e r s ,  c h e s t ,  a rm s ,  t r u n k  
and b u t t o c k s .
TOXAEMIA. W e ll  m arked  by s o r d e s ,  by h e ad a ch e ,  and
l a t e r  d e l i r i u m  e s p e c i a l l y  a t  n i g h t .
COMPLICATIONS. B r o n c h i t i s .
SERUM. C o n t r a - i n d i c a t e d  on a c c o u n t  o f  pulm onary
c o n d i t i o n .
RESULT. P ro lo n g e d  i l l n e s s :  w a n d e r in g  e r y s i p e l a s
P r o t r a c t e d  c o n v a le s c e n c e .
REMARKS. Case u n t r e a t e d  by se rum , s t u d i e d  a s  a 
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CASE NO* 4 .  { C o n tr o l  Case) .
NAME. A .S .
AGE. 58 y e a r s .
TYPE. I d i o p a t h i c .
CLINICAL NOTES. A c u te ly  i l l :  ( 3 r d  day o f  i l l n e s s  on
a d m is s io n . )  I r r e g u l a r  p y r e x i a .
99o -  103°F . f o r  12 d a y s ,  s e t t l i n g  by 
l y s i s •
LESION. B i l a t e r a l  f a c i a l  e r y s i p e l a s  s p r e a d in g
o v e r  th e  f o r e h e a d  and  s c a l p .
TOXAEMIA. W ell  m arked  by h e a d a c h e  and  v o m it in g  
(4 days) : m e n ta l  c o n f u s io n  (5 days)
d ry  to n g u e  and  s o r d e s  (6 d a y s . )
COMPLICATIONS. A bscess  o f  e y e l i d :  f a l l i n g  h a i r .
SERUM. No serum •
RESULT. Not v e ry  s a t i s f a c t o r y .
REMARKS. C o n t ro l  c a s e  i l l u s t r a t i n g  12 days
p y r e x ia  w i t h  c o n t in u a n c e  o f  to x a e m ia  
and  s p r e a d  o f  l e s i o n :  a b s c e s s  o f  e y e ­
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CASE NO. 6 .. ( C o n t r o l  C ase )
NAME. J . S .
AGE* 45 y e a r s *
TYPE. I d i o p a t h i c  (P r im ary )
DAY OF ILLNESS * 6t h  day on  a d m is s io n  to  h o s p i t a l .
DAY OF SERUM TREATMENT. No serum t h e r a p y .
CLINICAL NOTES. A c u te ly  i l l  w i t h  i r r e g u l a r  p y r e x i a  
100°F . -  104°F . l a s t i n g  f o r  20 days  
accom panied  by s p r e a d  o f  l e s i o n .
LESION. F a c i a l  e r y s i p e l a s ,  b i l a t e r a l ,  i n v o lv ­
in g  b o th  e a r s  an d  f i n a l l y  a ssum ing  
w a n d e r in g  t y p e .
TOXAEMIA. I n c r e a s e d  u n t i l  d e l i r i u m  on 8th  d a y :  
d ry  tong ue  an d  s o r d e s  p r e s e n t  f o r  
14 days •
COMPLICATIONS. B r o n c h i t i s .
RESULT. End r e s u l t  s a t i s f a c t o r y .
REMARKS. As an  a p p a r e n t  f a c i a l  e r y s i p e l a s  w h ich  
assumed th e  w a n d e r in g  ty p e  -  u n t r e a t e d  
by serum -  i l l n e s s  r u n n i n g  a c o u rs e  o f  < 
20 d a y s ,  w i t h  p r o t r a c t e d  c o n v a le s c e n c e .
78.
Case No. 91 . I l l u s t r a t e s  th e  non s u c c e s s  o f  
p o l  v a l e n t  a n t i  s t r e p t o c o c c a l  serum th e r a p y  i n  a  c ase  o f  
c e l l u l i t i s  o f  th e  hand  w i t h  e r y s i p e l a s  o f  th e  a rm , 
s h o u ld e r  and t ru n k *
T h is  serum h a s  f r e q u e n t l y  b een  u s e d  i n  th e  p a s t  
few y e a r s  b u t  th e  r e s u l t s  have  i n  g e n e r a l  b e e n  u n s a t i s ­
f a c t o r y  and u n r e l i a b l e  and  th e  r e s u l t s  i n  c a s e s  t r e a t e d  
by t h i s  serum i n  th e  p r e s e n t  i n v e s t i g a t i o n  h av e  te n d e d  
to  p ro ve  t h a t  t h e r e  a re  no a p p a r e n t  s p e c i f i c  a n t i t o x i c  
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CASE NO. 9 1 .
NAME. W.C.
AGE. 49 y e a r s .
TYPE. T ra u m a t ic .
DAY OF ILLNESS. 3 r d  Day.
DAY OF SERUM TREATMENT. 3 r d  Day.
CLINICAL NOTES. I n ju r y  to  f i n g e r  r e s u l t i n g  i n
c e l l u t i t i s  o f  h a n d  and  arm w i t h  
e r y s i p e l a s  o f  s h o u l d e r .  No 
r e p o n s e  a p p a r e n t  t o  serum t h e r a p y :  
4 w eeks a c u te  i l l n e s s .
LESION. C e l l u t i t i s  o f  han d  and  arm .
E r y s i p e l a s  o f  s h o u l d e r .
TOXAEMIA. P e r s i s t e n t  h e ad a ch e  and  v o m i t in g :
d ry  f u r r e d  to n g u e ,  slow s o f t  p u l s e ,  
c y a n o s i s ,  d e l i r i u m  a t  n i g h t s .  No 
a p p a r e n t  im provem ent a f t e r  serum  
t h e r a p y .
COMPLICATIONS. A bscess  f o r m a t io n  o f  c e l l u l a r  t i s s u e s
o f  arm r e q u i r i n g  m u l t i p l e  i n c i s i o n s  
R e c u r re n c e  o f  e r y s i p e l a s  i n  3 r d  
w eek .
RESULT. U n s a t i s f a c t o r y  from  th e  p o i n t  o f  view
o f  serum t h e r a p y .
REMARKS Case o f  C e l l u t i t i s  o f  h a n d  and arm 
w i t h  e r y s i p e l a s  o f  u p p e r  arm an d  
s h o u l d e r /
iO
s h o u ld e r  t r e a t e d  by P o l y v a l e n t  
A n t i s t r e p t o c o c c a l  serum 
i n t r a v e n o u s l y  (40 c . c . )  no 
b e n e f i c i a l  r e s u l t s .
81
Cases No* 3 ,  4 and  5 a r e  r e c o r d s  o f  e r y s i p e l a s  
t r e a t e d  by a s o - c a l l e d  s p e c i f i c  e r y s i p e l a s  s t r e p t o ­
coccus a n t i t o x i n *
T hese  r e c o r d s  o re  q u i t e  t y p i c a l  o f  th e  r e s u l t s  
o b ta in e d  by th e  f r e q u e n t  u s e  o f  t h i s  serum  d u r in g  
th e  i n v e s t i g a t i o n *  The r e s u l t s  w ere  v e ry  d i s a p p o i n t ­
i n g ,  and  t h e r e  was no e v id e n c e  a t  a l l  t o  i n d i c a t e  t h a t  
t h e  serum  was p o s s e s s e d  o f  an y  s p e c i f i c  a n t i t o x i n *
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r e s u l t .
3
H.G.
42 y e a r s .
I d i o p a t h i c .
A c u te ly  i l l :  l a u c i a l  c o n g e s t io n ;
i r r e g u l a r  p y r e x i a  i o r  3 d ays  
a f t e r  serum .
B i l a t e r a l  f a c i a l .
H eadache s e v e r e :  to n g u e  f u r r e d  and
d r y .  T oxaem ia  p r e s e n t  f o r  6 d a y s .
D ouble  O to r rh o e a .
E r y s i p e l a s  A n t i t o x i n .  20 c . c .  
I n t r a v e n o u s l y .
R a th e r  u n s a t i s f a c t o r y :  I r r e g u l a r
p y r e x i a  f o r  7 d ay s  w i th  c o n t in u a n c e  
o f  to x a e m ia  a n d -s p r e a d  o f  l e s i o n .
hemahxs. Ho a p p a re n t  s p e c i f i c  r e a c t i o n  from  
















































40 Y e a rs
I d i o p a t h i c  (R e c u r re n t )
8
A c u te ly  i l l  4 t h  d a y .  T . 102 . P .  128 
R .  2 4 .  a f t e r  serum th e r a p y  i r r e g u l a r  
p y r e x i a  u n t i l  th e  2 3 r d .  d a y .
B i l a t e r a l  f a c i a l  e r y s i p l a s  i n c lu d in g  
no se  and  f o r e h e a d .
W ell  m arked  by s e v e r e  h e a d a c h e ,  f u r r e d  
d ry  t o n g u e ,  m e n ta l  c o n f u s io n ,  low 
t e n s i o n  p u ls e
M u l t i p l e  a b s c e s s  f o r m a t io n  o f  s c a l p ,  
c h e s t  w a l l ,  and  c e r v i c a l  g l a n d s .  
R e c u r re n c e  5 th  w eek .
E r y s i p e l a s  A n t i t o x i n  20 c . c .  i n t r a v e n o u s  
l y .
D e f i n i t e l y  u n s a t i s f a c t o r y .
I r r e g u l a r  p y r e x ia  f o r  23 days a f t e r  
serum w i th  tox aem ia  m a in ta in e d  f o r  
8 d a y s .  S p re a d  o f  l e s i o n  o v e r  
s c a l p ,  n e ck  and c h e s t  w a l l  f o l lo w e d  
by a b s c e s s  f o r m a t io n .
R e c u rre n c e  5 th  w eek .
No a p p a r e n t  s p e c i f i c  r e a c t i o n  from  
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56 y e a r s .
I d i o p a t h i c .
A c u te ly  i l l .  B e fo re  serum  T .1 0 3 ,
P . 112 , R .24  • I r r e g u l a r  p y r e x i a
a f t e r  serum f o r  4 d a y s .
T .P .R .  n o rm a l  on 9 th  day o f  i l l n e s s .
B i l a t e r a l  f a c i a l  e r y s i p e l a s :  s c a l p
a l s o  in v o lv e d .
W ell  m arked by h ead ach e  and  d e l i r i u m :  
f u r r e d  tongue  and  s o rd e s  l a s t i n g  3 
days a f t e r  serum  t h e r a p y .
S c a lp  a b s c e s s .
20 c . c .  E r y s i p e l a s  A n t i t o x i n  i n t r a v e n ­
o u s l y .
D e f i n i t e l y  u n s a t i s f a c t o r y .
No s p e c i f i c  r e a c t i o n  from  * i r y s ip e l a s  
A n t i t o x i n .
Cases N o s .  6 , 7 ,  2 1 ,  2 6 ,  41  and  68 a r e  r e c o r d e d  
i l l u s t r a t i n g  t y p i c a l  r e s u l t s  o f  serum th e r a p y  in  
e r y s i p e l a s  by th e  u s e  o f  S c a r l e t  F e v e r  S t r e p to c o c c u s  
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CASE NO. 6 .
NAME. C.D. (Male)
AGE. 33 y e a r s .
TYPE. Id lo  pa t h  i  c .
CLINICAL NOTES. F i r s t  a t t a c k  o f  a c u te  f a c i a l  b i l a t ­
e r a l  e r y s i p e l a s .  A c u te ly  i l l .  
T .1 0 4 .  P .1 2 0 .  R .2 8 .  B e fo re  serum . 
T. 974 .P .8 0 .  R .2 4 .  24 h o u r s  a f t e r
serum .
LESION. B i l a t e r a l  f a c i a l  e r y s i p e l a s  w i t h
oedema o f  e y e l i d s .
TOXAEMIA. Marked by h e a d a c h e ,  f u r r e d  d ry
to n g u e ,  r a p i d  low t e n s i o n  p u l s e .
COMPLICATIONS. N i l .
SERUM. S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co,)
30 c . c .  i n t r a m u s c u l a r l y .
RESULT. E x c e l l e n t :  Im m ediate  c r i s i s  w i t h
e l i m i n a t i o n  o f  to x ae m ia  and  su b ­
s id e n c e  o f  th e  l e s i o n :  u n i n t e r r u p ­
t e d  c o n v a ls c e n c e  •
REMARKS. The p a t i e n t ,  a  com m erc ia l  t r a v e l l e r ,
was a  s t r o n g l y  b u i l t  and  a p p a r e n t l y  
good l i v i n g  ty p e  and  a l th o u g h  v e ry  
i l l  and t o x i c  on ad m isso n  made a 
d ra m a t ic  r e c o v e r y  a f t e r  serum 
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CASE NO. 7 .
NAME. G .S .
AGE.
TYPE.
31 y e a r s .  
T r a u m a t ic .
DAY OF ILLNESS. 2nd  day
DAY OF SERUM TREATMENT. 4t h  day
CLINICAL NOTES. I n j u r y  to  n o se  -  a b r a s i o n  f o l lo w e d  
by a c u te  i l l n e s s .  B e fo re  serum
T.104. P . 120 R .3 6  
24 h o u r s  a f t e r  serum . T .9 7 .  P .8 0 .  R*26
LESION. B i l a t e r a l - f a c i a l  e r y s i p e l a s ,  nose  
and  f o r e h e a d  a l s o  i n v o lv e d .
TOXAEMIA W ell  m arked  by  h e a d a c h e ,  v o m i t in g ,  
d e l i r i u m ,  d ry  to n g u e  and  low 
t e n s i o n  p u l s e .
COMPLICATIONS. N i l .
RESULT. E x c e l l e n t*
REMARKS. D ram atic  c r i s i s  a f t e r  20 c . c .
S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co) 
i n t r a m u s c u l a r l y  fo l lo w e d  by  e l im ­
i n a t i o n  o f  to x a e m ia  in  24 h o u r s  
and s u b s id e n c e  o f  l e s i o n  w i t h i n  
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60 y e a r s .
I d i o p a t h i c *
A c u te ly  i l l  and  r a t h e r  t o x i c .
T .1024 . P . 120 . R .2 6 .  B e fo re  serum* 
T. 9 8 .  P . 9 6 .  R *24• 12 h o u rs
a f t e r  serum .
B i l a t e r a l  f a c i a l  e r y s i p e l a s  i n v o lv in g  
a l s o  th e  fo re h e a d *
Headache v e ry  s e v e r e :  tong ue  d ry  and
v e ry  d i r t y .  S l i g h t l y  m e n ta l ly  
confoaed  • •
N i l .
S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.) 
2o c . c . i n t r a v e n o u  s l y •
E x c e l l e n t :  im m edia te  c r i s i s  w i th
e l i m i n a t i o n  o f  to x aem ia  and sub ­
s id e n c e  o f  l e s i o n  w i t h i n  36 h o u r s ,  
u n i n t e r r u p t e d  c o n v a le s c e n c e .



































5 ^ }  Temperature. {Centigrade)  ^
CASE NO 2 6 .
NAME. J . F .
AGE. 31 y e a r s .
TYPE. I d i o p a t h i c .
CLINICAL NOTES. Acute a c t i v e l y  s p r e a d in g  e r y s i p e l a s
o f  f a c e .
B e fo re  serum  T .1 0 6 .  P .  130 . R .2 2 .  
12 h o u r s  a f t e r  serum T. 98r7. P .  9 0 l .R .2 2 .
LESION. B i l a t e r a l  f a c i a l  e r y s i p e l a s  s p r e a d in g  
r a p i d l y :  subsidence  w i t h i n  24 h o u rs  o f  
serum t h e r a p y .
TOXAEMIA, Headache s e v e r e :  tong ue  v e ry  f u r r e d  and
d ry :  p u l s e  o f  low t e n s i o n .
COMPLICATIONS. N i l .
SERUM. S c a r l e t  F e v e r  A h t i t o x i n  (B.W. & Co.)
20 c . c .  i n t r a v e n o u s l y .
RESULT. E x c e l l e n t  r e s u l t .  Im m ediate  c r i s i s  and
p o s t  c r i t i c a l  d i s a p p e a r a n c e  o f  f e v e r ,  
to x ae m ia  and  o f  l e s i o n .
REMARKS. E x c e l l e n t  r e s u l t  o f  serum th e r a p y  in  
v e r y  i l l  p a t i e n t  w i t h  S c a r l e t  F e v e r  


























T e m p e ra tu re  ( F a h r e n h e it /
C oo
iT iT pyiN  I f& 
m E i i k m mn o
n
2^} T em pera tu re  ^  [C e n t ig r a d e }
9 0 .














P o s t  O p e r a t iv e .
I n c i s e d  wound o f  neck  f o l lo w e d  by 
a c u te  f a c i a l  e r y s i p e l a s  b i l a t e r a l  
l e  s io n  •
2nd day o f  i l l n e s s  T .1 0 4 .  P .  120 . R .2 6 .  
12 h o u rs  a f t e r  serum T .972 . P . 100 . R .2 6 .  
U n i n t e r r u p t e d  c o n v a le s c e n c e .
B i l a t e r a l  f a c i a l  e r y s i p e l a s :  s u b s id e d  
36 h o u r s  a f t e r  se rum .
W ell  m arked  by h e a d a c h e :  d r y ,  f u r r e d
to n g u e :  th e s e  t o x i c  s ig n s  and  symtoms 
were n o t  p r e s e n t  24 h o u rs  a f t e r  serum 
t h e r a p y •
N i l .
S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.) 
i n t r a v e n o u s l y .
E x c e l l e n t .
Im m ediate  c r i s i s  a f t e r  serum w i t h  e l im ­
i n a t i o n  o f  to x ae m ia  and  s u b s id e n c e  o f  
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Tem perature (C e n tig ra d e )  ^  ^CMD3
9 1 .
CASE NO. 6 8 .
NAME. J .H .
AGE. 50 y e a r s .
TYPE. I d i o p a t h i c  (P rim ary ) •
CLINICAL NOTES. A c u te ly  i l l :  T .1 0 4 .  P .1 0 0 .R .2 4 .
12 h o u r s  a f t e r  se rum . T. 9 7 .  P . 8 0 .  R .2 2 .
LESION. B i l a t e r a l  f a c i a l  e r y s i p e l a s  w hich  sub­
s id e d  24 h o u r s  l a t e r .
TOXAEMIA. Headache s e v e r e :  s l i g h t  d e l i r i u m :
tongue v e ry  d ry :  s o r d e s  p r e s e n t .
COMPLICATIONS. N i l .
SERUM. S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.)
30 c . c .  i n t r a v e n o u s l y .
RESULT. E x c e l l e n t .
REMARKS. Im m ediate c r i s i s  w i t h  e l i m i n a t i o n  o f  
to x aem ia  and  p o s t  c r i t i c a l  su b s id e n c e  
o f  l e s i o n .
C ases Bo. 2 2 ,  64 and 168 i l l u s t r a t e  serum th e r a p y  
in  e r y s i p e l a s  u s i n g  S c a r l e t  F e v e r  S t r e p to c o c c u s  
A n t i t o x i n  (P .D . & Co.)
T h is  ty p e  o f  serum was a p p a r e n t l y  l e s s  r e l i a b l e  
and  o f  l e s s  v a lu e  th a n  th e  o t h e r  (B.W. & Co.) 
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52 y e a r s .
I d i o p a t h i c .
M o d e ra te ly  i l l :  T .1028 . P . 9 6 .  R .2 4 .
( 3 r d  day)
24 h o u r s  a f t e r  se rum . T .1 0 1 .  P . 108 . R .2 6 .
( 4 t h  day)
48 h o u r s  a f t e r  serum T .1 0 1 .  P .8 8 . R .2 4 .
( 5 t h  day)
72 h o u r s  a f t e r  serum T .9 8 7 . P . 8 8 . R .2 4 .
(6 t h  day)
B i l a t e r a l  f a c i a l  e r y s i p e l a s  ( i n t e n s e . )
W ell  m arked by h ead a ch e  ( s e v e re )  and by dry  
to n g u e  and s o r d e s :  s t i l l  t o x i c  on 6 t h
d a y .
N i l .
S c a r l e t  F e v e r  A n t i t o x i n  (P .D . & Co.) 30 c . c .  
i n t r a m u s c u l a r l y  •
Not v e ry  s a t i s f a c t o r y .
REMARKS. I l l u s t r a t i n g  th e  l e s s e n e d  v a lu e  o f  t h e  
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38 y e a r s .
T ra u m a t ic .
A c u te ly  i l l .  S c a lp  wound s e p t i c .
B e fo re  serum T .1 0 5 .  P . 1 1 2 . R .2 6 .  
24 h o u rs  a f t e r  serum T .1022 , p . 108 . R .2 6 .  
I r r e g u l a r  p y r e x ia  u n t i l  1 2 th  day o f  i l l ­
n e s s  •
B i l a t e r a l  f a c i a l  and  s c a l p  e r y s i p e l a s  
n o t  i n f l u e n c e d  by serum t h e r a p y .
Headache s e v e r e :  to n g u e  v e ry  d ry  and
f u r r e d .  D e l ir iu m  m arked: to x aem ia
p r e s e n t  6 d a y s .
A b sc e sse s  o f  s c a l p  and  e y e l i d s .
30 c . c .  S c a r l e t  F e v e r  A n t i t o x i n  (P .D . & 
Co.) i n t r a v e n o u s l y .
D e f i n i t e l y  u n s a t i s f a c t o r y .
REMARKS. Case o f  a c u t e  e r y s i p e l a s  o f  f a c e  t r e a t e d  
by (P .D . & Co.) ty p e  o f  serum w i t h o u t  
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CASE HO. 168.
NAME* E .B .
AGE* 50 y e a r s .
TYPE* I d i o p a t h i c .  (P rim ary )
CLINICAL NOTES. A c u te ly  i l l :  T .1024 . P . 116 . R .2 6 .  b e f o r e
serum .
36  hours a f t e r  serum T. 9 7 . p .  92 . R .2 2 .
LESION. E x te n s iv e  l e s i o n  a f f e c t i n g  b o th  c h e e k s ,  n o se
and  f o r e h e a d :  s l i g h t  s p r e a d  a f t e r  serum
t h e r a p y .
TOXAEMIA. M oderate  on  a d m is s io n  on 2nd day  o f  i l l n e s s :
v e ry  much in c r e a s e d  by 3 r d  day  o f  i l l n e s s .
COMPLICATIONS. N i l .
SERUM. 30 c . c .  S c a r l e t  F ev e r  A n t i t o x i n  (P .D . & Co.)
i n t r a v e n o u s l y .
RESULT. R ig o r  f  h o u r  a f t e r  se ru m . C r i s i s  w i t h i n
36 h o u r s .  P o s t  c r i t i c a l  e l e v a t i o n  o f  
te m p e r a tu re  5 th  d a y .  L e s se n in g  o f  t o x ­
aem ia  and  p a r t i a l  s u b s id e n c e  o f  l e s i o n  
w i t h i n  48 h o u r s .
REMARKS. Case o f  a c u te  e r y s i p e l a s  o f  f a c e  w i th
to x aem ia  w h ich  re s p o n d e d  s a t i s f a c t o r i l y  
to  S c a r l e t  F e v e r  A n t i t o x i n  (P .D . & Co.) 
i n t r a v e n o u s ly  •




Two t a b l e s  have b e e n  p re p a re d  t o  sum m arise t h e  r e s u l t s  
o f  th e  c l i n i c a l  i n v e s t i g a t i o n s  on serum t h e r a p y  i n  e r y s i p e ­
l a s .  The t o t a l  number o f  c a s e s  t r e a t e d  was 178 which 
in c lu d e d  5 o a s e s  m oribund on a d m iss io n  t o  h o s p i t a l  and 
12 c a s e s  i n  w h ic h  t h e  e r y s i p e l a s  was e s s e n t i a l l y  an i n t e r ­
c u r r e n t  i n f e c t i o n  o r  su p e r im p o sed  on some o t h e r  p a t h o l o g i c a l  
c o n d i t i o n .
T a b le  A. shows t h e  Age G roups , t h e  number o f  c a s e s  and 
o f  d e a th s  i n  e a c h  g ro u p .
The m o r t a l i t y  f i g u r e  o f  10*1$ i s  t h u s  n o t c o r r e c t e d  i n  
any way b u t  i s  i n c l u s i v e  o f  a l l  d e a th s  o f  p a t i e n t s  r e c e i v i n g  
serum  t h e r a p y  ev en  when a d m i t te d  t o  h o s p i t a l  i n  a  m oribund  
c o n d i t i o n .
T a b le  B. h a s  b e e n  p r e p a r e d  t o  summarise t h e  r e s u l t s  o f  
t h e  serum th e r a p y  i n v e s t i g a t i o n  and  shows th e  a p p a re n t  o u t­
s t a n d in g  v a lu e  o f  S c a r l e t  F ev e r  A n t i t o x i n  (B.W. & C o .)  a s  a  
t h e r a p e u t i c  m ea su re .
I n  e s t i m a t i n g  t h e  b e n e f i c i a l  r e s u l t s  o b t a i n e d ,  due 
c o n s i d e r a t i o n  h a s  been  g i v e n  t o  t h e  e f f e c t s  o f  t h e  serum  on 
t h e  p y r e x i a ,  t n e  c i r c u l a t i o n ,  t h e  to x a e m ia  and  t h e  l e s i o n ;  
a l s o  on c o m p l i c a t io n s  and r e c u r r e n c e s  •
TABLE A.
RESULTS OP SERUM THERAPY IN ERYSIPELAS.
MORTALITY RATE 1 0 .1 ^
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OTHER FEATURES OF THE INVESTIGATION.
I .  BACTERIOLOGY.
IXiring th e  c l i n i c a l  i n v e s t i g a t i o n s  on serum th e r a p y  
some o f  t h e  b a c t e r i o l o g i c a l  a s p e c t s  w ere  s tu d ie d *  The 
work c o n s i s t e d  o f  th e  i s o l a t i o n  o f  th e  o rg an ism  o f  
e r y s i p e l a s ,  th e  p r e p a r a t i o n  o f  th e  e r y s i p e l a s  t o x i n  
and  th e  e x p e r im e n ta l  u s e  o f  th e  t o x i n  a s  a s k in  t e s t  o f  
s u s c e p t i b i l i t y  to  th e  d i s e a s e *  T h is  l a t t e r  t e s t  i s  
now known a s  th e  B irk h a u g  s k in  t e s t  i n  E r y s i p e l a s *
(A) THE ISOLATION OF THE CAUSAL ORGANISM OF ERYSIPELAS.
I t  was d e c id e d  to  make a t t e m p t s  to  o b t a i n  c u l t u r e s  
from  v a r i o u s  s o u r c e s  p o s s ib l y  c o n ta in i n g  th e  o rg an ism  
o f  E r y s i p e l a s *  These s o u r c e s  w ere  a s  f o l l o w s : -
(1)The s p r e a d in g  m arg in  o f  th e  e r y s i p e l a s  l e s i o n .
(2) The pus o f  a r e s i d u a l  e r y s i p e l a s  a b s c e s s .
( 3 ) The b lo o d  o f  p a t i e n t  w i t h  a c t i v e  e r y s i p e l a s .
(4) The desqu am ated  s k in  o f  t h e  e r y s i p e l a s  l e s i o n .
(5) The f l u i d  from  th e  v e s i c l e s  <r’ b u l l a e  o f  
e r y s i p e l a s *
loo.
gECHNIQUE AND METHODS.
A l l  t e c h n iq u e  and  m ethods w ere  a d a p te d  from
(1) M annual o f  B a c t e r io lo g y  (Muir & R i t c h i e )  •
(2) I n t r o d u c t i o n  to  P r a c t i c a l  B a c t e r io lo g y  (Mackie & 
McCartney) •
IXiring th e  b a c t e r i o l o g i c a l  i n v e s t i g a t i o n s  th e  
f o l lo w in g  m edia  w ere u s e d  and  w ere p r e p a r e d  f r e s h  a s  
r e q u i r e d .
(1) T r y p t i c  d i g e s t  b r o t h  (21  days)
(2) T r y p t i c  d i g e s t  A gar.
(3) H a r t l e y ’ s b r o t h .
(4) B lood  A gar.
The f l u i d  m edia  w ere  p r e p a r e d  f o r  a l l  p r im ary  
in o c u la t io n s  and  t h e  s o l i d  m ed ia  w ere  u s e d  f o r  
s u b c u l t u r e s .
PREPARATION OF MEDIA.
(1) T r y p t i c  D ig e s t  (21 days) •
(1) F r e s h  h o r s e  h e a r t ................. .. 1 lb  m ea t.
(2) Add l , 0 0 0 c . c .  w a t e r .
(3) R ender a l k a l i n e  w i th  4 $  Na 0 H.
(4) H ea t i n  Koch s t e r i l i s e r  a t  80°C. f o r  30 m in s .
(5) Add 20 c . c .  t r y p S i n .
( 6) Add 40 c . c .  c h lo ro fo rm .
(7) In c u b a te  a t  3 7 ° C f o r  10 d a y s .
( 8) Add 20 c . c .  t r y p s i n .
(9) A f t e r  1 0 th  day o f  i n c u b a t i o n ,  t e s t  r e a c t i o n  o f
medium d a i l y  w i t h  l i tm u s  p ap er  and  add  4$  NaO.H. 
a s  r e q u i r e d  to  keep  th e  m ix tu re  a l k a l i n e .
101 .
(2) D ig e s t  Agar (21 d a y s ) .
(1) T r y p t i c  d i g e s t  (21 days) . , ............................ . . .  800 c . c .
(2) A d d N a .C l .  0.25% ............................................................ 4 gm.
(3) Add Agar f i b r e  3#     24 gm.
(4) D is s o lv e  a t  115°C f o r  20 m in u te s  . $
(5) Render s l i g h t l y  a l k a l i n e  w h i l e  h o t  w ith "X
( 6) Cool medium to  40°C u n d e r  t a p  w a t e r .
(7) Add w h i t e  of an egg to  1 l i t r e  o f medium, to
c l a r i f y  same.
( 8) Pu t medium in  Koch s t e r i l i s e r  f o r  2 h o u r s .
(9) F i l t e r  in  s te a m e r  th ro u g h  C hard in  p a p e r .
(10) Tube t h e  medium and  s t e r i l i s e  same r e p e a t e d l y  a s  
r e q u i r e d .
(3) H a r t l e y ' s  B r o t h .
(1) H orse h e a r t  m u sc le  (m inced and  f a t  f r e e )  . . . . .  150 gm.
(2) Tap w a t e r  ...................................................................................  250 c . c .
(3) H eat i n  s te a m e r  t o  80°C.
(4) Add 0 .8 #  sodium c a rb o n a te  (Anhydrous) .................... 250 c . c .
(5) Cool down to  45°C .
( 6) Add c h lo ro fo rm   ...................   • • • • ...............  5 c . c .
(7) Add p a n c r e a t i c  e x t r a c t   ....................................................  5 c . c .
( 8) I n c u b a te  m ix tu re  a t  37°C f o r  6 h o u r s .
(9) Add 40 c . c .  n o rm a l  H.C1. a n d  h e a t  i n  t h e  s te a m e r  
f o r  30 m in u te s .
( 10) Cool medium and  f i l t e r .
(11) A d ju s t  r e a c t i o n  t o  pH. 7 . 6 .
( 12) S t e r i l i s e  f i n a l l y  i n  A u to c la v e .
N«B. In  s t e p  (7) th e  P a n c r e a t iv e  E x t r a c t  u s e d  was
p r e p a re d  from  f r e s h  p ig  p a n c r e a s .
(4) B lood  A g a r .
T h is  medium was p r e p a r e d  a c c o rd in g  to  m ethod  
d e s c r i b e d  by Muir & R i t c h i e ,  t h e  b lo o d  b e in g  o b t a i n e d  by
v e in  p u n c tu re  from  c o n v a le s c e n t  pneumonia p a t i e n t s .
CULTURAL METHODS
The p r im a ry  i n o c u l a t i o n s  w ere made i n t o  b o th  
T r y p t i c  d i g e s t  and  H a r t l e y ' s  b r o th  and  th e  c u l t u r e s  w ere  
in c u b a te d  a t  37°C . These were exam ined  a f t e r  24 h o u rs  
and a g a in  a f t e r  48 h o u rs  i n c u b a t i o n .
S u b c u l tu r e s  w ere  made on T r y p t i c  d i g e s t  Agar and on 
Blood Agar p l a t e s .
STAINING METHODS.
Smears w ere  p r e p a r e d  from  th e  c u l t u r e s  and  were 
s t a i n e d  by G ram 's  m ethod p r i o r  to  m i c r o s c o p i c a l  e x a m in a t io n .
SPECIAL TECHNICAL METHODS.
(1) In  t h e  c a se  o f  th e  e x p e r im e n ta l  i s o l a t i o n  o f  th e  
e r y s i p e l a s  o rg an ism  from  th e  a c u te  l e s i o n ,  th e  m ethod 
a d o p te d  was t h a t  o f  c l e a n s in g  th e  s k i n  w i th  p u re  e t h e r  and  
s c a r i f i c a t i o n  o f  th e  s p r e a d in g  m arg in  o f  th e  l e s i o n .  T h is  
s c a r i f i c a t i o n  w as p e rfo rm ed  w i th  a  s m a l l  s t e r i l i s e d  s c a r i ­
f i e r  a t  r i g h t  a n g le s  to  th e  s p r e a d in g  m arg in  t h u s  i n c l u d i n g  
th e  a r e a  o f  s k in  j u s t  beyond  th e  a c t u a l  m a rg in .  I n o c u l a ­
t i o n  o f  f l u i d  medium was t h e n  made from  th e  e x u d in g  b lo o d  
serum w hich  w ou ld  c o n ta in  some e x u d a t io n  from  t h e  r u p t u r e d  
ly m p h a t ic  c h a n n e ls  o f  th e  sk in *
(2) The i s o l a t i o n  o f  o rg an ism s  from  pus o f  r e s i d u a l  
a b s c e s s e s /
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a b s c e s s e s  o f  e r y s i p e l a s  w as c a r r i e d  o u t  a c c o rd in g  to  th e  
te c h n iq u e  o f  Muir & R i t c h i e .
(3) B lood c u l t u r e s  w ere  made from  p a t i e n t s  s u f f e r i n g  
from  a c u te  and a c t i v e  e r y s i p e l a s  l e s i o n s .  The te c h n iq u e  
em ployed was t h a t  o f  Muir & R i t c h i e .
(4) I s o l a t i o n  o f  o rg an ism s  from  th e  d esquam ated
s k in  o f  an  e r y s i p e l a s  l e s i o n  was p e rfo rm ed  by t r a n s f e r r i n g  
th e  s k i n  d i r e c t  t o  f l u i d  medium.
(5) The i n o c u l a t i o n  o f  f l u i d  medium w i th  f l u i d  from
th e  v e s i c l e s  and b u l l a e  o f  an  a c t i v e  e r y s i p e l a s  l e s i o n  
was p e rfo rm ed  by c l e a n s in g  th e  s u r f a c e  w i th  p u re  e th e r  
and t h e n  by c a r e f u l  p u n c tu re  by means o f  a  f i n e  s k in  
t e s t i n g  n e e d le  f i t t e d  to  a  s m a l l  hypoderm ic  s y r in g e  w hich  
h a d  b e e n  c a r e f u l l y  s t e r i l i s e d .
RESULTS.
A f t e r  some p r e l i m i n a r y  a t t e m p ts  accom panied  by many 
f a i l u r e s  th e  v a r i o u s  m ethods o f  t e c h n iq u e  w ere f i n a l l y  
p e r f e c t e d  and th e  i s o l a t i o n  o f  o rg an ism s  from  th e  v a r io u s  
s o u r c e s  was a t t e m p te d  from  tim e  to  t im e  a s  s u i t a b l e  c a s e s  
p r e s e n t e d  th e m s e lv e s  f o r  a d m is s io n  to  th e  w ards  o f  th e  
h o s p i t a l .
( 1) H a em o ly tic  s t r e p t o c o c c i  w ere  i s o l a t e d  from  th e  
s p r e a d in g  m arg in  o f  th e  e r y s i p e l a s  l e s i o n  i n  38  c a s e s  o f  
P r im ary  I d i o p a t h i c  o r  T ra u m a tic  e r y s i p e l a s .  The r e s u l t ­
i n g /
r e s u l t i n g  g ro w th  i n  2 o t h e r  c a s e s  was s ta p h y lo c o c c u s  a u re u s  
w h i le  10 o a s e s  o f  R e c u r re n t  E a c i a l  E r y s i p e l a s  e x h i b i t e d  no 
g ro w th  a f t e r  72 h o u rs  i n c u b a t i o n  o f  c u l t u r e s .
(2) I n  tw en ty  c a s e s  t h e  pus from  r e s i d u a l  a b s c e s s  
fo r m a t io n  was exam ined ana  found t o  c o n t a i n  t h e  s t r e p t o c o ­
c c i .  On c u l t u r e ,  t h e  o rg a n ism s  were o b t a in e d  i n  p u re  
c u l t u r e ,  i n  18 c a se s ,  b u t  i n  2 c a s e s  t h e  p r e d o m in a t in g  
o rg an ism  p ro ved  t o  be s ta p h y lo c o c c u s  a u re u s ,  a l th o u g h  a few 
o o l o n i e s  o f  s t r e p t o o o c o i  were o b se rv e d  on s u b c u l t u r e  b u t  
d ie d  out r a p i d l y .
(3 ) B lood c u l t u r e s  were made by v e i n  p u n c tu re  from  
12 p a t i e n t s  s u f f e r i n g  from  e r y s i p e l a s :  p ro lo n g e d  in o u b a t io n  
r e s u l t e d  i n  10 n e g a t iv e  r e s u l t s  w h i le  2 c u l t u r e s  were
found  t o  be c o n ta m in a te d .
(4 )  A l l  a t t e m p t s  t o  i s o l a t e  o rg an ism s  o f  t h e  s t r e p t o ­
c o c c a l  g ro u p  from  squama p roved  q u i t e  u n s u c c e s s f u l .
( 5) The i s o l a t i o n  o f  o rg an ism s  from  th e  f l u i d  o f  th e  
v e s i c l e s  o r  b u l l a e  i n  a c t i v e  e r y s i p e l a s  l e s i o n s  was 
a t t e m p te d  in  20 o a s e s  o f  f a c i a l  o r  c o r p o r a l  e r y s i p e l a s .  
H aem oly tio  s t r e p t o c o c c i  were o b t a in e d  i n  c u l t u r e  only  on
3 o c c a s io n s .
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B. PREPARATION OF TOXIN.
The p r e p a r a t i o n  o f  e r y s i p e l a s  s t r e p t o c o c c a l  to x in  
was u n d e r t a k e n  f o r  th e  su b s e q u e n t  e x p e r im e n ta l  s k in  
t e s t s .
T h is  was done by i s o l a t i n g  th e  o rg an ism  in  pure  
c u l t u r e  from  th e  spread ing  m arg in  o f  th e  l e s i o n  e x h i b i t e d  
by a young male a d u l t  w i th  a c u te  f a c i a l  i d i o p a t h i c  
e r y s i p e l a s .  The p r im ary  i n o c u l a t i o n  was made i n  
H a r t l e y * s  b r o th  and  r e s u l t e d  i n  a p u re  grow th o f  s h o r t  
c h a in e d  c o c c i  w h ich  on s u b c u l tu r e  on b lo o d  a g a r  p l a t e s  
e x h i b i t e d  w e l l  m arked h a e m o ly t ic  r e a c t i o n .
T h is  o rg an ism  proved  to  be h i g h l y  v i r u l e n t  f o r  m ice 
w hich  a r e  a c c e p te d  a s  somewhat i n s u s c e p t i b l e  t o  th e  
s t r e p t o c o c c i ;  t h e  i n t r a p e r i t o n e a l  i n j e c t i o n  o f  1 c . c .  o f  
th e  p r im a ry  f l u i d  c u l t u r e  a f t e r  24 h o u r s  i n c u b a t i o n  a t  
37°C r e s u l t e d  in  th e  d e a th  o f  a w h i te  mouse (No. 11) .
A f t e r  48  h o u r s  i n c u b a t io n  a t  37° C th e  c u l t u r e  was t e s t e d  
a g a in ;  a  s e r i e s  o f  5 mice were each  g iv e n  by i n t r a p e r i ­
t o n e a l  i n j e c t i o n  1 c . c .  o f  th e  48 h o u r s  o l d  s t r e p t o c o c c a l  
c u l t u r e  w h i le  a  c o n t r o l  s e r i e s  o f  5 m ice each  w ere  
i n j e c t e d  i n t r a p e r i t o n e a l l y  w i th  1 c . c .  o f  s t e r i l e  H a r t le y *  
b r o t h .
The c o n t r o l  s e r i e s  re m a in e d  h e a l t h y  w h i l e  th e  mice 
d ie d  a s  f o l l o w s : -
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Mouse No. 12
it ti 1 3
•  i / x c U  w l l u  J J a j  •
1 3 . D ied 4 th  Day.
14 . Died 2nd Day•
1 5 . D ied  5 th  Day.
5 .  D ied 6 th  Day.
Died 2nd D y.
it w
ft It
The cause  o f  d e a th  o f  Mouse No. 1 1 .  a p p e a re d  to  be 
from a r a p i d l y  f a t a l  s e p t ic a e m ia  w h i le  th e  v i r u l e n c e  o f  
th e  o rg an ism  was h i g h .
T h is  v i r u l e n c e  a p p e a re d  to  be l o s t  q u i t e  d e f i n i t e l y  
a f t e r  th e  o rg an ism  was in c u b a te d  in  f l u i d  c u l t u r e  medium 
f o r  th e  f u r t h e r  p e r i o d  o f  24 h o u r s  a s  th e  s e r i e s  o f  m ice 
s u b s e q u e n t ly  t e s t e d  d ie d  o f  a sub a c u te  s e p t ic a e m ia  
m a in ly  c h a r a c t e r i s e d  by p r o s t r a t i o n  and  d i a r r h o e a .
E x a m in a t io n  o f  th e  o rg an ism s  o f  th e  48 h o u r s  in c u b ­
a t i o n  p ro v ed  them c u l t u r a l l y  and m o r p h o lo g ic a l ly  to  be 
h a e m o ly t i c  s t r e p t o c o c c i  and  a  s u b c u l tu r e  was t h e n  made i n t o  
a f l a s k  o f  H a r t l e y ’ s b r o t h  (p .H  7 : 6 . )  T h is  f l a s k  was 
f r e q u e n t l y  a g i t a t e d  and th e  c u l t u r e  in c u b a te d  f o r  72 h o u r s .  
T h is  b r o t h  c u l t u r e  was s u b s e q u e n t ly  p a s s e d  th ro u g h  a 
B e r k e f e l d  f i l t e r  and  th e  t o x i n  f i l t r a t e  u s e d  f o r  s k in  
t e s t i n g  e x p e r im e n t s .
The t o x i n  was p r e s e r v e d  by th e  a d d i t i o n  o f  0 .5 ^  
ph en o l •
T h is  t o x i n  w i l l  be r e f e r r e d  t o  a s  Toxin (R) .
As a means o f  c o n t r o l  h a l f  th e  t o x i n  was b o i l e d  f o r  
1 h o u r  (T ox in  C) w h i le  a l l  th e  e x p e r im e n ts  w ere  r e p e a t e d  
u s i n g  E r y s i p e l a s .  S t r e p to c o c c u s  T ox in  p r e p a r e d  in  P a rk e  
D a v is /
Davis R e s e a r c h  L a b o r a to r y  i n  D e t r o i t ,  
be r e f e r r e d  to  a s  Toxin (D) .
- . : i
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This  t o x i n  w i l l
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(2) SKIM NESTING EXPEHBlEEUTS.
B irk h au g  h as  d e s c r i b e d  th e  s k i n  r e a c t i o n  t o  E r y s i ­
p e l a s  s t r e p t o c o c c a l  i n j e c t i o n  i n t r a d e r n a l l y  and h i s  name 
has been  a s s ig n e d  t o  t h e  e r y s i p e l a s  s u s c e p t i b i l i t y  t e s t  
s i m i l a r  t o  t h e  D ick  and S c h ic k  t e s t s  i n  S c a r l e t  P e v e r  
and D ip h th e r ia *
P r i o r  t o  p e r fo rm in g  t h e  B irk h au g  t e s t s  on p a t i e n t s  
t h e  p o te n c y  o f  T o x in  (R) and o f  T o x in  (D) was t e s t e d  by 
an im a l  i n o c u l a t i o n .  A s e r i e s  o f  mice were i n j e c t e d  
i n t r a p e r i t o n e a l l y  w i th  v a ry in g  q u a n t i t i e s  o f  T o x in  b u t  a l l  
m ice were u n a f f e c t e d .  (T a b le  D) .
110
RESULTS OF EXPERIMENTAL INOCULATION OF MICE FOR 















TOXIN RESULT AFTER 
7 DAYS.
2 1 . 0 .0 0 1  c . c . T oxin (D) A l i v e .
2 2 . 0 .0 0 5  c . c . T ox in (D) A l i v e .
2 3 . 0 .  05 c . c . T ox in (D) A l i v e .
2 4 . 0 •  5 c . c . T ox in (D) A l i v e .
2 5 . 5 .  c . c . T ox in (D) A l i v e •
2 6 . 0 .0 0 1  c . c . T ox in (H) A l i v e •
2 7 . 0 .005  c . c . T ox in (R) A l i v e •
2 8 . 0 .  05 c . c . T ox in (R) A l i v e •
2 9 . 0 • 5 c . c • T ox in (R) A l i v e .
3 0 . 5 .  c . c • T ox in (R) A l i v e •
Two r a b b i t s ,  how ever, r e c e i v i n g  0 .5  c . o .  o f  t o x i n  
i n t r a v e n o u s ly  b o th  s u f f e r e d  from  te m p o ra ry  m a la i s e  l a s t i n g  
two and t h r e e  d ays  r e s p e c t i v e l y  . (T ab le  E ) .
Aa a  c o n t r o l  a  t h i r d  r a b b i t  was i n j e c t e d  w i th  a  
s i m i l a r  amount o f  T o x in  (c)  and e x h i b i t e d  no abnorm al 
o f  d i s t u r b a n c e  a s  a  r e s u l t  o f  t h e  e x p e r im e n t .
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! 3 . 0 .5  c . c . T o x in  (D) M a la is e  (2 DAYS.)
| 4 .
i _____ ______
0 .5  c . c .  
_____________ ____
T o x in  (R) 
____________ _ __
M a la is e  (3 DAYS.)
! 5 * 0 .5  c . c . T o x in  (C)
_____________________
Ho e f f e c t .
U 5
The po tency  o f  t h e  t o x i n s  was n e x t  t e s t e d  by in tra ^ -  
derm al i n f e c t i o n  i n  a r a b b i t .  A young r a b b i t  was shaved  
over t h e  abdomen and f l a n k s  and th e  s k i n  c l e a n s e d  
th o ro u g h ly  w i th  e t h e r .  The i n f e c t i o n s  o f  b o th  T o x in  (D) 
and T o x in  (H) were made i n t r a d e r m a l l y , th e  am ounts b e in g
0 .0 1  c . c .  o f  eac h  t o x i n ,  w h i le  a  s i m i l a r  q u a n t i t y  o f  
t o x i n  (G) was i n f e c t e d  a s  a  c o n t r o l .  B o th  T o x in  (R) and 
T o x in  (D) p ro d u ced  i n  24 h o u rs  a  f a i n t  b u t  q u i t e  d e f i n i t e  
c i r c u l a r  a r e a  o f  e ry th e m a  m e a su r in g  abou t 1 cm. i n  d iam e te r*  
A f t e r  48 h o u rs  t h e s e  s k i n  r e a c t i o n s  were more c l e a r l y  
d e f in e d  and fa d e d  t h e r e a f t e r  l e a v i n g  no o b s e rv a b le  
s t a i n i n g  and no d e sq u a m a tio n .
The f i r s t  e x p e r im e n t  w i th  e r y s i p e l a s  p a t i e n t s  was 
c o n d u c te d  on a  s e r i e s  o f  50 o a s e s  o f  e r y s i p e l a s  o f  
v a r i o u s  t y p e s  and a t  d i f f e r e n t  s t a g e s  o f  t h e  i l l n e s s .
T hese  p a t i e n t s  were f i r s t  s u b j e c t e d  t o  t h e  Diok t e s t  and  
s u b s e q u e n t ly  t o  t h e  B irk h au g  t e s t ,  b o th  (R) and (D) 
t o x i n s  b e in g  u sed  and t h e  h e a te d  t o x i n s  u sed  a s  a c o n t r o l ,  
t o x i n  (C ).
T e c h n iq u e .
The s t r e p t o c o c c u s  e r y s i p e l a t i s  t o x i n s  were made up 
i n  d i l u t i o n s  o f  j gffo anci ti ie  auaoun^ i n f e c t e d  in  e a c h  c a s e  
was 0 .1  c . c .  T h i s  amount was i n f e c t e d  i n t r a d e r m a l l y  i n t o  
th e  s k in  o f  t h e  l e f t  fo re a rm  by means o f  a  f i n e  s k i n  t e s t ­
in g  n e e d le  and s y r i n g e .  The c o n t r o l  i n f e c t i o n  was made 
i n t o /
114
i n t o  t h e  s k i n  o f  t h e  r i g h t  fo re a rm  and th e  r e s u l t s  were 
examined 12 h o u r s ,  24 h o u r s ,  48 h o u rs  and 72 h o u r s  l a t e r .  
The r e a c t i o n  o f  an e ry th e m a to u s  a r e a  w i t h  a minimum d i a ­
m e te r  o f  one c e n t im e te r  was c o n s id e r e d  p o s i t i v e .  The 
f o l lo w in g  t a b l e  shows t h e  r e s u l t s  w i th  a f a i n t  p o s i t i v e  
r e a c t i o n  b e in g  i n d i c a t e d  by a p lu s  mark ( + ) d e f i n i t e  
p o s i t i v e  by doub le  p lu s  {++), a  marked p o s i t i v e  r e a c t i o n  
by t h r e e  p lu s  m arks (+++) and a  f a d in g  r e a c t i o n  by t h e  
p o s i t i v e  mark fo l lo w e d  by a minus s i g n  e . g .  (+ - ) .
A l l  D ick t e s t s  were p e rfo rm ed  by u s in g  D ick T o x in s  
s u p p l i e d  by B o rro u g h s ,  Wellcome & Go. and t h e  same t e c h ­
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W ith th e  same t o x i n s  th e  B irk h au g  t e s t  was 
p e rfo rm ed  on a number o f  male pneumonia p a t i e n t s  
i n c l u d i n g  7 b o y s ;  some o f  th e  c a s e s  w ere  i l l ,  
some w ere c o n v a le s c e n t*
RESULTS OF BIRKHAUG TEST AND DICK TESTS 



















A s e r i e s  o f  c a s e s  o f  S c a r l e t  F ev e r  a t  d i f f e r e n t  
s t a g e s  o f  th e  i l l n e s s  w ere  t r e a t e d  w i th  th e  same 
e r y s i p e l a s  T ox in  u s i n g  Toxin (R) and  i n  a l l  c a se s  th e  
B irk h au g  T e s t  p ro v e d  p o s i t i v e .
RESULTS OF BIRKHAUG TEST AND DICK TESTS IN 






BIRKHAUG TEST. DICK RESULT.
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SKIN TESTS IN ERYSIPELAS USING TOXIN AND ANTITOXIN
 ...........  i'" * ’ “ ~   - -
MIXTURES*
A s e r i e s  o f  s k in  t e s t s  was s u b s e q u e n t ly  p e rfo rm ed  
on e r y s i p e l a s  p a t i e n t s  a t  a l l  s t a g e s  o f  th e  i l l n e s s  
u s i n g  m ix t u r e s  o f  (1) E r y s i p e l a s  S t r e p to c o c c u s  T oxin  (D) 
and  C o n c e n t r a te d  S c a r l e t  F e v e r  A n t i t o x i n  (P .D . & Co.)
(2) E r y s i p e l a s  S t r e p to c o c c u s  T oxin  (D)
and
C o n c e n t r a te d  S c a r l e t  F e v e r  A n t i t o x i n  (B.W. & Co.)
(3) E r y s i p e l a s  S t r e p to c o c c u s  T ox in  (D)
and
C o n c e n t r a te d  E r y s i p e l a s  A n t i t o x i n  (P .D . & CO.)
(4) E r y s i p e l a s  S t r e p to c o c c u s  T o x in  (D)
and
C o n v a le sc e n t  E r y s i p e l a s  Serum.
TECHNIQUE.
The m ix tu re  o f  T oxin  (D) lOoO and e q u a l  q u a n t i t i e s  
o f  th e  v a r i o u s  s e r a  w ere  p r e p a r e d  i n  s t e r i l e  am poules 
j u s t  im m e d ia te ly  b e f o r e  u s e .  The t h r e e  ty p e s  o f  a n t i ­
t o x i n  a re  th o s e  p r e p a r e d  on a  com m ercial b a s i s  by w e l l  
known d rug  f i r m s .
The c o n v a l e s c e n t  e r y s i p e l a s  serum was p r e p a r e d  by 
v e in  p u n c tu re  o f  a  c a se  o f  e r y s i p e l a s  on th e  10t h  day o f  
t h e /
t h e  i l l n e s s ,  th e  p a t i e n t  b e in g  a male a d u l t  s u f f e r i n g  
from  p r im a ry  i d i o p a t h i c  e r y s i p e l a s .  The te c h n iq u e  o f  th e  
i n t r a d e r m a l  i n j e c t i o n s  was s i m i l a r  to  a l l  p r e c e d in g  s k in  
t e s t s
RESULTS OP SKIN TESTS IN ERYSIPELAS 
USING TOXIN ANTITOXIN: MIXTURES.
A* M ix tu re :  E r y s i p e l a s  Toxin and  S c a r l e t  F e v e r
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B. M ix tu re :  E r y s i p e l a s  Toxin and  S c a r l e t  F e v e r
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7 . + + (M oderate)  i
C. M ix tu re :  E r y s i p e l a s  T ox in  and E r y s i p e l a s
S t r e p to c o c c u s  A n t i t o x i n  ( p r e p a r e d  









RESULT OF SKIN TEST 
USING MIXTURE. 
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D. M ix tu re :  E r y s i p e l a s  Toxin  and  c o n v a le s c e n t
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INTgtfRSTATION OF RESULTS OF SKIN TESTING BXPMRIMENTS.
The few e x p e r im e n ts  p e rfo rm ed  a n d  t h e  few e a s e s  
t e s t e d  i n  each  e x p e r im e n t  a r e  p e rh a p s  i n a d e q u a te  on 
w h ich  t o  make d e f i n i t e  c o n c lu s io n s  b u t  I t  w o u ld  a p p e a r  
from  t h e  r e s u l t s  o b t a i n e d  i n  t h i s  i n v e s t i g a t i o n  t h a t  
t h e  t o x i n  o f  e r y s i p e l a s  s t r e p t o c o c c u s  c a u se s  a s k i n  
r e a c t i o n  i n  p a t i e n t s  who a r e  s u s c e p t i b l e  t o  e r y s i p e l a s  
q u i t e  s i m i l a r  t o  t h e  D ick r e a c t i o n  i n  S c a r l e t  F e v e r  an d  
S c h ick  r e a c t i o n  i n  D i p h t h e r i a .  I t  w ould a p p e a r  from 
t a b l e  F and  G t h a t  t h e  B irk h au g  t e s t  i s  s t r o n g l y  p o s i t i v e  
d u r in g  t h e  f i r s t  few days  o f  e r y s i p e l a s  and  becomes 
n e g a t i v e  from  t h e  9 th  t o  t h e  1 2 th  day  a f t e r  w h ic h  t h e  r e ­
a c t i o n  a g a i n  becomes p o s i t i v e *  From T ab le  H. i t  a p p e a r s  
t h a t  m ost a d u l t s  a r e  i n s u s c e p t l o l e  t o  e r y s i p e l a s  b u t  i t  i s  
i n t e r e s t i n g  t o  o b se rv e  t h e  p o s i t i v e  r e a c t i o n  i n  two b o y s  
s u s c e p t i b l e  t o  S c a r l e t  F e v e r  (D ick+ O  and  a l s o  two a d u l t s  
w i t h  a  p r e v io u s  h i s t o r y  o f  e r y s i p e l a s .  The r e s u l t s  shown 
i n  T a b le  K a p p e a r  t o  i n d i c a t e  t h e  s u s c e p t i b i l i t y  o f  
S c a r l e t  F e v e r  p a t i e n t s  t o  E r y s i p e l a s .
The r e s u l t s  o f  s k i n  t e s t s  i n  e r y s i p e l a s  p a t i e n t s  u s i n g  
t o x i n  a n t i t o x i n  m ix tu r e s  i s  i n t e r e s t i n g  from  t h e  t h e r a p e u t i c  
p o i n t  o f  view a s  a d d i t i o n a l  e v id e n c e  t o  t h e  c l i n i c a l  
i n v e s t i g a t i o n s  on  serum t h e r a p y .
I t  i s  somewhat u n e x p e c te d  t o  f i n d  t h a t  t h e  su p p o sed  
s p e c i f i c  e r y s i p e l a s  s t r e p to c o c c u s  a n t i t o x i n  w i l l  n o t
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n o t  (T a b le  N) n e u t r a l i s e  a n  e r y s i p e l a s  t o x i n  a s  shown 
by  s k i n  r e a c t i o n s .
T here  i s  some e v id e n c e  t o  show t h a t  t h e  S c a r l e t  
F e v e r  A n t i t o x i n  does n o t  n e u t r a l i s e  th e  e r y s i p e l a s  
t o x i n  a l th o u g h  t h e  A n t i t o x i n  (B.w. & Co. ) a p p e a r s  t o  
h a v e  (See T a b le  W .) some n e u t r a l i s i n g  pow er.
The c o n v a le s c e n t  serum how ever i s  t h e  m ost p o t e n t  
serum  a v a i l a b l e  a s  e v id e n c e d  by  t h e  r e s u l t s  o f  s k in  
t e s t s #  (See  T ab le  0)
I I I #  TRANSMISSION OF ERYSIPELAS Tp ANIMALS.
D uring  t h e  s t u d i e s  o f  t h e  b a c t e r i o l o g y  o f  e r y s i p e l a s  
i t  was d e c id e d  t o  en deavo u r  t o  t r a n s m i t  t o  a n im a ls  t h e  
e r y s i p e l a t o u s  s k i n  I n f e c t i o n  from  a n  a c t i v e  l e s i o n  i n  
m an.
The s t r a i n  o f  v i r u l e n t  s t r e p t o c o c c i  from  w hich  T ox in  
(R) was p r e p a r e d  was u s e d  a s  t h e  i n f e c t i n g  a g e n t  a n d  t h r e e  
r a b b i t s  w ere  u s e d .  The a n im a ls  w e re  sh av ed  and  t h e  s k i n  
o v e r  t h e  f l a n k s  c le a n e d  t h o r o u g h ly .  From a  s u b c u l t u r e  on 
B lood  Agar a  f i n e  s t r e p t o c o c c a l  s u s p e n s io n  was p r e p a r e d  
w i t h  s t e r i l e  s a l i n e  ( 0 . 9 $ ) .  T h ree  i n t r a d e r m a l  i n j e c t i o n s  
w e re  made i n t o  t h e  f l a n k  o f  each  r a b b i t ,  t h e  d o se s  b e in g
0 .0 0 1  c . c . ,  0 .01  c . c . # 0 . 1 .  c . c . ,  r e s p e c t i v e l y .  I n t o  t h e  
o p p o s i t e  f l a n k s  was i n j e c t e d  s t e r i l e  s a l i n e  i n t r a d e r m a l l y  i n  
s i m i l a r  a m o u n ts .
The r e s u l t s  o f  t h e s e  e x p e r im e n ts  a r e  r e a s o n a b l y  
i n t e r e s t i n g /
i n t e r e s t i n g .  124 .
R a b b i t  No. 1 .  was u n f o r t u n a t e l y  n o t  p r o p e r l y  c o n t r o l l e d  
d u r in g  th e  s k i n  . i n j e c t i o n  and  i t  a p p e a re d  r a t h e r  d o u b t­
f u l  a s  t o  t h e  a c t u a l  i n j e c t i o n  b e in g  i n t r a d e r m a l .
T h is  r a b b i t  showed t h r e e  r e d  a r e a s  o f  in f la m m a tio n  24 
h o u r s  l a t e r  w h ich  r a p i d l y  became t h e  s i z e  o f  s ix p e n n y  
p ie c e s  an d  became c o a l e s c e n t  i n  48 h o u r s .  T h is  was 
accom pan ied  by m a l a i s e  and  l a t t e r l y  a  phlegmonous c o n d i t i o n  
became a p p a r e n t  b u t  quietened down i n  a b o u t  6 days  t im e  
l e a v in g  o n ly  a s m a l l  s c a r .
R a b b i t  N o .2 however d e v e lo p e d  t h r e e  t y p i c a l  e r y s i p e l ­
a to u s  a r e a s  m e a su r in g  1. cm. i n  d ia m e te r  a f t e r  24 h o u r s .
The l e s i o n  c au se d  by t h e  l a r g e s t  i n j e c t i o n  o f  i n f e c t i v e  
m a t e r i a l  however r a p i d l y  became v e ry  a c u t e  an d  a c t i v e l y  
s p r e a d  o v e r  t h e  f l a n k  to w a rd s  t h e  b a ck  an d  a c r o s s  t h e  
abdomen o f  t h e  r a b b i t .
In  48 h o u rs  t h e  two o t h e r  s m a l l  l e s i o n s  w e re  subm erged 
i n  t h e  g e n e r a l  e r y s i p e l a t o u s  l e s i o n  o f  t h e  abdom en. 2h e  
l e s i o n  was q u i t e  t y p i c a l  o f  o r d i n a r y  e r y s i p e l a s  a s  seen  in  
man, h a v in g  an  an g ry  r e d  a p p e a r a n c e ,  h o t  t o  t o u c h ,  and  
h a v in g  q u i t e  a n  a p p r e c i a b l e  r a i s e d  m a rg in  a t  t h e  s p r e a d in g  
e d g e .  T h is  l e s i o n  d id  n o t  a p p e a r  t o  cau se  much g e n e r a l  
c o n s t i t u t i o n a l  d i s t u r b a n c e  a f t e r  t h e  f i r s t  two d a y s  and  
began  to  s u b s id e  on t h e  f i f t h  d a y .  Q u i t e  a p p r e c i a b l e  
d e sq u am a tio n  was o b s e rv e d  from  t h e  11t h .  day onw ards a n d  t h e  
h a i r /
125.
h a i r  o v e r  t h e  f l a n k s  to o k  o v e r  6 weeks t o  grow i n  a g a in *  
R a b b i t  No* 3 d e v e lo p e d  (a s  No* 1 .)  s m a l l  phlegmonous 
l e s i o n s  w h ich  r a p i d l y  c o a le s c e d *
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CONCLUSIONS.
She r e s u l t s  of t h e  i n v e s t i g a t i o n s  on serum  t h e r a p y  i n  
E r y s i p e l a s  a p p e a r  t o  j u s t i f y  t h e  f o l lo w in g  c o n c l u s i o n s 2-
(1) Serum th e r a p y  a s  an e f f i c a c i o u s  m easure  i n  E r y s i p e l a s  
i s  c o n f in e d  t o  t h e  use  o f  S c a r l e t  l e v e r  A h t i t o x i n  (B.W.& Go) 
w hich a d m in i s t e r e d  e a r l y  i n  th e  c o u r s e  of E r y s i p e l a s  h a s  a 
d e f i n i t e  e f f e c t  on th e  su b s e q u e n t  c o u rs e  of t h e  i l l n e s s .
(2 ) S c a r l e t  l e v e r  A n t i t o x i n  (B.W.& Co), when used as  a  
t h e r a p e u t i o  m easure  i n  E r y s i p e l a s  p r e c i p i t a t e s  an  e a r l y  
c r i s i s ,  w i t h i n  f rom  24-48  h o u rs  g e n e r a l l y ,  accom panied by 
a  d e f i n i t e  e l i m i n a t i o n  of to x a e m ia  and a v a r y i n g  d e g re e  o f  
s u b s id e n c e  of t h e  E r y s i p e l a t o u s  l e s i o n .
( 3 ) S he  t im e  o f  t h e  a d m i n i s t r a t i o n  o f  a n t i t o x i n  and t h e  
amount of serum  u sed , t o g e t h e r  w i t h  t h e  method o f  a d m in is ­
t r a t i o n  a r e  t h e  f a c t o r s  w hich  have a  d e f i n i t e  r e l a t i o n s h i p  
t o  t h e  im m ed ia te  and rem ote  e f f e c t s  of serum  th e r a p y  i n  
E r y s i p e l a s .
(4) S c a r l e t  l e v e r  A n t i t o x i n  (B.W.& C o), when u sed  a s  a 
t h e r a p e u t i c  a g e n t  i n  E r y s i p e l a s  m in im ise s  c o m p l i c a t i o n s  of 
t h e  d i s e a s e  bu t d o es  n o t  p re v e n t  r e l a p s e s  o r  r e c u r r e n c e s .
( 5) I’h e re  a p p e a r s  t o  be no s p e c i f i c  a n t i t o x i c  p r o p e r t i e s  
i n  t h e  s o - c a l l e d  E r y s i p e l a s  A n t i t o x i n  (P.D.& C o ) ,  w h i le  t h e  
v a lu e  o f  D i p h t h e r i a  A n t i t o x i n  and o f  P o ly v a le n t  a n t i s t r e p t o -  
o o c o a l  Serum a p p e a r s  t o  be n e g l i g i b l e .
I ro m /
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From t h e  c l i n i c a l  r e s u l t s  o f  th e  i n v e s t i g a t i o n s  t h e  
v a lu e  of S c a r l e t  F e v e r  A n t i t o x i n  (B.W.& Go) i s  v e r y  much 
g r e a t e r  t h a n  S c a r l e t  F e v e r  A n t i t o x i n  (P.D.A C o ).
( 6 ) The S t r e p to c o c c u s  of E r y s i p e l a s  can  r e a d i l y  be i s o ­
l a t e d  from  many c a s e s  of t h e  d i s e a s e  by t h e  u se  of s p e o i a l  
medium and t e c h n i c a l  m ethods.
( 7 ) The t o x i n  o f  t h e  S t r e p to c o c c u s  of E r y s i p e l a s  c a n  be 
used  by i n t r a d e r m a l  m ethods t o  i n d i c a t e  s u s c e p t i b i l i t y  of 
t h e  i n d i v i d u a l  t o  E r y s i p e l a s .
( 8 ) T r a n s m is s io n  o f  t h e  E r y s i p e l a s  l e s i o n  from  man t o  
r a b b i t s  i s  p o s s i b l e  b u t  r e q u i r e s  v e ry  c a r e f u l  t e c h n i c a l  
m ethods.
DISCUSSION.
p r i o r  t o  the< ep idem ic  o f  S c a r l e t  F e v e r  i n  1926, t h e  
serum  t r e a t m e n t  of S c a r l a t i n a l  p a t i e n t s  i n  t h e  C i ty  of 
Glasgow C o r p o ra t io n  F e v e r  H o s p i t a l  a t  K u c h i l l  was c o n f in e d  
t o  t h e  u se  o f  P o ly v a le n t  A n ti  s t r e p t o c o c c a l  Serum and t o  
C o n v a le sc e n t  Serum (Human).
The t r e a t m e n t  by p o ly v a l e n t  a n t i s t r e p t o c o c c i c  serum  was 
u sed  m ain ly  i n  o a s e s  of S c a r l a t i n a  A ng in osa  i n  an en deavo u r  
t o  n e u t r a l i s e  t h e  e f f e c t s  of t h e  s e p t i c  c o m p l i c a t i o n s  p r e s e n t  
i n  such c a s e s .
Human serum  removed from  c o n v a le s c e n t  p a t i e n t s  on t h e  
10t h  day of t h e  d i s e a s e  by v e i n  p u n c tu r e  of th e  arm had  been  
u sed  p r i o r  t o  1926 o c c a s i o n a l l y  b u t o n ly  p ro ved  r e a l l y  
e f f i c a c i o u s  when t h e  do sage  was l a r g e :  i n  co n seq u en ce  of t h e  
o b v io u s  d i f f i c u l t i e s  o f o b t a in in g  t h e  n e c e s s a r y  l a r g e  amount 
o f  c o n v a le s c e n t  serum  f o r  one t h e r a p e u t i c  d o se ,  t h e  a p p l i ­
c a t i o n  of human c o n v a le s c e n t  serum t h e r a p y  on a  l a r g e  s c a l e  
i s  d e f i n i t e l y  ou t o f  t h e  q u e s t io n .  ^ h e  i n v e s t i g a t i o n s ,  
t h e r e f o r e ,  i n  t h e  l i g h t  o f  p r e v io u s  serum  th e r a p y  i n  S c a r ­
l a t i n a ,  w ere  i n  t h e  n a tu r e  of c l i n i c a l  r e s e a r c h  on th e  v a lu e  
of S o a r l e t  F e v e r  S t r e p to c o c c u s  A n t i t o x i n  a s  a  t h e r a p e u t i o  
m easu re  i n  S c a r l a t i n a .
I t  i s  ad m itted , in  the f i r s t  p la c e ,  th a t  th e  r a t io n a le  
o f  th e  use ctf t h i s  serum p resu p p o ses s  d e f in i t e  a e t i o l o g io a l  
f a c t o r /
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f a c t o r ,  namely t h e  H aem o ly tic  S t r e p to c o c c u s  of S c a r l e t  S e v e r .  
The modern v iew s of t h e  Am erican S cho o l and of our own w o rk e rs  
i n  t h i s  c o u n try  a p p e a r  t o  su p p o r t  t h e  s t r e p t o c o c c a l  t h e o r y  
r a t h e r  t h a n  th e  I t a l i a n  th e o r y  of a  f i l t e r a b l e  v i r u s  a s  t h e  
c a u s a l  organism*
l i n a l l y ?th e  p u b l i c a t i o n  i n  19^9 of t h e  r e s u l t s  of f o u r  
y e a r s  of e x p e r im e n ta l  r e s e a r c h e s  on t h e  E t io lo g y  of S c a r l e t  
F e v e r  by Toyoda, I&oriwaki and F u t a g i  (1 ) i n  D a i re n ,  M anchuria  
h a s  b ro u g h t  t o  l i ^ i t  many h i t h e r t o  d o u b t f u l  and u n e x p la in e d  
p o i n t s  and d i f f i c u l t i e s  i n  t h e  s t r e p t o c o c c a l  th e o r y  and on 
c r i t i c a l  e x a m in a t io n  l e a v e s  l i t t l e  doub t now on t h e  s u b j e o t .
D u rin g  t h e  i n v e s t i g a t i o n s  t h e  r o u t i n e  t r e a tm e n t  o f  
p a t i e n t s  s u f f e r i n g  from  S c a r l e t  F e v e r  was n o t  a l t e r e d  i n  any 
way and t h e  t e c h n i c a l  d i f f i c u l t i e s  o f  serum  a d m i n i s t r a t i o n  
were n o t  g r e a t .  C r i t i c i s m  may be made on th e  s e l e c t i o n  o f  
o a s e s  a s  a l l  t h e  r e a l l y  i l l  p a t i e n t s  d u r in g  t h e  e p id e m ic  w ere 
t r e a t e d  by serum t h e r a p y  t h u s  l e a v in g  no c o n t r o l  o a s e s .
From t h e  s t a t i s t i c a l  p o i n t  o f  v iew  t h i s  s e l e o t i o n  of 
o a s e s  m ust n e o e s s a r i l y  be i l l - j u d g e d , b u t  t h e  e x t r a o r d i n a r y  
v a lu e  o f  t h e  new serum  beoame very  obv io us  from  t h e  e a r l y  
days  o f  t h e  i n v e s t i g a t i o n  and a s  a  r e s u l t  t h e  serum  was n o t  
w i th h e ld  from  p a t i e n t s  who w ere  s u f f i c i e n t l y  i l l  t o  i n d i c a t e  
t h a t  b e n e f i t  would a c c ru e  fro m  serum  t h e r a p y .  Thus th e  e a sy  
and o f t e n  a c c e p te d  method o f  o b t a i n i n g  c o n t r o l  o a s e s  was n o t
used  i n  t h i s  i n v e s t i g a t i o n .
However/
1 3 0 .
However, t h e  g e n e r a l  c o n t r o l  of t h e  i n v e s t i g a t i o n  was 
o b ta in e d  from  a  c l i n i c a l  co m parison  o f  t h e  l e n g t h s  o f  t h e  
p y r e x i a l  p e r io d s ,  of t h e  l e n g t h s  of t im e  of a c t u a l  d i s c o m f o r t  
o f  t h e  p a t i e n t s ,  of t h e  amounts of a c t u a l  n u r s in g  and o f  t h e  
r e s p o n s e  t o  su c h ,  o f s c a r l e t  f e v e r  p a t i e n t s ,  b e f o r e  and a f t e r
t h e  i n t r o d u c t i o n  of serum  t h e r a p y .
M oreover t h e  f a c t  t h a t  t h e  use  o f  t h e  serum  h a s  b e en
g e n e r a l l y  a d o p te d  i n  t h e  t r e a t m e n t  of S c a r l a t i n a  s i n c e  t h i s  
i n i t i a l  i n v e s t i g a t i o n  i s  of more im p o r ta n c e  from  th e  c l i n i c i a n ' s  
p o in t  o f  v iew  t h a n  th e  p r e s e n t a t i o n  of s t a t i s t i c s  o f  c o n t r o l  
c a s e s .
S in c e  1926 t h e  S c a r l e t  f e v e r  S t r e p to c o c c u s  A n t i t o x i n  h a s  
been c o n s i s t e n t l y  r e l i e d  on i n  many e p id e m ic s  and t h e  t y p e  o f  
serum  w hich  t e n d s  t o  be e s p e c i a l l y  u s e f u l  i n  Glasgow i s  made 
by one p a r t i c u l a r  f i r m  (P.D.& C o). I t  i s  p o s s i b l e  t h a t  t h e  
s t r a i n  of o rgan ism  used  by t h e  m a n u f a c tu r e r s  of t h e  serum  i n  
i t s  p r e p a r a t i o n  i s  th e  fu n d a m e n ta l  r e a s o n  f o r  t h i s  t e n d e n c y .
The u se  of t h e  serum  i s  a t t e n d e d  w i th  no un tow ard  r e s u l t s  u n d e r  
o rd in a r y  c i r c u m s ta n c e s  and ju d g in g  by t h e  r e s u l t s  o b ta in e d ,  
t h e  S c a r l e t  f e v e r  S t r e p to c o c c u s  A n t i t o x i n  i s  an  e x c e p t i o n a l l y  
f i n e  a d d i t i o n  t o  t h e  arm am entarium  o f  modern s c i e n c e .  
P a r t i c u l a r l y  i s  t h i s  so i f  one c o n s i d e r s  t h e  u se  o f  t h i s  serum  
a l s o  i n  f r y  s i  p e l  a s  w hich  m a n i f e s t s  many c l i n i c a l  s i g n s  
i n d i c a t i v e  of to x a e m ia  which i s  assum ed, and g e n e r a l l y  a c c e p te d  
t o /
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t o  be due t o  a h a e m o ly t ic  s t r e p t o c o c c u s  o f  t h e  same g roup  
a s  th e  s t r e p to c o c c u s  of S c a r l a t i n a .
The f a c t  t h a t  s u c c e s s  i n  t h e  l o c a l  t r e a t m e n t  of E r y s i ­
p e l a s  i s  se ldom  met w i th  can  be e s t im a te d ,  and e a s i l y  p ro ved  
by t r i a l ,  i f  one c o n s i d e r s  t h e  l e g i o n s  of much a d v e r t i s e d  and 
w e l l  recommended o in tm e n ts ,  l o t i o n s  and o t h e r  p r e p a r a t i o n s .
A p r e l im in a r y  i n v e s t i g a t i o n  on t o p i c a l  th e r a p y  i n  
E r y s i p e l a s  h a s  borne o u t  t h i s  f a c t  and t h e r e  i s  n o th in g  t o  be 
g a in e d  from V acc ine  th e r a p y  a c c o r d in g  t o  P e t e r s  ( 2 ) and a l s o  
r e c e n t l y  t o  Benson ( 3  ) .
The i n v e s t i g a t i o n  on t h e  v a lu e  of serum  th e r a p y  i n  
E r y s i p e l a s  assum es t h e  h a e m o ly t ia  s t r e p t o c o c c u s  t o  be t h e  
c a u s a l  o rg an ism , and t h e  s e v e r i t y  of t h e  i l l n e s s  due t o  t h e  
g e n e r a l  a b s o r p t i o n  o f  t o x i n s  p ro d u ced  i n  t h e  l o c a l  e r y s i p e l a t o u  
l e s i o n .
The r e s u l t s  o f  t h i s  i n v e s t i g a t i o n  a r e ,  i f  n o t  a l t o g e t h e r  
c o n v in c in g ,  n e v e r t h e l e s s  e x c e e d in g ly  i n t e r e s t i n g ,  and i n d i c a t e  
t h a t  a t  l e a s t  one serum i s  w orthy  of t r i a l  i n  t h e  t r e a t m e n t  o f  
E r y s i p e l a s .  The u se  of S c a r l e t  F e v e r  A n t i t o x i n  (B.W.& Co) i n  
E r y s i p e l a s  a p p e a r s  t o  have a  d e f i n i t e  a c t i o n  which i t  must be  
a d m i t te d  may be p a r t l y  a  n o n - s p e o i f i o  p r o t e i n  r e a c t i o n  and 
p a r t l y  an  a n t i t o x i c  e f f e c t .  The o t h e r  s e r a  u se d  d u r in g  t h e  
i n v e s t i g a t i o n ,  a c c o rd in g  t o  o b se rv ed  r e s u l t s ,  d id  n o t  a p p e a r  
t o  c a u s e  s p e o i f i c  r e a c t i o n s  o r  p r o t e i n  r e a c t i o n s .  The 
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wa b sen c e  o f  any s p e c i f i c  r e a c t i o n  from  t h e  u se  of s o - c a l l e d  
E r y s i p e l a s  S t r e p to c o c c u s  A n t i t o x i n  p r e p a r e d  by a  r e l i a b l e  
f i r m  of m a n u f a c tu r e r s  i s  r a t h e r  u n e x p e c te d  b u t  th e  r e s u l t s  
show t h a t  t h e r e  a p p e a r s  t o  be a g r e a t e r  p r o p o r t i o n  o f  a n t i ­
t o x i n  i n  S c a r l e t  F e v e r  A n t i t o x i n  (B.W.& Co) w hich i s  c a p a b le  
o f  n e u t r a l i s i n g  some a t  l e a s t  of t h e  E r y s i p e l a s  t o x i n s ,  t h a n  
i n  t h e  s o - c a l l e d  E r y s i p e l a s  S t r e p to c o c c u s  A n t i t o x i n .  T h is  
a p p e a r s  t o  be r e l a t i v e l y  so even  w i th  S c a r l e t  F e v e r  A n t i t o x i n  
(P.D.& Co) w h ich , a l th o u ^ a  h i g h ly  s a t i s f a c t o r y  when u sed  i n  
S o a r l a t i n a ,  y e t  i s  u n d o u b ted ly  a c c o rd in g  t o  t h e  o b se rv ed  
r e s u l t s  of t h e  i n v e s t i g a t i o n ,  of l e s s  v a lu e  t h a n  S c a r l e t  F e v e r
A n t i t o x i n  (B.W.& Co) i n  t h e  t r e a tm e n t  o f  E r y s i p e l a s .
Thus t h e  c l i n i c a l  f i n d i n g s  p o i n t  to  t h e  f a c t  t h a t  th e
most p o t e n t  a n t i t o x i n  o a p a b le  of n e u t r a l i s i n g  t o x i n s  from  t h e  
h a e m o ly t ic  g ro up  i s  t h e  a n t i t o x i n  p r e p a r e d  from  s c a r l e t  f e v e r  
s t r e p t o c o c c i .  T hese  c l i n i c a l  f i n d i n g s  b e a r  out th e  r e s u l t s  
o f  e x p e r im e n ta l  work on t h i s  s u b j e c t  by P a r i s h  and O k e l l  ( 4 ) 
and seem s u f f i c i e n t  t o  w a r r a n t  t h e  u se  of S c a r l e t  F e v e r  A n t i ­
t o x i n  (B.W.& Co) i n  t h e  t r e a t m e n t  o f  E r y s i p e l a s .
The i n c i d e n t a l  w o r t  on t h e  b a c t e r i o l o g y ,  s e r o lo g y ,  s k i n  
t e s t s  and an im al e x p e r im e n ta l  work i s  open t o  many c r i t i c i s m s  
and t h e  work i s  a d m i t t e d ly  r a t h e r  on t h e  s m a l l  s c a l e  to  be 
p a r t i c u l a r l y  c o n v in c in g .
A l l  t h e  work, how ever, was p e rfo rm e d  u n d e r  many c l i n i c a l
and/
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and l a b o r a to r y  d i f f i c u l t i e s  w i th o u t  t h e  h e lp  o f  any l a b o r a t o r y  
a t t e n d a n t ,  w hich  n e c e s s i t a t e d  much v a lu a b le  t im e  b e in g  s p e n t  
on c e r t a i n  m a t t e r s  r e a s o n a b ly  in c lu d e d  u n d e r  t h e  h e a d in g  of 
” spade work” . Under o th e r  c i r c u m s ta n c e s  t h i s  t im e  m ight have 
been  d ev o ted  t o  a more e x t e n s i v e  and u s e f u l  c o l l a t e r a l  in v e s ­
t i g a t i o n .
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2 . R u ed ig e r  .........................................................
3* S ch oner  ............................................................
4 . T u n n i c l i i ' f ....................................................
3* Bought o n   ...........................................
6 . C h a r r in  & R o g e rs  ......................................
7* M a rm o re k .........................................................
8 * A r o n s o n .......................................... ..
9 . Moser « . . . ......................................................
10 . R iv e r s  ............................................................
11 .  B irkhaug .........................................................
Die A e t io l o g i e  des 
E r y s i p e l s .
B e r l i n  1 8 8 3 .
Jo u r .A m er.M ed .A ssoc . 
x l v i ,  1 08 . 1906 .
Amer. J o u r .  Med. S c ie n c e .
1 3 4 , 7 2 8 . 1907.
J o u r . Amer.Med. A sso c . 
lx x v ,  1 3 3 9 . 1 9 2 0 .
T ra n s .C h ic a g o  P a th .S o c .
v i i i ,  2 4 . 1909 .
J 0 u r . I n f e c t . h i  se  a se  s • 
v i i ,  1 1 1 . 1 9 1 0 .
C o m p t.re n d .S o c .d e  B io l ,  
i i ,  124-126 & 224- 2 2 6 .
1 8 9 5 .
O o m p t.ren d -S o o .d e  BioX.
i l ,  1 2 3 . 1895-
B u l l .  Aoad.de a e d .  P a r i s .
4 8 , 181 . 1902 .
B e r l i n  Ic lin .Y /chnsoh r . 
x x x i i i ,  7 1 7 • 1896 .
x x x ix ,  9 7 9 - 1902 .
x l v i ,  6 8 8 . 1 9 0 9 .
W ie n .ic l in .  W c h n s c h r . 
xv , IO5 3 . 1 9 0 2 -
J o u r .E x p e r .H e d i o i n e .
41, 179- 1925-
B u l l .  Jo h n s  H o p t in s  Hosp.
37. 8 5 . 1925 .
P r o o .S o o .E x p e r .B io l .A  Med.
23 , 2 0 1 . I 9 2 5 .
d i s c u s s i o n .
1 . x u t a g i  ..................................
2 . P e t e r s  ........................................
3 . Denson ........................................
4 . P a r r i s h  O k e l l  ...................
137-
E x p e r .R e s e a rc h  on E t i o l .  
o f S c a r l e t  F e v e r .  
( I s o l a t i o n  H o s p i t a l  
D a ire n  1929)*
"Im m uno log ica l C o n s id e r ­
a t i o n s  i n  E r y s i p e l a s . ” 
M .D . th e s i s :  Glasgow 
U n iv e r s i ty  L i b r a r y ) .
L a n c e t ,  V o l . I I ,  1236, 
1930.
L a n c e t ,  V o l . I ,  7 4 6 , 1928
